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     Abstract 
The development and use of nanoscale biomaterials offer tremendous potential for 
future medical diagnosis and analysis. Various types of ceramic biomaterials 
(bioceramics) have been studied intensively for their potential in numerous biomedical 
applications. Among others, advances in the synthesis and characterisation of calcium 
phosphate (CaP) bioceramics have contributed much to this field. The growing demand 
for CaP bioceramics has stimulated research and production of materials suitable for 
biomedical applications such as implants. Among all the materials presented by the 
recent technology, only a very small fraction overcome biological and mechanical 
limitations rendering them suitable for use as a biomaterial. There is, therefore, a need 
to develop a clean synthesis methodology which could work under mild conditions to 
allow the synthesis of high purity, nanoscale bioceramic materials with a fine particle 
size and controlled surface area.   
The work in this thesis involves the use of a continuous plastic flow synthesis (CPFS) 
technology to synthesise various nano-scale bioceramics. Novel CPFS is a single step,  
continuous synthesis method for a stable, high purity phase-pure nanosized 
hydroxyapatite and other calcium phosphates at near ambient conditions (20°C to 
80°C). The phase-pure HA nanoparticles obtained from this method possess a 
substantially superior high-temperature stability (1200°C), with remarkably high 
surface area (up to 264 m2/g) and the smallest particle size (20 nm) ever reported. These 
high surface area nanoparticles have a great range of applications for use in replacement 
of living hard tissues such as bone and teeth, as bone graft substitutes, injectable, 
coatings on metallic implants, as fillers or additives in commercial products, such as 
toothpastes; materials for the controlled release of drugs, or other controlled release 
therapies; reinforcements in biomedical composites, and in bone and dental cements. 
Other calcium phosphate phases (Brushite, β-TCP, CDHA and biphasic HA / β-TCP) 
were also obtained by changing the Ca:P ratio and pH of the precursor solutions. A 
variety of ion substituted calcium phosphates (Mg, Sr, Ba, Zn, Fe, Mn, Si, CO3
2-), 
nanocomposite materials (Fe3O4-HA, TiO2-HA) and surface modified organopolymer 
nano-dental composites have also been developed successfully by using CPFS. 
Furthermore, the process has the potential to offer high purity calcium phosphates 
because the reactor components are made of plastic and therefore will not cause 
contamination of the product with metals. The in vitro biocompatibility analysis indicate 
that these high surface area nano-sized bioceramics have better performance than 
commercial products and may have the potential to be used for biomedical applications 
where bone regeneration / replacement is required. 
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Chapter 1  
Literature Review on Synthesis and Structural 
Characterization of Bioceramics 
There has been a striking advancement in the field of medicine in past few decades owing 
to life saving and sustaining drugs, materials and instruments. Among these inventions, 
bioceramics hold a very special prominence. Dr. L.L. Hench (Hench, 1998b) is of the 
view that vaccines, antibiotics, chemical treatment of water and similar factors have 
helped in the improvement of general health, but has increased the incidence of age-
related decline in human tissue (Hench and Wilson, 1993). 
 
Figure 1-1 Comparison of human survivability in year 1900 vs. 2000 with effects of 
age on the quality of connective tissue (Hench and Wilson, 1993, Hench, 1998a) 
Damaged and fractured body parts have always been problematic but the use of 
bioceramics in repair, reconstruction, and replacement of diseased body parts has proved 
vital. Bioceramics need to satisfy a few prerequisites such as good stability, 
biocompatibility, and biograability (Hench, 1998a). Bioceramic applications rose to 
prominence as their need in the medical field sparked great deal of research. 
Hydroxyapatite was researched  the most because of its usage in hard tissue replacement 
[(Hench, 1991, Oonishi et al., 1997, Elliott, 1994, Wu et al., 2004). The reliability of 
nanomaterials needs to be studied in detail to test their suitability for implementation in 
human beings, so it is pertinent to introduce the concept of hard tissue biominerallisation 
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before going over the advancement in the field of bioceramics.  
1.1 Introduction to Bones and Teeth 
Bone and teeth are naturally occurring biomaterials, which play vital roles in the human 
body and are termed as hard tissues. Despite wide ranging research, science is still far 
from producing biomaterials that can entirely substitute the naturally existing materials. 
Synthetic hydroxyapatite (HA) is a type of calcium phosphate that exhibit similarities to 
the mineralized mammalian tissues, such as bone and tooth. 
1.1.1 Structure, Function and Properties of Bone 
Bone is a highly structured porous matrix, composed of nanocrystalline and 
nonstoichiometric apatite, calcium deficient and carbonated, entangled with collagen 
fibers and blood vessel (Fratzl et al., 2004, Weiner and Wagner, 1998, Rho et al., 1998). 
Carbonate-hydroxyapatite, an inorganic nanocrystalline solid, is one of the important 
compounds of the bone and teeth of all vertebrates and comprises of 65 % of the total 
bone mass while collagen and water compose 20 and 9 wt% respectively.  Additionally, 
other organic materials, such as proteins, polysaccharides, and lipids are also present in 
small quantities. Collagen, which forms the organic portion of the bone matrix,, is in the 
form of small mineral platelets. While rest of the mass is formed by water and organic 
matter (Weiner and Wagner, 1998). Schematic diagram of this nanocomposite is shown 
in Figure 1-2.  
 
Figure 1-2 Arrangement of mineral particles in collagen fibrils (Fratzl et al., 2004) 
The carbonated apatite and organic matrix provide toughness, ability to withstand 
pressure and elasticity and resistance to stress, bending and fracture (Zaffe, 2005, Hench 
and Wilson, 1993). 
     Table 1-1 Composition of human bone (Hench and Wilson, 1993). 
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Constituent Bone (wt %) 
Calcium, Ca2+ 
Phosphorus, P 
Sodium, Na+ 
Potassium, K+ 
Magnesium, Mg2+ 
Carbonate, CO3
2- 
Fluoride, F- 
Chloride, Cl- 
24.5 
11.5 
0.7 
0.03 
0.55 
5.8 
0.02 
0.10 
Total inorganic 
Total organic 
Absorbed H2O 
65.0 
25.0 
9.7 
 
Bone has a hierarchical structure (Rho et al., 1998, Hench and Wilson, 1993) and is 
inconsistently dense. The organic-inorganic composite nature of the bone is crucial for 
different structural arrangements depending on different locations of the skeleton. From 
the macroscopic point of view, bone can be described into two terms, the outer layer of 
the bone, cortical or compact bone surrounds a less dense and porous, trabecular or 
cancellous bone (Figure1-4) which in turn is filled with a jelly tissue called the bone 
marrow as shown in Figure 1-3 (A). 
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Figure 1-3 Schematic diagram of the hierarchical structure of the bone (Pasteris et al., 
2008). 
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From the microscopic point of view, bone is made up of the basic building blocks called 
osteons as shown in Figure 1-3 (B, C). Each Osteon consists of lamellae that are formed 
by bundling fibers, which are built up by numerous collagen fibrils in an array, as 
indicated in Figure 1-3 (D, E). As represented in Figure 1-3 (G, H), small platelet-like 
apatite crystals with average dimensions of ~30 × 50 × 2 nm, are fitted in the holes, 
which are generated by the collagen fibrils with the c-axis parallel to the micorfibral long 
axis (Pasteris et al., 2008, Fratzl et al., 1991, Thompson and Hench, 1998). 
 
Figure 1-4 Schematic presentation of compact bone cross-section (Martin and Burr, 
1989). 
1.1.2 Structure, Function and Properties of Teeth 
Tooth is a bone like hard tissue. It consists of two parts, the crown and the root (Figure 
1-5). The root is covered by a layer of cementum, attached to the bone by periodontal 
membrane (a layer of fibrous connective tissue). Enamel and dentine form the main two 
parts of the crown. Enamel is the hardest substance in the body and 97 %  (w/w) of 
which consists of relatively large HA crystals (25 nm thick, 40-120 nm wide, and 160-
1000 nm long) and the remaining part organic substances and water (Waters, 1979). 
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Dentine is the mineralized tissue similar in composition to regular compact bone 
(Zioupos and Rogers, 2006, Suchanek and Yoshimura, 1998, Pasteris et al., 2008). 
 
                           Figure 1-5 Schematic diagram of a tooth (Jones, 2001) 
1.2 Types of Bioceramics 
Bioceramics are specifically formulated for reconstruction of damaged sections of the 
skeletal system due to their ability to form a stable interface with surrounding tissues 
and preform as efficiently as the natural tissue (Hench and Wilson, 1993). In general, 
bioceramics can be described according to the tissues response in three terms. These are 
bioinert, bioactive and bioresorbable. Table 1-2 summarized the implant-tissue response 
of each type of bioceramics. 
Bioceramics offer more advantages in terms of biocompatibility, therefore, their 
application as reinforcements in biomedical composites, polymeric matrices and 
osteoinductive coatings on metallic implants leads to materials with enhanced 
biocompatibility. A huge number of clinical applications of bioceramics in the human 
body (Hench and Wilson, 1993) are summarized in Figure 1-6 
 
 
             Table 1-2 Consequences of implant tissue interactions (Hench and Wilson, 1993) . 
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Implant-tissue 
reaction 
Consequence Example 
Bioinert 
Tissues form a non-adherent 
fibrous capsule around the 
implant 
Alumina (Al2O3), Zirconia 
(Zro2) and Carbon 
Bioactive 
Tissues form an interfacial bond 
with the implant 
Hydroxyapatite, Bioglass, 
A-W glass 
Bioresorable Tissues replace implant 
β-tricalcium phosphate, 
carbonated 
hydroxyapatite, calcium 
carbonate 
 
1.2.1 Bioinert Bioceramics 
The term bioinert refers to any material that has minimal interaction with its surrounding 
tissues post-implantation. This type of bioceramic shows little chemical reactivity, even 
after long term of exposure to the physiological environment, and therefore forms 
minimal interfacial bonds with the living tissues (Hench, 1993). Some examples of these 
bioceramics are stainless steel, zirconia, titanium, alumina and high molecular weight 
polyethylene. Zirconia and alumina have a great range of applications because of their 
remarkable corrosion resistance property, high hardness and low friction coefficient 
properties. Alumina has also been used in dental implantation and for orthopedic 
products recently (Hench, 1991, Heness and Ben-Nissan, 2004). 
1.2.2 Bioactive Bioceramics 
Bioactive ceramics are materials, which have the ability to interact with the surrounding 
tissue or bone upon placement within the human body (Heness and Ben-Nissan, 2004). 
Upon implantation, surface-reactive ceramics form strong bonds with the closest tissue. 
The surface reactive implants respond to local pH changes by releasing Ca2+, Na+ and 
K+ ions and lead to bonding of tissues at the interfaces. The most common ceramics used 
are hydroxyapatite (HA) 45S5 Bioglass (Cao and Hench, 1996). 
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        Figure 1-6 Clinical uses of bioceramics (Hench and Wilson, 1993). 
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1.2.3 Bioresorbable Bioceramics 
Bioresorbable refers to a material that has the ability to controllably degrade or dissolve 
once placed in the body and if required it can gradually be replaced by advancing tissue 
or bone. In other words, resorbable implants are designed to degrade gradually with 
time and be replaced with natural tissues (Hench and Wilson, 1993). The rate of 
degradation varies from one material to another. The advantage of this implant is that it 
will be replaced by normal, functional bone thus eliminating any long-term 
biocompatibility problems.  
However, during the remodeling process, the load bearing capacity of the implant could 
possibly be weakened and result in mechanical failure. Therefore, the resorption rates of 
the material should be matched with the repair rates of body tissues (Hench, 1993). 
Common examples are tricalcium phosphate, calcium carbonate, gypsum and polylactic-
polyglycolic acid copolymers.  
1.3 Examples of Bioceramics 
1.3.1 Alumina (Al2O3), Zirconia (ZrO2) and Titania (TiO2) 
Alumina is now being widely used in hip prostheses and dental implants. Alumina had 
already been used extensively as a bioceramic clinically (Thamaraiselvi and Rajeswari, 
2004). Alumina exhibits the characteristics, like biocompatibility, high strength, high 
wear resistance, and high corrosion that make it valuable to the bioceramic industry 
(Hench, 1998a, Katti, 2004, Hench, 1998b). 
Zirconia has great mechanical strength because of its transformation toughening 
behaviour. In its pure state, zirconia cannot be used in medical applications as the 
sintering process causes phase transformation, from tetragonal to monoclinic, that takes 
place during the cooling phase above room temperature (Manicone et al., 2007). This 
phase transformation, which is associated with a 3-4% volume expansion, engenders 
internal material stresses and cracks (Marti, 2000, Chevalier, 2006). 
Another bioinert bioceramic with excellent biocompatibility is titania (Fidancevska et 
al., 2007). Different nanostructured porous titania-based devices deliver antiepileptic 
drugs straight to the central nervous system through the temporal lobe of the human brain 
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(López et al., 2007). Titania is used in plasma-sprayed bioceramic coatings on Ti-6Al-
4V hip endoprostheses and other metallic implants. A bioactive interface is needed for a 
strong interaction between the implant and tissue. This is a problem found in bioinert 
bioceramics (Kurzweg et al., 1998, Hench, 2000). 
1.3.2 Bioactive Glasses and Glass-Ceramics 
Traditionally, bioactive glasses and glass-ceramics are manufactured with SiO2, Na2O, 
CaO and P2O5 as base components at high temperature, followed by melting, casting and 
sintering. Mostly, bioactive glasses, such as SiO2, are prepared with the 45S5 formula 
containing 45% SiO2 (Chen et al., 2006). Glasses with greater quantities of P2O5 do not 
bond with bone. The compositional dependence of bone and soft tissue bonding of 
bioactive glasses and glass ceramics has been shown in Figure 1-7.   
 
Figure 1-7 Compositional dependence of bone bonding and soft-tissue bonding of 
bioactive glasses and glass ceramics (Hench, 1991). 
As shown in Figure 1-7, glasses in region A are bioactive and bond with bone. In region 
B, Glasses are inert and result in the formation of a fibrous capsule at the implant-tissue 
interface. Region C shows glasses, which are resorbed within 10-30 days in tissue. IB 
lines represent the index of bioactivity. Depending on composition, therefore, certain 
glasses are resorbable. The region inside the dashed lines shows compositions which can 
even bond to soft tissue. The poor mechanical properties of monophase bioglasses inhibit 
clinical applications (Cao and Hench, 1996).  
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Bioactive glasses and glass ceramics have been used to replace small damaged bones of 
the middle ear for more than ten years now. 45S5 bioglass was used to preserve the 
jawbone of patients who had their teeth extracted prior to being fitted with dentures 
(Hench and Wilson, 1993).  
1.3.3 Calcium Phosphate Ceramics 
Calcium phosphates are most widely used bioceramics for implants mainly due to their 
resemblance to bone mineral in chemical composition and their ability to form strong 
chemical, physical and biological bonds with the tissue interface. They are well known 
for their use as bone graft substitutes, coatings on metallic implants, gene therapy, 
reinforcements in biomedical composites and bone, and as components in dental cements 
(Elliott, 1994, Hench, 1991).   
In 1920, calcium phosphate ceramics were used successfully for bone repair applications 
in clinical surgery (Albee, 1920). The serious efforts towards the development and 
commercialisation of calcium phosphates, particularly hydroxyapatite, were made in 
early 1980s. It is interesting to note that, the lower the Ca:P molar ratio, the more acidic 
and water soluble the calcium phosphate is, due to the solubility criteria and the kinetics 
of precipitate formation and transformation (Elliott, 1994). The dissolution and reactions 
of calcium phosphate bioceramics (in vivo and in vitro) were found to be largely 
dependent on the composition, nature of precursors and crystallinity (Aoki, 1991, Hench, 
1998b). Variations in pH alter the relative concentrations of the four polymorphs of 
orthophosphoric acid (Figure 1-8) and thus both the chemical composition and the 
amount of calcium orthophosphate that forms by direct precipitation (Lynn and Bonfield, 
2005).  
Hydroxyapatite (HA) and tricalcium phosphate (TCP) are amongst the most common 
calcium phosphates. Synthetic HA is bioactive and similar to biological apatite, the main 
mineral constituent of teeth and bone, because of its biocompatibility, bioactivity and 
low solubility in wet media. Such bioceramics have been employed as scaffold materials 
to encourage new bone formation for osteoinductive coatings on metal implants and as 
a bulking agent for bone fillers (Hench, 1991, Hench, 2000, Katti, 2004). In contrast, 
beta-tricalcium phosphate, β-TCP, [Ca3(PO4)2], another bioceramic, has a high 
dissolution rate compared to HA in vivo (Kannan et al., 2005, Famery et al., 1994). 
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The use of biphasic calcium phosphate ceramics composed of HA and β-TCP mixtures 
for bone grafts can assist rapid bone formation around the implant site compared to HA 
alone (Pan et al., 2003, Ginebra et al., 2004). Calcium deficient hydroxyapatite (CDHA) 
has also gained importance as a component in injectable bone cements; regulating 
particle properties is often used to affect cement setting behaviour (Hutchens et al., 
2006). In recent studies, brushite (CaHPO4.2H2O) bioceramic has been considered as a 
potential bone substitute material and raised great interest because of its high 
resorbability (Theiss et al., 2005, Bohner, 2000). An important characteristic of brushite 
is its use as a precursor for synthesizing HA (Ferreira et al., 2003). 
 
 
 
 
 Figure 1-8 pH variation of ionic concentration for phosphoric acids solutions (Lynn 
and Bonfield, 2005). 
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Table 1-3 Calcium orthophosphates and their major properties reproduced from Dorozhkin (Dorozhkin, 2009).
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1.4  Hydroxyapatite (HA) 
Hydroxyapatite [Ca10(PO4)6(OH)2] is the most widely used synthetic calcium 
phosphate (Figure 1-10) for implant fabrication as it is most similar material to the 
mineral component of bone and has the capability to promote bone regeneration. In 
recent years, it has attracted much attention because of its biocompatibility, bioactivity 
and low solubility in wet media (Hench, 2000, Cao and Hench, 1996, Oonishi, 1991) 
1.4.1 Structure of Hydroxyapatite 
Slightly non-stoichiometric HA has hexagonal symmetry (S.G P63/m) and lattice 
parameters that are a = 0.95 nm and c = 0.68 nm (Elliott, 1994), whilst stoichiometric 
HA is monoclinic with P21/b space group. The smallest building unit, known as the unit 
cell, contains a complete representation of HA hexagonal crystal (Sarig, 2004) as shown 
in Figure 1-9..  
 
 Figure 1-9 Hydroxyapatite structure viewed onto the (0001) surface (Ca = green, O = 
red, P = purple, H = white) (Narasaraju and Phebe, 1996) 
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Four calcium (Ca I) ions in the unit cell are generally labeled as columnar calcium as 
they form single atomic columns perpendicular to the basal plane. Six of the ten calcium 
ions (Ca II) in the unit cell form hexagonal channels along the c-direction of the 
structure. Each unit cell is based on four OH groups, available in each channel, leading 
to a 0.5 partial occupancy of each position as shown in Fig. 1-9. 
 
Figure 1-10 XRD pattern of stoichiometric HA powder 
1.4.2 Substitutions into Hydroxyapatite 
The biological and physiochemical properties of HA can be enhanced by ionic 
substitutions, some of which are usually present in natural bone apatite. Most natural 
apatites are non-stoichiometric because of the presence of minor constituents such as 
metal cations (Mg2+, Mn2+, Zn2+, Na+, Sr2+) or anions (HPO4
2− or CO3
2−). HA is capable 
of accommodating substitute ions within its lattice. Trace ions substituted in apatites 
can have a dramatic effect on crystal structure parameters, crystallinity, dissolution 
kinetics as well as influence the biological response in the final applications (Miao et 
al., 2005).  As a consequence, synthesis of substituted HA has drawn much attention, as 
substituted HA can show desirable properties and satisfy variety of needs in a wide 
range of applications (LeGeros, 1990, de Groot, 1983). 
1.4.2.1 Carbonate SubstitutionCarbonate Substitution 
The carbonate content in human bone is about 8 wt% (Rey et al., 1991)and it depends 
on the age of the individual (Burnell et al., 1980, Ito et al., 1997). Different levels of 
substitution can occur for  both the hydroxyl and the phosphate ions, giving rise to A-
type and B-type substitution, respectively. In 1963, Kuhl and Nebergall suggested the 
following formula for B-type carbonate-substituted HA (Murugan and Ramakrishna, 
2006, Chaudhry et al., 2013). 
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                                            Ca10-x+y(CO3)x(PO4)6-x(OH)2-x+2y 
B-type substitution is preferred for carbonate as it is found naturally in the bone of a 
variety of species, with the A/B type ratio in the range 0.7–0.9 (Li et al., 2012, Redey 
et al., 2000).  A higher value of the A/B ratio has been observed in older hard tissues.  
 
Figure 1-11 TEM micrographs of AB-type CO3
2- apatite with different bicarbonate 
concentration at 70 °C: (a) 10 mM, (b) 40 mM, (c) 160 mM, and (d) 320 mM (Barralet 
et al., 1998). 
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The synthesis of AB-type CO3
2- apatite samples were also investigated by Barralet and 
co-workers, who used different reagents, tri-ammonium orthophosphate, calcium 
nitrate 4-hydrate, and sodium bicarbonate by using a precipitation method. They 
observed that with increased bicarbonate concentration from 10 to 160 mM, the apatite 
crystallite size was slightly decreased, and the morphology of the apatite was changed 
from needle shape into more spheroidal particles (Barralet et al., 1998) as shown in 
Figure 1-11.  
1.4.2.2 Silicon Substitution 
Silicon-substituted HA (Si-HA) has been reported to promote rapid bone 
mineralization, however, it also leads to a smaller crystallite size and faster dissolution 
(Thian et al., 2006b, Porter et al., 2003). Many literature reports have shown that with 
incorporation of Si into HA did not induce direct changes in the crystallographic 
structure, as same XRD patterns were observed in the HA samples with different Si 
substitution, ranging from 0 to 1.5 wt% (Botelho et al., 2006). Silicon-substituted HA 
has been synthesized using wet-precipitation and batch hydrothermal techniques. For 
example, Gibson et al. produced phase pure Si-HA by an aqueous precipitation of a 
calcium containing solution and a phosphate containing solution at high pH by using Si 
acetate as the source of silicate ions (Gibson et al., 1999).  
There have also been many reports on the development of silicon- substituted HA 
coatings on metallic substrates for enhanced osseointegration. Silicon enters the HA 
lattice in the form of silicate ions which substitute phosphate ions. Silicon levels up to 
4 wt% in HA have been identified using a batch hydrothermal process (Patel et al., 
2002, Kim et al., 2003, Hing et al., 2006, Leventouri et al., 2003, Thian et al., 2006a, 
Thian et al., 2007).  
Tang and co-workers reported that Si-HA samples with Si substitution ranging from 0 
to 4 wt% were prepared by using Ca(NO3)2·4H2O, (NH4)3PO4, and Si(OCH2CH3)4 
(TEOS) via hydrothermal method. As observed in Figure 1-12, Tang and co-workers 
noticed that the mean crystallite size of apatite was decreased with the content of Tetra 
ethyl orthosilicate, while the numbers of the need-like apatite crystals were increased 
(Tang et al., 2005). 
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Figure 1-12 TEM micrographs of four Si-HA samples with different Si concentration: 
(a) HA, (b) HA with 0.8 wt% Si, (c) HA with 1.5 wt% Si, (d) HA with 4 wt% Si (Tang 
et al., 2005). 
1.4.2.3 Magnesium Substitution 
Magnesium (Mg2+) is a divalent cationic substitute for calcium (Ca2+) in the HA lattice. 
Such substitution often inhibits crystallization, increases solubility, and lowers the 
temperature at which conversion of HA into β-TCP occurs which possibly related to 
the smaller Mg cation with radius (0.65 Å) substituted larger cation of Ca (0.99 Å) in 
the HA structure (Suchanek et al., 2004b, Wu et al., 2005, Bertoni et al., 1998, 
Suchanek et al., 2004a, Chaudhry et al., 2008, Bigi et al., 1993). Yasukawa and co-
workers reported various effect of Mg on the crystallite size of apatite and prepared 
Mg-HA solid solutions with Mg/Ca molar ratio ranging from 0 to 0.5 by wet method, 
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using the reagents of Mg(NO3)2·6H2O, Ca(OH)2, and H3PO4. They observed that the 
crystallite size of apatite increased with increasing Mg/Ca ratio from 0 to 0.31 
(Yasukawa et al., 1996). When the ratio reached 0.38, amorphous morphology was 
observed as shown in Figure 1-13. 
 
Figure 1-13 TEM images of Mg-HA samples with different Mg content: (a) 0, (b) 
0.09 mol %, (c) 0.16, (d) 0. 23, (e) 0.31, (f) 0.38 (Yasukawa et al., 1996). 
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Fadeev and co-workers synthesized Mg substituted HA samples using wet 
precipitation methods with chemical formula Ca10-xMgx(PO4)6(OH)2, where NH4OH 
was used to adjusted pH of the solution. They also found that Mg exhibited 
destabilizing effect on the apatite structure, since the transition temperature from 
hydroxyapatite to whitlockite decreased with increasing Mg substitution from 1 to 10 
atom % (Fadeev et al., 2003). 
1.4.2.4 Strontium Substitution  
Strontium is present in the mineral phase of bone and connective tissue at levels of 
320-400 mg of strontium. Unlike the trace elements of Zn, and Mg, the synthesis of 
phase pure apatite can be achieved with the incorporation of Sr substitution in the 
whole range of compositions (Bigi et al., 2007). It was reported that the larger cation 
Sr2+ (1.18 Å) substituted in the HA structure for the smaller Ca2+ (1.00 Å) cation. Due 
to the size difference between these two cations, modification of the lattice parameters 
of HA were therefore expected (O’Donnell et al., 2008, Li et al., 2007). Clinically, 
strontium has been observed to confer beneficial effects on bone growth especially at 
the regions where high metabolic turn-over occurs (McEwan, 1997). In vitro, 
strontium increases the number of osteoblast cells followed by the reduction osteoclast 
cells, whereas strontium administration decreases bone resorption and stimulates bone 
formation (Canalis et al., 1996, Dahl et al., 2001, Grynpas et al., 1996).  
Bigi and co-workers reported variations in crystallite size with Sr substitution. They 
prepared a group of Sr-HA samples using Ca(NO3)2·4H2O, Sr(NO3)2, and 
(NH4)2HPO4 via a coprecipitation method. They observed that with increased Sr 
substitution from 0 to 100 %, a systematic changes of the crystallite size and 
crystallinity of the Sr-HA samples were evident in TEM images, as shown in figure 
18 (Bigi et al., 2007). 
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Figure 1-14 [a-d] TEM images of Sr-HA samples with different Sr concentration: (a) 
HA, (b) HA with 20 % Sr, (c) HA with 70 % Sr, (d) HA with 100 % Sr (Bigi et al., 
2007). 
As indicated by figure 1-14, that the HA sample contained 0% Sr substitution exhibited 
plate-like crystals, while with 20 % Sr substitution, ill-defined apatite shapes were 
observed in Figure 1-14 (b). It was observed that by increasing Sr substitution to 70 % 
or higher, the apatite crystallite size was increased. When the Sr substitution reached 
100 %, fully Sr substituted elongated apatite crystals were observed (Bigi et al., 2007).  
1.4.3 Surface Functionalization  
Surface properties of hydroxyapatite (HA) play an important role in its applications, 
as its surface is in direct contact with the body fluids once placed inside a body. Surface 
modified HA has gained much attention from researchers in recent years. Surface 
modified groups are commonly employed to avoid agglomeration of nanoparticles and 
give controlled particle growth. These functional groups make the surface more 
suitable to the host tissue in biomedical applications.  (Lu et al., 2007, Arcı́s et al., 
2002).  
Surface functionalization of HA by organic molecules or polymers provides an 
efficient way to control the surface properties of HA. There are two common methods 
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to modify the HA surface by organic molecules. The first approach is surface 
adsorption as many polymers and proteins can be formally adsorbed onto the surface 
of HA (Hlady and Füredi-Milhofer, 1979). Secondly, grafting of organic molecules 
through covalent bonding to the hydroxyl groups, which are available on the crystal 
surface of HA. These surface grafted nanoparticles including methyl methacrylate, 
vinylphosphonic acid, polyethylene, and polyurethane have great range of applications 
in the field of HA/polymer composites, column chromatography of protein, cell culture 
carrier and carriers of catalysts in chemical engineering(Schaad et al., 1994, Haque et 
al., 2007, Puvvada et al., 2010). 
              
 
Figure 1-15 Coupling agents used hydroxyapatite and other phosphate grafting: (a) 
methacrylic acid, (b) adipic acid, (c) vinylphosphonic acid, (d) citric acid. 
1.4.4 Nano-biocomposites  
Hydroxyapatite has been widely used as a bioactive filler component phase in  
nanocomposites, particularly in dental applications. Numerous HA-polymer based 
nano-biocomposites have been produced to enhance the mechanical and biological 
properties of bone. Chemical coupling of a polymer matrix with HA and creating 
reactive sites on the surface of inorganic filler particles can improve the interfacial 
bonding of a composite. (Arcı́s et al., 2002, Willems et al., 1992). Dental resin with 
HA particles as a filler component, is considered to be a potential restorative material 
for non-load bearing human tooth tissues. Dental composites are mainly based on an 
organic polymer matrix (BisGMA and TEGDMA) in Figure 1-16, coupling agents, 
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inorganic filler particles and initiators. Liang Chen and coworkers reported that 
impregnating a small fraction of HA (5-10 wt%) into BisGMA/TEGDMA dental 
resins can significantly enhance the biaxial flexural strength of the resulting composite 
(Saito et al., 1994, Chen et al., 2011). 
 
Figure 1-16 Bisphenol glycidyl methacrylate (BisGMA) and triethylene glycol 
dimethacrylate (TEGDMA).  
1.4.5 Synthesis of Hydroxyapatite  
Multiple techniques have been used for the preparation of HA including solid state 
synthesis (Güler et al., 2011), coprecipitation methods (Afshar et al., 2003), sol gel 
techniques (Hench and West, 1990), emulsion synthesis (Kimura, 2007) and batch 
hydrothermal synthesis (Manafi and Joughehdoust, 2009). More recently, the authors 
pioneered the continuous hydrothermal flow synthesis (CHFS) (Zhang et al., 2010, 
Chaudhry et al., 2008, Chaudhry et al., 2006) of bioceramics containing HA or its 
doped phases under supercritical conditions of high temperature and pressure. 
1.4.5.1 Solid-State Reactions 
The solid state route is the high temperature synthesis of hydroxyapatite using solid 
precursors of calcium and phosphate. Synthesis of hydroxyapatite using calcium 
nitrate and tri-sodium phosphate by heating in microwave oven was reported by Cao 
and co-workers (Cao et al., 2005). In this method, the stoichiometric ratio of solid 
calcium and phosphate precursors were mixed in a ball mill followed by a heat-
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treatment step under suitable temperature and pressure. A spherical morphology of 
synthesized HA particles were observed after a short heating time of 0.5 minutes which 
changed into nano-rods upon continuous heating for one minute as shown in Figure 1-
175. 
Mechanochemical methods are also considered as solid state routes wherein, 
mechanical mixing leads to chemical reactions. Chemical reactions occur due to 
favorable temperature and pressure. The time required to synthesize HA varies from a 
few hours to 60 hours. After initial mixing, powder mixture may require a heat 
treatment step to transform into phase pure HA. This heat treatment results in lower 
surface area hydroxyapatite as reported by Chen and coworkers had saw a reduction 
in surface area from 175 m2g-1 for as synthesized HA to 7.2 m2g-1 after heat treatment 
at 900 ◦C for one hour (Chen et al., 2004). Ion substituted hydroxyapatite powders 
have also been synthesized using similar methods (Getman et al., 2004).  
          
Figure 1-17 FE-SEM image of HA nanoparticles prepared by (a) microwave heating 
with 15 second intervals for 0.5 minutes (b) continuous microwave heating for 1 
minute (Cao et al., 2005).  
1.4.5.2 Co-precipitation Method 
Co-precipitation is one of the oldest methods used for the synthesis of HA nanoparticles. 
These reactions usually involve a mixture of soluble calcium and phosphorous sources 
and the addition of base to result in precipitation of crystalline HA (Haque et al., 2007). 
Hence co-precipitation refers to the simultaneous occurrence of nucleation, growth and 
agglomeration processes. In these types of reactions, sparingly soluble products are 
generally formed under high super saturation. As a result, a large number of small 
particles are formed by nucleation (a major step in this reaction).  
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This is followed by the second step of Ostwald ripening (consumption of smaller 
particles by larger ones) and aggregation, which largely affects the size, morphology and 
properties of the final obtained particles. The product size, morphology and particle size 
distribution are mainly influenced by reaction conditions like mixing rate, rate of reactant 
addition, concentration, temperature and stirring rate (Cushing et al., 2004). Typical 
calcium ion sources include calcium nitrate [Ca(NO3)2], calcium chloride [CaCl2] and 
calcium hydroxide [Ca(OH)2]. Typical phosphate ion sources include diammonium 
hydrogen phosphate [(NH4)2HPO4], phosphoric acid (H3PO4), di-sodium hydrogen 
phosphate [Na2HPO4] and potassium dihydrogen phosphate. The Ca
2+ and PO4
3- sources 
react immediately to yield an amorphous precipitate. Reactions carried out in basic 
conditions (NH4OH) with a Ca:P molar ratio of 1.67 (at pH 10-11) result in formation of  
stoichiometric HA (Donadel et al., 2005).  
Two precipitation methods have been reported in the literature for HA production 
(Hench and Wilson, 1993). Rathje, Hayek, and Newesly proposed the first method. They 
employed a reaction involving 0.6 M phosphoric acid solution into 1 M Calcium 
hydroxide solution.    
                 10[Ca(OH)2] + 6 H3PO4                           [Ca10(PO4)6(OH)2] +18 H2O 
The second batch process described by Hayeck and Stadlman was based on the addition 
of diammonium hydrogen phosphate into a solution of calcium nitrate and ammonium 
hydroxide solution as an agent for pH adjustment. The similar work has been done by 
Changsheng Liu and his co-workers in April 2000 (Liu et al., 2001a). They described the 
mechanism and kinetics of hydroxyapatite precipitation at pH 10-11 which were greatly 
affected by variation in time and Ca:P ratio under different temperatures. 
10[(Ca(NO3)2.4H2O] + 6[(NH4)2HPO4] + 8NH4OH           [Ca10(PO4)6(OH)2] + 20 
NH4NO3 + 6H2O 
Based on their research, it can be summarized that heating at 60 °C for a batch process 
of calcium nitrate [Ca(NO3)2.4H2O] and diammonium hydrogen phosphate 
[(NH4)2HPO4]  then the reaction can be completed in 5 minutes. 
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From this premise, it may be possible to carry out a flow synthesis (rather than batch) 
in which temperature of reagents reaches 60 °C and thereafter there is a residence time 
of at least 5 minutes. The properties, nature and crystallinity of the precipitated HA 
powder depended significantly on the temperature, pH, time and other precipitation 
conditions like aging time, variation in Ca:P ratio (Raynaud et al., 2002, Rodrı́guez-
Lorenzo et al., 2001, Arends et al., 1987). 
 
 
Figure 1-18 SEM of pre-sintered HA particles produced by coprecipitation at room 
temperature (Donadel et al., 2005).   
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Figure 1-19 Flow chart for the synthesis of hydroxyapatite powder made via 
coprecipitation method at room temperature. 
Ammonium hydroxide    
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Adding drop wise of phosphate 
solution into ca calcium nitrate  
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Aging for 24 hours 
Centrifuging 
Washing with 
dionized water 
Drying by freeze drier 
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characterization 
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1.4.5.3 Sol-gel Method 
The earliest Sol-gel process was done by Ebelmen in 1846 and formed the basis of 
modern sol-gel synthesis. This involved the hydrolysis of SiCl4 complexed with 
alcohols to make SiO2 (Dislich, 1986). In the late 1930’s, oxide films were prepared 
from sol-gel precursors, which proved useful in the synthesis of stained glass 
(Geffcken and Berger, 1939). The sol-gel process involves three distinct steps. The 
first step is the formation of sol (a stable solution of alkoxide or metal precursor) 
followed by gelation (formation of oxide or alcohol- bridged network), which causes 
an increase in the viscosity of the solution. The transformation of gel to solid mass 
takes place in the third step leading to drying and dehydration (Cushing et al., 2004).  
  
Figure 1-20 TEM images of (a) amorphous co-precipitated HA “needles” (b) heat-
treated at 900 °C for two hours (Phillips et al., 2003) 
The sol-gel chemistry has also been used to synthesize HA particles but includes aging 
up to 24 hours and subsequent heat treatment as shown in Figure 1-20. As a consequence 
of this heat treatment, highly agglomerated particles with changed morphology are 
formed (Liu et al., 2001b). 
1.4.5.4 Emulsion Synthesis 
Emulsion is a homogenous combination of water, oil and a surfactant. Emulsion 
syntheses are used to produce a large variety of metal and metal oxide nanoparticles. 
By using Stobber method, SiO2 particles were prepared in ethanol at room temperature 
(Stöber et al.). The droplet size can be controlled by tailoring the water and the solvent 
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phases, which can be useful in order to control the product (López-Quintela and Rivas, 
1993). HA has been synthesized using emulsion synthesis. However, this needs a large 
amount of surfactants with organic solvent (oil) and subsequent heat treatment is 
needed to obtain crystalline HA product (Koumoulidis et al., 2003). 
Sun and co-workers also reported (Sun et al., 2007) the synthesis of rod-like HA using 
microemulsions under hydrothermal conditions of 160 °C for 12 hours under 
autogenous pressure at neutral pH. They found that by increasing reaction pH almost 
spherical particles were obtained as shown in Figure 1-21. 
  
Figure 1-21 Transmission electron microscope images of HA obtained using a 
microemulsion technique under hydrothermal conditions at (a) pH 7 [bar = 200 nm] 
and (b) pH 11 [bar = 100 nm] (Sun et al., 2007). 
1.4.5.5 Batch Hydrothermal Synthesis 
Hydrothermal processes are one of the earliest synthesized methods and can take 
several hours or days to complete, typically at 150-260 °C. The reactions are typically 
done in the closed container in order to increase temperature above the boiling point 
and achieve crystals. However for safety purpose, the pressure should be estimated 
after heating in the sealed container.  In supercritical water [water above both of its 
critical pressure (Pc) and critical temperature (Tc)], the reaction can proceed in a 
cleaner and greener way. We can manipulate the phase behavior of the mixture and 
also change the morphology of the products (Byrappa and Adschiri, 2007). 
Hydroxyapatite has also been synthesized using batch hydrothermal methods by 
mixing and pouring Ca2+ and PO4
3- into a sealed container. As compared to other 
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methods, batch hydrothermal synthesis produces crystalline, well defined and phase 
pure HA in a single step. Ageing times vary between a few hours to 24 hours with 
synthesis temperature of 90 to150 °C (Guo and Xiao, 2006).  
Zhou and co-workers reported on the decrease in particle size of rod-like HA from 75 
x 25 nm to 65 x 26 nm (Figure 1-22) when a dendrimer (polyamidoamine, PAMAM) 
was used during the hydrothermal batch reaction between calcium nitrate [Ca(NO3)2] 
and diammonium hydrogen phosphate [(NH4)2HPO4] at 150 °C for 10 hours (Zhou et 
al., 2007). 
 
Figure 1-22 Transmission electron microscope images of HA synthesised by a batch 
hydrothermal reaction (a) without and (b) with a dendrimer (PAMAM) (Zhou et al., 
2007). 
Zhang and co-workers also reported the hydrothermal synthesis of HA rods  
employing anhydrous dicalcium phosphate (CaHPO4, DCPA) and CaCO3 in the 
temperature range from 120 to 180°C. They found the resulting material was mostly 
HA with slight traces of β-TCP as a by product (at 140 °C for 24 hours). Figure 1-23 
shows the morphology of HA rods with width of approximately 200 nm and length of 
several microns (Zhang and Vecchio, 2007).  
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Figure 1-23 SEM image of HA rods synthesized by a hydrothermal reaction between 
DCPA and calcite at 140 °C for 24 h (Zhang and Vecchio, 2007) 
HA particles morphology and crystallinity is affected by pressure, temperature, pH 
and ageing time. In order to evaluate the influence of pH and temperature on the 
structure and morphology of HA, different pH values ranging from 6 to 14, and the 
different temperatures in the range from 60 to 140 °C, were used, during the synthesis 
(Liu et al., 2003). It was observed that pH greatly affected the morphology, and 
crystallinity of HA as shown in Figure 1-24 [a-c] .  
   
Figure 1-24 [a-c] SEM images of HA whiskers and crystals grown at different pH 
value at 140 °C: (a) pH = 6, (b) pH = 9, (c) pH =14 (Liu et al., 2003). 
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Synthesis of various ion-substituted hydroxyapatites using batch hydrothermal 
processing has also been reported in literature (Jokanović et al., 2006). A decrease in 
surface area (126 to 50 m2g-1) was observed by increasing synthesis temperature from 
50 to 200 °C in batch process (Riman et al., 2002). By lowering pH below 10, and the 
Ca:P ratio below 1.67, calcium deficient HA is usually obtained (Andres-Verges et al., 
1998). 
1.4.5.6 Continuous hydrothermal flow synthesis  
Continuous hydrothermal flow synthesis (CHFS) has recently gained interest as a fast 
and controllable method for producing inorganic nanomaterial (Chaudhry et al., 2006, 
Sue et al., 2003). Previous examples include the rapid synthesis of nanomaterials that 
normally require long synthesis times or those are difficult to manufacture using more 
conventional methods.  
In continuous hydrothermal flow synthesis, the starting materials are formed in 
aqueous solution and secondly the reactants are combined at a mixing point with high 
temperature and pressure as shown in Figure 1-25. Water becomes supercritical at this 
high temperature and pressure. As a result, this rapid heating of reactants allows 
hydrothermal synthesis, precipitation and crystallization [(Darr and Poliakoff, 1999).  
 
 Figure 1-25 Schematic diagram of a CHFS system (Chaudhry et al., 2006) 
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The crystalline nanoparticle hydroxyapatite rods were obtained in a continuous 
hydrothermal flow system using water at 400 °C and 24 MPa pressure. In this process, 
basic solutions of calcium nitrate and ammonium phosphate, respectively, were 
pumped to meet at a ‘Tee’’ piece mixer. 
This initial mixture was then brought to meet a superheated water feed in a counter 
current reactor, whereupon, rapid ageing occurred. The apatite suspension was 
collected at the exit of the backpressure regulator after first passing though the in-line 
cooler and a 7 mm filter. The collected particles were centrifuged and the wet solids 
were freeze-dried prior to further analysis. The CHFS process was successfully used 
to synthesize nano-sized HA rods as well as a great range of ion substituted calcium 
phosphates (Chaudhry et al., 2006, Chaudhry et al., 2011, Chaudhry et al., 2013, 
Chaudhry et al., 2008) as shown in Figure 1-26 and Figure 1-27. 
 
Figure 1-26 TEM image of nano HA rods prepared using a three pump continuous 
hydrothermal flow system at 400°C and 24MPa (bar = 100nm) (Chaudhry et al., 2006). 
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Figure 1-27 Transmission electron microscope images of (a) HA at x40k 
magnification [bar = 200 nm] and (b) 5SiHA at x40k magnification [bar = 200 
nm](Chaudhry et al., 2012a). 
Furthermore, the CHFS process has also been refined and scaled to Kg/h scale 
production of nanomaterials (Gruar et al., 2013). In particular, this group of authors, 
published the first ever synthesis of HA using CHFS (Chaudhry et al., 2006) and more 
recently, Mg doped HA (Chaudhry et al., 2008) and the carbonate and silicate doped 
HA (Chaudhry et al., 2012a) and also HA/ZrO2 nanocomposites (Chaudhry et al., 
2012b). This work by Darr and Chaudhry has clearly shown that if the temperature is 
sufficiently high enough, the conversion from precursors to the stoichiometric HA can 
be achieved near instantaneously (Chaudhry et al., 2006). Another problem with this 
process was the use of metal pipes, which were needed due to the high temperature 
and pressure. This work did not however explore the possible use of lower 
temperatures and pressures for the same reactions. 
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1.5 Hypothesis and Aims  
The majority of room temperature batch synthesis methods for phase pure HA and 
other calcium phosphates tend to be multi-step, energy intensive or time consuming 
processes. For example, in wet chemical syntheses of HA, a maturation step (>18 h), 
followed by a heat treatment of 650 °C, is required. Failure to allow sufficient 
maturation, gives a phase-separated product upon heat treatment, which can adversely 
affect biological properties in vivo. Emulsion synthesis is suitable for small sized 
powdered product however it is also time consuming and needs subsequent heat-
treatment and it uses solvents. Although batch hydrothermal process facilitates a 
simple, low temperature and efficient way to synthesize phase pure HA however, most 
of the time it requires templating agents along with long reaction time (up to 24 hours). 
Continuous production of HA are carried out at temperatures in excess of the range of 
200-400 °C, which is energy intensive. Furthermore, at such high temperatures, 
although nucleation occurs, there is substantial growth or agglomeration of smaller 
nuclei to form substantially larger particles, typically >100 nm in size (i.e. the length 
of needles). Additionally, there is a disadvantage of having to use high temperature 
continuous reactors, in that they are conducted in metal pipes due to the high reaction 
temperatures and therefore if such a process were used to make bioceramics, they 
would contain substantial levels of leached metals from the steel (e.g. Fe, Cr, etc). This 
would mean that the bioceramics may not be acceptable for clinical use according to 
the latest international standards and guidelines. Furthermore, many of the particle 
sizes obtained in such reactors are not particularly small and indeed are very similar 
to those obtained using more conventional synthesis methods. Smaller particles would 
open up and improve many applications such as more rapid dissolution (due to higher 
surface area) or use as injectable or as a hard filler for bone replacement. Consequently, 
a need arises to develop smaller nano-sized calcium phosphates using methods, which 
allow for fine control over particle sizes, preferably under relatively mild conditions 
of temperature and pressure, and with purity acceptable for use in a clinical setting 
such as for bone replacement. One known method of HA production at near ambient 
conditions (20-60 °C) was reported in the patent literature that involves the mixing of 
reagents in multiple stages using a multiple step reactor with strong stirring 
(Bozhevolnov et al., 2007).  
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Therefore, attempts have been made to develop a simple, low cost, clean, synthesis 
technique, which could work under mild conditions and allow the synthesis of high 
purity stoichiometric HA and other bioceramic materials in a considerably short time 
period with a fine and controllable particle size (range from 20-150 nm) and controlled 
surface area (typically range from 95-300 m2g-1), depending on reaction conditions 
and containing trace contaminating elements which are well below acceptable levels 
as stipulated by international recognized standards for clinical use of bioceramics 
[ISO13779-3]. 
Based on these inferences, the main aims of this work can be outlined as follows 
 
 To prepare phase pure stoichiometric hydroxyapatite (<100nm) and other 
bioceramics as fast as possible and at alow temperature as possible. 
 The HA must be very stoichiometric, ie No decomposition of HA into other 
phases after heating at 1200ºC in air for 2h 
 To demonstrate control over particulate properties using CPFS system 
parameters. 
 To evaluate the effects of different size particles by biological testing. 
 To produce ion-substituted calcium phosphates with variable properties and 
explore the substitution limits in a quick and controllable manner using CPFS 
system parameters.  
 To avoid corrosion and blockage in flow synthesis 
 To obtain specific products/phases with controlled particle size and shape by 
tailoring temperature, time and reaction pH.  
 To prepare high purity product in a plastic flow system; suitable for biomedical 
applications.   
 To use low cost and using readily available precursors, to fulfill the need of 
simplified production methods under mild conditions for developing countries 
like Pakistan. 
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Chapter 2  
Materials and Methods 
This chapter describes the materials and experimental procedures used in this thesis. 
This includes details of chemicals used for reactions in the continuous plastic flow 
synthesis (CPFS) system, synthesis methodology (calculations, reaction parameters), 
characterization techniques (sample preparation and measurement details) and in-vitro 
cell viability studies.  
2.1 Chemicals and Methods 
The following chemicals were used for the preparation of phase pure calcium 
phosphates. 
 Calcium nitrate tetrahydrate [Ca(NO3)2.4H2O, 99%] and Calcium hydroxide  
[Ca(OH)2, 99.99%] precursors supplied from Sigma Aldrich, Chemical 
Company (Dorset, UK.) were used as a calcium ion sources. 
 Diammonium hydrogen phosphate [(NH4)2HPO4, 99%] and Phosphoric acid 
[H3PO4, 99.99%] precursors supplied from Sigma Aldrich, Chemical Company 
(Dorset, UK.) were used as phosphate ion source. 
 To synthesize ion substituted calcium phosphates, surface grafted and 
nanocomposite materials the following chemicals were used. 
 Urea [(NH2)2CO, 99.5%] supplied by VWR International (UK) was used as a 
carbonate ion source. 
 Silicon tetraacetate [Si(OCOCH3)4, 98%] purchased from Sigma-Aldrich 
Chemical Company (Dorset, UK) was used as a silicate ion source. 
 Magnesium nitrate hexahydrate [Mg(NO3)2.6H2O, 98%] purchased from 
Sigma-Aldrich Chemical Company (Dorset, UK.) was used as a magnesium ion 
source. 
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 Zinc nitrate hexahydrate [Zn(NO3)2.6H2O, 97%] purchased by Sigma-Aldrich 
Chemical Company (Dorset, UK.) used as a zinc ion source. 
 Strontium nitrate hexahydrate [Sr(NO3)2.6H2O, 98%] supplied by Sigma-
Aldrich Chemical Company (Dorset, UK.) used as a strontium ion source. 
 Barium hydroxide octahydrate [Ba(OH)2.8H2O, 98%] supplied by Sigma-
Aldrich Chemical Company (Dorset, UK.) used as a barium ion source. 
 Silver nitrate [AgNO3, 99 %] supplied by Sigma-Aldrich Chemical Company 
(Dorset, UK.) used as a silver ion source. 
 Iron citrate [C6H5O7Fe.3H2O, 98%] obtained from Scientific Fischer, UK was 
used as an iron source. 
 Manganese nitrate tetrahydrate [Mn(NO3)2.4H2O,97%] obtained from Scientific 
Fischer, UK was used as a manganese ion source. 
 Methacrylic acid [C4H6O2, 99+%] Polyvinyl alcohol [(C2H4OX), 99+%],  Adipic 
acid [C6H10O4, 99%], Citric acid [C6H8O7, 99%]  and Vinyl phosphonic acid 
[CH2=CHP(O)(OH)2, 97%] were purchased from Sigma Aldrich  Chemical 
Company (Dorset, UK). 
 Triethylene glycol di-methacrylate [TEGDMA, C14H22O6, 95%], Bisphenol A 
diglycidyl ether dimethacrylate [Bis-GMA,C29H36O8], and Camphorquinone 
[CQ, C10H14O2, 97%] were purchased from Sigma Aldrich, Steinheim, Germany.  
 Dimethyl aminoethyl methacrylate [DMAM] and N, N-Dimethyl-p-toluidine 
[C9H13N, >98%] were supplied by Merck, Hohenbrunn, Germany. 
Ammonium hydroxide solution (NH4OH, 28%) was used to adjust pH where required 
supplied by VWR International (UK). Deionised water was used throughout all 
experimentation. 
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2.2 Synthesis Method for Nanopowders 
2.2.1 Continuous Plastic Flow Synthesis System  
The continuous plastic flow synthesis (CPFS) system is a simple, single step method 
that was used for the synthesis of HA and other high purity bioceramics under near 
ambient conditions with affordable and readily available reagents.  
The CPFS system consists of two HPLC Gilson pumps (Gilson Model 307 Pumps with 
25 SC Pump heads), connected to 8 m long Polyflon™ PTFE tubing which was coiled 
inside an oil bath with one end of the tubing splitting via a T-junction connection into 
precursor reservoir and the other end emerging from the heating system (oil bath) in a 
collection beaker.  
 
Figure 2-1 Two pump (P1, P2) plastic flow system used for the synthesis of nano-
bioceramics.  
In the CPFS process, precursor solutions were pumped to meet at a 1/16 inch Polyflon™ 
T-piece through a 1/8 in. Polyflon™ straight union reducer (D6-D1/8”, PFA). This 
initial mixture was connected to 8 m long 1/16 inch Polyflon™ PTFE tubing (internal 
diameter 4.0mm x outer diameter 6.0mm) which was coiled inside an oil bath which 
gave an effective 5 minutes from the tee to the exit of the pipe. The reactor tube is made 
of a fluoropolymer which gives good resistance to strong pH and  is easy to clean. For 
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given flow rates for the two pumps of 10 mL per minute (total flow= 20 mL min-1), 
gives an approximate residence time of five minutes as a typical set of process 
parameters. Preferably, the tube is heated externally via a heat exchanger placed 
downstream of the T-junction mixing point.  The tube is located inside an oil bath which 
acts as a heat exchanger downstream of the mixing point, allowing the reaction to go to 
completion.  
 
 
Figure 2-2 Scheme of the two pump (P1, P2) plastic flow system used for the synthesis 
of nano-bioceramics Key: P = pump, H = heat exchanger,  T = ‘‘Tee’’ piece mixer. 
The product is collected from the end of the tube at ambient pressure. The tube 
diameters, type of heat exchanger and flow rates and types of pumps differ considerably 
depending on what is required to achieve similar performance and lab scale. The CPFS 
system allows access to the range of reaction conditions required for rapid and 
continuous synthesis of calcium phosphates (summarized in table 2-1). Dr. Chris Tighe, 
a chemical engineer in the CMTG materials chemistry group, calculated all CPFS 
reactor parameters. 
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Table 2-1 Parameters for continuous plastic flow system 
 
Flow rate 
F = V/τ 
 
Residence 
time 
Τ = v/F 
 
Outer diameter of 
tubing 
(do)  
 
 Inner diameter 
of tubing 
 (di) 
 
Length of 
tubing used 
L = 4Fτ/πd2  
 
Heat 
required 
Q = ρFCp 
(T out - Tin) 
 
Heat transfer area 
required 
L⁄ = Q/UπdΔTLMTD   
 
 
Surface 
area 
S = πd L⁄  
   mLmin-1     minutes               cm             cm         cm        J/s               cm       cm2 
5 5 0.60 0.40 199 13.95 100.43 126.20 
10 5 0.60 0.40 398 27.90 200.86 252.41 
15 5 0.60 0.40 597 41.85 301.29 378.62 
20 5 0.60 0.40 796 55.80 401.72 504.82 
25 5 0.60 0.40 995 69.75 502.16 631.03 
30 5 0.60 0.40 1194 83.71 602.59 757.24 
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2.3 Synthesis Methodology 
In this section, exact amounts of chemicals used to make solutions, synthesis conditions 
for the CPFS systems (temperature, concentration, pH, flow rates), clean up, 
centrifugation parameters and freeze drying and thermal stability study parameters are 
described. 
2.3.1 Synthesis of High Surface Area Nano-sized Hydroxyapatite and 
Effect of CPFS System Parameters 
2.3.1.1 Synthesis of Phase Pure Stoichiometric Nanohydroxyapatite  
Method 1: The pure nano-hydroxyapatite (HA) was prepared at 60°C using a simple 
continuous plastic flow synthesis system (CPFS). 0.3 M phosphoric acid solution and 
0.5 M calcium hydroxide solutions were used (Ca : P molar ratio: 1.67). Both reagent 
solutions were made in 500mL deionised water and pumped at 20 mL min-1, to meet at 
a 1/16 in. Polyflon™ T-piece through a 1/8 in. Polyflon™ Straight union reducer (D6-
D1/8”, PFA). This initial mixture was connected to 8 m long 1/16 in. Polyflon™ PTFE 
tubing surrounded by a heating jacket whereupon reaction completed in 5 minutes 
which was the residence time for the reaction. The resulting precipitates were collected 
from the exit point. The precipitation of HA can be described by the following equation. 
10[Ca(OH)2] + 6 H3PO4                  [Ca10(PO4)6(0H)2] +18 H20 
Method 2: In this process, 0.3 M diammonium hydrogen phosphate solution and 0.5 M 
calcium nitrate solutions were used (Ca : P molar ratio: 1.67). The pH of both the 
solutions prior to the reaction was kept above pH 10. 15.0 ml of ammonium hydroxide 
were added to calcium nitrate (500 mL) and diammonium hydrogen phosphate solutions 
(500 ml), respectively. Both reagent solutions were pumped at 20 mL min-1, to meet at 
a T-piece. This initial mixture was  connected to 8 m long tubing surrounded by heating 
jacket. The flow rates used for calcium nitrate and diammonium hydrogen phosphate 
solutions for pump 1 and pump 2, respectively, were selected to give a total residence 
time of 5 minutes. The precipitation of HA can be described by the following equation. 
10 [Ca(NO3)2.4H2O] + 6 [(NH4)2HPO4] + 8 NH4OH              [Ca10(PO4)6(OH)2] 
+20NH4NO3 + 6H2O 
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The slurries were collected from the exit (at the end of the CPFS system) in 50 mL 
Falcon tubes. Between consecutive collections, the CPFS system was purged with clean 
water for 20 minutes. Each slurry was centrifuged at 4500 rpm for five minute (per 50 
mL suspension), ca. 45 mL of liquid was removed from each sample and ca. 45 mL 
deionised water was added followed by vigorous shaking using a vortex mixer. Each 
sample was then recentrifuged at 4500 rpm for five minutes and ca. 45 mL liquid was 
removed for a final time to give a concentrated slurry. The wet residue was frozen in 
liquid N2 and then freeze-dried using a VirTis Genesis Pilot Lyophilizer 35XL at 0.3 Pa 
for 24 hours.  
Table 2-2 Reaction conditions for the synthesis of phase pure hydroxyapatite 
Temperature Initial pH of solution 1 Initial pH of solution 2 
Temp. (60 °C) 
Ca(NO
3
)
2
 ~  8 
 Ca(OH)2 ~  13 
(NH
4
)
2
HPO
4
 ~ 8.5 
H3PO4 ~  3 
Dropping Mechanism Flow Rate (variable) Residence Time 
Gilson pump 20 mL min-1  5 min. 
Ca:P ratio Drying Method pH Adjustment 
1.67 Freeze drying NH4OH (28% vol) 
 
The powders were also separately heat–treated to show that the as-prepared materials 
were able to form phase pure synthetic hydroxyapatite that was stable at 1200°C in air 
(this suggested that it was stoichiometric hydroxyapatite as it did not decompose). 
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2.3.1.2 Disc Preparation 
The obtained as prepared and sintered powders were compacted into cylindrical discs 
of 13 mm diameter and 2 mm thickness by using a laboratory hydraulic press at 5 MPa. 
These samples were used for cell viability studies after sterilization in 70 % ethanol for 
1 hour.  
 
                   Figure 2-3 Cylindrical HA disc made for cell viability analysis  
             (a) Effect Of Temperature 
Six separate reactions were carried out to study the effects of reaction temperature on 
the end products. For each case, samples were synthesized under basic pH 10 conditions 
with Ca/P ratio 1.67.  
59 g (0.25 moles) and 19.8 g (0.15 moles) of calcium nitrate and diammonium hydrogen 
phosphate were separately dissolved in 1000 mL deionised water for stock solution. In 
total, 6 different reactions were carried out using 150 mL of calcium nitrate and 
diammonium hydrogen phosphate solutions for each case. The pH was adjusted to pH 
10 by adding 30 mL ammonium hydroxide solution to each solution. 
The samples were labeled as HA30, HA40, HA50, HA60, HA70 and HA80 depending 
on reaction temperatures ranges from 30 to 80 °C, respectively. The numbers in the 
sample ID specifies the different temperatures on which reactions are carried out. The 
pH values were measured from suspensions immediately after collection.  
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Table 2-3 Effect of temperature on the synthesis of hydroxyapatite 
Sr. # Sample ID Flow rate (mLmin-1) 
Reaction 
temperature 
Product formed 
1 HA30 20 30 Impure Product 
2 HA40 20 40 HA/TCP 
3 HA50 20 50 HA/Traces of TCP 
4 HA60 20 60 Pure HA 
5 HA70 20 70 Pure HA 
6 HA80 20 80 Pure HA 
 
These reactions were carried out using the CPFS system as explained in section 2.2.1. 
Pump rates of 20 mL min-1 were used for calcium nitrate and diammonium hydrogen 
phosphate solutions, respectively. All reactions were carried out at atmospheric 
pressure. Results have shown that apatite obtained below 60 °C after heat-treatment at 
1200 °C for 1 hour was not phase pure synthetic hydroxyapatite, as shown in Table 2-
3. 
(b) Effect of Flow rates  
59 g of calcium nitrate were dissolved in 1000 mL deionised water to result in 0.25 M 
stock solution. The pH of this solution was adjusted to pH 10 by adding 30 mL of neat 
ammonium hydroxide solution. 19.8 g of diammonium hydrogen phosphate were 
dissolved in 1000 mL of deionised water to result in a 0.15M stock solution. In total, 
five different reactions were carried out using 200 mL of calcium nitrate and 
diammonium hydrogen phosphate solutions for each case.  
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Table 2-4 Effect of different flow rates on the synthesis of hydroxyapatite 
Sr. # Sample No. Flow rate Product formed 
1 HA1 50 Impure 
2 HA2 40 HA/TCP 
3 HA3 30 Pure HA 
4 HA4 20 Pure HA 
5 HA5 10 Pure HA 
 
All samples were centrifuged, washed and freeze-dried as explained earlier; see section 
2.3.1.1. 
(c) Effect of Concentration 
A series of experiments (six in total) were carried out by varying concentration and by 
keeping all other parameters the same. For each case, samples were synthesized under 
basic pH 10 conditions with Ca:P ratio 1.67.  
The fine HA powder obtained from all reactions using different concentration were 
hereafter referred to as 1HA, 0.5HA and 0.25HA and 0.125HA, respectively. All 
reactions were carried out at 60 °C and atmospheric pressure. It was observed that 
tailoring reaction concentration while keeping the reaction time as five minutes in all 
reactions greatly influenced the particle size and specific surface area as shown in Table 
2-5. The dried product was a fine, free flowing white powder.  
It was observed that the method works very well at higher concentrations of precursors. 
However, the particle size increases, with a subsequent lowering of surface area. 
Therefore, at higher concentrations of precursors, the method can still be used for the 
rapid and continuous manufacture of stoichiometric hydroxyapatite or other 
bioceramics (e.g. calcium phosphates and their derivatives). 
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Table 2-5 Effect of reaction concentration on the final product 
Sr. 
# 
Sample 
ID 
CaN 
(molL-1) 
DAHP   
(molL-1) 
Ca/P 
ratio 
Flow rate 
(mLmin-1) 
Product 
formed (g) 
BET 
Surface 
Area (m2g-
1) 
1 1HA 1 0.6 1.67 20 
Impure 
(~150g/h) 
50-100 
2 0.5HA 0.5 0.3 1.67 20 
Pure HA 
(~75g/h) 
100-150 
3 O.25HA 0.25 0.15 1.67 20 
Pure HA 
(~35g/h) 
100-200 
4 0.125HA 0.125 0.075 1.67 20 
Pure HA 
(~20g/h) 
200-300 
 
Under such conditions, the particles are typically around one hundred nanometers or 
more in length and surface areas are about 100 m2g-1. The properties of the precipitated 
material depended on the temperature, concentration, pH, time and other precipitation 
conditions such as variation in Ca:P ratio and residence time. By tuning the reaction 
parameters, products of any required particle size (ranging from 20-150 nm) and surface 
area (ranging from 95-300 m2g-1) can be produced. 
2.3.1.3 Synthesis of Other Phase Pure Calcium Phosphates (DCPD, CDHA, TCP)  
(a) Synthesis of Brushite 
Brushite (DCPD: dicalcium phosphate dihydrate: CaHPO4.2H2O) nanoparticles 
(<100nm) were rapidly synthesised using a novel two pump continuous plastic flow 
synthesis (CPFS) at room temperature (22 °C) in 3 minutes (residence time) at pH 5.5 
from aqueous solutions of calcium nitrate tetrahydrate and diammonium hydrogen 
phosphate. The product was obtained as a phase pure material with a Ca:P molar ratio 
for the reagents of 0.8, and without the need for an initial prolonged ageing step. 
Brushite is transformed into monetite by losing its crystal water upon heating above 110 
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°C. The transition of monetite into pyrophosphate typically occurs at temperatures 
above 400 °C. The product obtained was fine white powder with ~ 85 % yield.  
(b) Synthesis of Calcium Deficient HA and β- Tricalcium Phosphate  
Other calcium phosphate phases (β-TCP, CDHA) were also obtained by changing the 
Ca:P ratio (1.5~ 1.67) by keeping other conditions as shown in Table 2-6. β-TCP was 
obtained by the heat-treatment of as-prepared CDHA at 1100 °C. The influence of initial 
Ca:P molar ratio, pH and precipitation temperature on the phase evolution and 
crystallinity of the nanopowder were systematically investigated and optimized. The 
product obtained was a fine white powder with ~ 85 % yield.  
Table 2-6 Synthesis of various phase purse calcium phosphates made on CPFS 
Ca/P Name Formula Acronym 
pH 
range 
1.67 Hydroxyapatite Ca10(PO4)6(OH)2 HA 9.5-12 
1.5-
1.67 
Calcium-deficient 
hydroxyapatite 
Ca10-x(HPO4)x(PO4)6-
x(OH)2-x 
CDHA 6.5-9.5 
1.0 
Dicalcium phosphate 
dihydrate (brushite) 
CaHPO
4
.2H
2
0 DCPD 2.0-6.0 
1.5 
β-tricalcium 
phosphate 
β-Ca
3
(PO
4
)
2
 B-TCP 7.4 
1.0 
Dicalcium phosphate 
anhydrous  (monetite) 
CaHPO
4
 DCPA 2.0-6.0 
1.0 
Calcium 
pyrophosphate 
Ca
2
P
2
O
7
 CPP 4-6 
 
2.3.1.4 Synthesis of Phase Pure Strontium and Barium Hydroxyapatite 
(a) Synthesis of Strontium Hydroxyapatite 
The as-prepared phase pure strontium and barium hydroxyapatite (containing no 
calcium) were prepared at 60°C using a simple continuous (plastic) flow synthesis 
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system (CPFS). 52.9g (0.25 moles) of strontium nitrate and 19.8 g (0.15 moles) of 
diammonium hydrogen phosphate were dissolved in 1000 mL deionised water and the 
pH of the solution was adjusted to pH 12 by adding 30 mL neat ammonium hydroxide 
solution.  
CPFS system was used for these reactions and pump rates of 20 mL min-1 were used for 
calcium nitrate/urea and diammonium hydrogen phosphate solutions, respectively. All 
reactions were carried out at 70 °C and atmospheric pressure. All samples were 
centrifuged, washed and freeze-dried as explained earlier; see section 2.3.1.1. The dried 
product was free flowing white powder with ~ 85 % yield.  
(b) Synthesis of Barium Hydroxyapatite 
In the synthesis process, 78.8 g (0.25 M) basic solutions of barium hydroxide solutions 
with (Ba:P molar ratio: 1.67) and 19.8 g (0.15 M) diammonium hydrogen phosphate, 
respectively, were pumped to meet at a T-piece. This initial mixture was connected to 
an 8 m long pipe which was coiled inside an oil bath which gave an effective 5 minute 
residence time from the tee to the exit of the pipe. The pH of both the solutions prior to 
the reaction was ideally kept above pH 12.  
The CPFS system was used for these reactions and pump rates of 20 mL min-1 were 
used for barium hydroxide and diammonium hydrogen phosphate solutions, 
respectively. All reactions were carried out at 70 °C (reaction temperature) and 
atmospheric pressure. All samples were centrifuged, washed and freeze-dried as 
explained earlier; see section 2.3.1.1. The product obtained was a fine white powder 
with ~ 85 % yield.  
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2.4 Synthesis of Ion Substituted Calcium Phosphates 
2.4.1 Synthesis of Magnesium Substituted Calcium Phosphates 
All samples were made using a novel continuous plastic flow synthesis (CPFS) system, 
which consisted of two HPLC Gilson pumps as explained in section 2.2.1. In the 
synthesis process, separate reservoirs of calcium nitrate with different wt% of metal 
ions (Ca + Mg)/P = 1.67) ranging from 1 to 10 wt%, and diammonium hydrogen 
phosphate, respectively, were pumped to meet at T-piece. Ammonium hydroxide was 
used to maintain the pH of both the solutions prior to the reaction above pH 10. The 
residence time from the T-piece to the exit of the tubing was 5 minutes.  
The product was collected as a suspension in a beaker at the exit point. All samples were 
centrifuged, washed and freeze-dried as explained earlier; see section 2.3.2. The dried 
powders were then heat-treated at 1000 °C for 2 hours in air at a heating rate of 10 
°C/min.  The samples were labelled as 1Mg-CaP, 2Mg-CaP, 3Mg-CaP, 4 Mg-CaP, 
5Mg-CaP, 6 Mg-CaP, 7Mg-CaP, 8Mg-CaP, 9Mg-CaP and 10Mg-CaP. The numbers in 
the sample IDs represent the expected magnesium content (wt%). The dried product 
was fine white powder with ~ 85 % yield. The as prepared and heat-treated powdered 
samples were compacted into cylindrical discs of ca. 13 mm diameter and 2 mm 
thickness by using a hydraulic press at 5 MPa.   
2.4.2 Synthesis of Carbonate and Silicate Substituted Calcium 
Phosphates 
(a) Synthesis of Carbonate Substituted Calcium Phosphates    
A series of carbonate substitution reactions were carried out for this study. The 
continuous plastic flow synthesis was carried out as previously described ; see section 
2.2.1. 59 g (0.25 moles) of calcium nitrate were dissolved in 1000 mL deionised water 
and the pH of this solution was adjusted to pH 11 by adding 30 mL neat ammonium 
hydroxide solution.  Urea (carbonate ion source) was added to diammonium hydrogen 
phosphate (adjusted to pH 10). This solution was reacted with calcium nitrate solution 
(adjusted pH 11). A Ca:[PO4
3-+CO3
2-] molar ratio of 1.67 was maintained in all 
precursor solutions. All calculations were based on the formula Ca10(PO4)6-
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x(CO3)x(OH)2, wherein carbonate ions partially replace phosphate ions in the HA lattice. 
Samples are labelled as 2CHA, 4CHA, 6CHA and 8CHA. The initial numbers in the 
sample IDs show the nominal carbonate content (wt%). 
CPFS system was used for these reactions and pump rates of 20 mL min-1 were used for 
calcium nitrate/urea and diammonium hydrogen phosphate solutions. All reactions were 
carried out at 70 °C and atmospheric pressure. All samples were centrifuged, washed 
and freeze-dried as explained earlier; see section 2.3.1.1. The product obtained was fine 
white powder with ~ 85 % yield.  
(b) Synthesis of Silicate Substituted Calcium Phosphates 
A similar procedure to carbonate substitution was adopted for the synthesis of silicon-
substituted calcium phosphates using the CPFS system. In total, nine reactions were 
carried out using silicon acetate as a silicate ion source. For a typical reagent solution, 
silicate tetra-acetate and calcium nitrate were accurately weighed and added to 200 mL 
deionised water so that the combined ratio of calcium nitrate with silicate ion and 
diammonium hydrogen phosphate was 1.67. For these reactions it was assumed that 
silicate ions partially substitute phosphate ions in HA lattice [Ca10(PO4)6-x(SiO4)x(OH)2-
x].  
The pH of this solution was adjusted to pH 10 by adding 10 mL of neat ammonium 
hydroxide solution. The samples are labeled as 1Si-HA, 2Si-HA, 3Si-HA, 4Si-HA, 5Si-
HA, 6Si-HA, 7Si-HA, and 8Si-HA. The numbers in the sample IDs represent the 
nominal silicon content (wt%) according to how much silicate precursor was used in 
the precursors. All samples were centrifuged, washed and freeze-dried as explained 
earlier; see section 2.3.1.1.  The product obtained was fine white powder with ~ 85 % 
yield.  
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2.4.3 Synthesis of Strontium and Barium Substituted Calcium 
Phosphates  
  (a) Synthesis of Strontium Substituted Calcium Phosphates  
A customized synthesis of strontium substituted calcium phosphates was made using A 
CPFS system which has capacity to prepare nanobioceramic materials with controllable 
particle size by tailoring the reaction parameters like temperature, pH and flow rates of 
precursors. All samples were made using the continuous plastic flow synthesis as 
previously described in section 2.2.1. In the synthesis process, basic solutions of 
calcium nitrate with different wt% of metal ions (Ca + Sr)/P = 1.67 strontium and 
diammonium hydrogen phosphate were used.  
A CPFS system was used for these reactions and pump rates of 20 mL min-1 were used 
for calcium nitrate/strontium nitrate and diammonium hydrogen phosphate solutions, 
respectively. All reactions were carried out at 70 °C and atmospheric pressure. All 
samples were centrifuged, washed and freeze-dried as explained earlier; see section 
2.3.1.1.  The product obtained was a fine white powder with ~ 85 % yield.  
(b) Synthesis of Barium Substituted Calcium Phosphates 
All samples were made using a CPFS system as previously described in section 2.2.1.  
In the synthesis process, basic solutions of calcium nitrate and strontium nitrate (total 
conc. = 0.5M and (Ca + Ba)/P = 1.67) and diammonium hydrogen phosphate, 
respectively, were pumped to meet at T-piece. The pH of both the solutions prior to the 
reaction was kept above pH 10.  
The CPFS system was used for these reactions with pump rates of 20 mL min-1 for the 
calcium nitrate/barium hydroxide and diammonium hydrogen phosphate solutions. All 
reactions were carried out 70 °C and atmospheric pressure. All samples were 
centrifuged, washed and freeze-dried as explained earlier; see section 2.3.1.1. 
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Table 2-7 Synthesis of various Ion substituted calcium phosphates made on CPFS 
Serial 
# 
Substituted Ions Substitution site 
Temp(°C) 
Residence time 
(minutes) 
1 Carbonate (CO
3
2-
) Phosphate (PO
4
3-
) 70 5 
2 Silicate (SiO
4
4-
) Phosphate (PO
4
3-
) 70 5 
3 Magnesium (Mg
2+
) Calcium (Ca
2+ 
) 70 5 
4 Strontium (Sr
2+
) Calcium (Ca
2+ 
) 70 5 
5 Barium (Ba2+) Calcium (Ca
2+ 
) 70 5 
6 Silver(Ag2+) Calcium (Ca
2+ 
) 70 5 
8 Iron (Fe
2+
, Fe
3+
) Calcium (Ca
2+ 
) 70 5 
9 Manganese (Mn
2+
) Calcium (Ca
2+ 
) 70 5 
A CPFS reactor was used to successfully synthesize ion substituted calcium phosphates 
from calcium nitrate tetrahydrate [(Ca(NO3)2.4H2O)], and diammonium hydrogen 
phosphate [(NH4)2HPO4)] precursor solutions at (near) ambient conditions in a rapid 
single step.  
2.5 Synthesis of Hydroxyapatite Based Nanocomposites  
2.5.1 HA-Magnetite Nanocomposites 
(a) Synthesis of Magnetite 
Magnetite nanoparticles were rapidly synthesised using a novel two pump continuous 
plastic flow synthesis at 70 °C in 5 minutes (residence time) at pH above 10. In our 
process, 20.2g Iron nitrate and 11.52 g citric acid were pumped to meet at a ‘‘Tee’’ 
piece mixer. This initial mixture was connected to 8 meter plastic tubing surrounded by 
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a heating jacket whereupon reaction will be completed in 5 minutes, which is the 
residence time for the reaction. The suspension was collected in a beaker at the exit 
point. The precipitates were centrifuged and dried by using freeze drier as explained 
earlier; see section 2.3.1.1. The product obtained was a dark brown powder with ~ 85 
% yield. 
(b) Synthesis Of HA-Magnetite Nanocomposites 
Hydroxyapatite nanoparticles were prepared using a similar method as described in 
section 2.3.1.1. Composite materials of magnetite-HA were made by passing HA and 
magnetite through a CPFS system with a total flow rate of 40 mL min-1  at 70 °C. 
2.5.2 HA-Titania Nanocomposites 
(a) Synthesis of Titania 
Titania samples were made using a CPFS system, which consists of two HPLC Gilson 
pumps fitted with 25 mL pump heads. In the synthesis process, 0.25 M titanium 
oxysulfate solution and 0.20 M basic solution of potassium hydroxide were pumped to 
meet at a T-piece. The pH of both the solutions prior to the reaction was kept above pH 
10. This initial mixture was connected to 8 m long PTFE tubing which was coiled inside 
an oil bath which gave an effective 5 minutes from the tee to the exit of the pipe. The 
suspension was collected in a beaker at the exit point and then centrifuged as described 
in section 2.3.1.1. The product obtained was a white powder dark with ~ 85 % yield. 
The obtained powder was compacted into cylindrical discs of 13 mm diameter and 2 
mm thickness  using a laboratory hydraulic press at 5 MPa. These samples were used 
for cell viability studies after sterilization in 70 % ethanol for 1 hour.  
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(b) Synthesis of HA-Titania Nanocomposites 
The hydroxyapatites nanoparticles were obtained following a similar procedure as 
described in section 2.3.1.1. Composite materials of Titania-HA were made by passing 
HA and titania suspensions through a CPFS system. The details of which are described 
in section 2.2.1. The reactions were carried out by setting the total flow rate to 40 mL 
min-1 at 70 °C. The final precipitates were centrifuged and freeze dried as explained in 
section 2.3.1.1.  The product obtained was a white powder with ~ 85 % yield. 
The obtained powder was compacted into cylindrical discs of 13 mm diameter and 2 
mm thickness using a laboratory hydraulic press at 5 MPa. These samples were used for 
cell viability studies after sterilization in 70 % ethanol for 1 hour.  
2.5.3 HA Based Dental Nanocomposites 
(a) Synthesis of Surface grafted hydroxyapatite 
The surface modified hydroxyapatites were obtained following a similar procedure as 
for pure nano-HA (mentioned above in section 2.3.1.1), except the calcium containing 
precursor additionally contained the appropriate amount of (0.05 M) functionalised 
carboxylic acid or organic phosphoric acid. The resulting nanopowders were termed 
PVA-HA (polyvinyl alcohol), AA-HA (adipic acid), CA-HA, (citric acid), VPA-HA 
(vinylphosphonic acid) and MA-HA (methacrylic acid). 
(b) Synthesis of surface grafted strontium hydroxyapatite 
The surface modified strontium (containing no calcium) hydroxyapatite nanopowders 
were prepared at 60°C using a simple continuous (plastic) flow synthesis system 
(CPFS). In the synthesis process, 0.5M basic solutions of strontium nitrate with organic 
surface modifier (Sr+RCO2
-R) / P = 1.67) and 0.3 M diammonium hydrogen phosphate, 
respectively, were pumped to meet at a T-piece. The pH of both the solutions prior to 
the reaction was ideally kept above pH 12. This initial mixture was connected to an 8 
m long pipe which was coiled inside an oil bath which gave an effective 5 minute 
residence time from the tee to the exit of the pipe. The product obtained was white fine 
powder with ~ 85 % yield. 
  85 
(c) Synthesis of surface grafted barium hydroxyapatite 
A similar procedure was adopted for the synthesis of Ba-hydroxyapatite using CPFS 
system as described earlier in section 2.2.1. In the synthesis process, basic solutions of 
barium hydroxide with organic surface modifier (Ba+RCO2
-R) /P = 1.67) were used. 
The pH of both the solutions prior to the reaction was ideally kept above pH 12. This 
initial mixture was connected to an 8 m long plastic tube, which was coiled inside an 
oil bath that gave an effective 5 minutes residence time from the tee to the exit of the 
pipe. The obtained precipitates were centrifuged and freeze dried as described 
previously (section 2.3.1.1).  The product obtained was dark brown powder with ~ 85 
% yield. 
2.5.4 Dental composite preparation 
The organic matrix consisted of 60 wt% Bis-GMA  and 40 wt%  diluent TEGDMA as 
a comonomer. Various mass fractions of surface-modified hydroxyapatite, 
nanoparticles were added into the monomer. The solution was stirred for 24 hrs and 
shifted to a light sensitive vial to avoid photocuring prior to addition of  further 
components (initiator, coinitiator, filler). 0.5 wt% camphorquinone and 2 wt% 
dimethylaminoethyl methacrylate along with 0.2 wt% N, N-Dimethyl-p-toluidine were 
added into the monomer solution as the initiator and coinitiators, respectively. After 
mixing thoroughly for 2 hours, the mixture was carefully transferred into a disk shaped 
Teflon mold (diameter 6mm, thickness 1 mm). Then samples were photo-cured using a 
blue LED activation light (Demetron LC, Ser no 66004022, KERR corporation, 
Danbury).  X-ray images were then taken of the samples after leaving the sample to cure 
for at least 30 minutes. A similar procedure was repeated for surface modified strontium 
and barium phosphates.  
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2.5.4.1 Depth of Cure Measurement 
The degree of cure of visible light activated dental resins was recognized as important 
to the clinical success of these materials soon after these materials were introduced. The 
scraping off technique has been codified as the depth of cure measure in the ISO 
standard 4049. Three specimens of each material type, 4 mm in diameter and 6 mm 
deep were condensed into Teflon mould.  
Figure 2-4 Showing the composite material condensed into Teflon mould. 
A microscope glass slide was placed on top of the mould to hold the tip of the activating 
light 1 mm away from the surface of the resin. The specimens were activated for 20 secs 
using a blue LED activation light (Demetron LC, Ser no 66004022, KERR corporation, 
Danbury).  
After activation, the specimens were immediately removed from the mould and the 
uncured material was scraped off with a spatula. The length of the remaining material 
was measured with a digital micrometer in three different places and an average length 
was obtained. This value was then divided by 2 to obtain the ISO 4049 depth of cure. 
The ISO 4049 standard requires that the result should be at least 1.5 mm for non-opaque 
shades and 0.5 mm for opaque shades. 
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Figure 2-5 Light curing of composite for 20 sec using a high power blue LED activation 
light. 
 
Figure 2-6 Peeling off the uncured material from the bottom of the sample using the 
spatula. 
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Figure 2-7 Measurement of the remaining thickness of the sample using a micrometer  
2.5.4.2 Radiopacity image investigations 
For each sample, a Teflon mould was used to produce three disks, measuring 6 mm in 
diameter and 1 mm in thickness, in accordance with ISO 4049. The specimens were 
photopolymerized using a blue LED light (Demetron LC, Ser no 66004022, KERR 
corporation, Danbury). The specimens were hand ground for few minutes using 150-
grit sandpaper to create a flat surface. Specimens were measured using a digital 
micrometer. One specimen of each sample along with an aluminium wedge were placed 
side by side on an occlusal radiographic film. The Al step wedge served as a standard 
for each radiographic exposure. Films were exposed for 0.6 milliseconds using a 
radiography unit at 70 kV and 8 mA, the object to film distance was 300 mm. 
                 
Figure 2-8 Radiographic images of calcium, barium and strontium-hydroxyapatite 
based dental composite  
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2.6 Characterization 
The following are the techniques used to characterize all the samples obtained from the 
CPFS method.  
2.6.1 Centrifugation 
A Sigma 4K15 Centrifuge with a rotor housing four buckets, having a capacity of seven 
50 mL Falcon tubes each, was used to centrifuge the aqueous slurries at 4500 rpm for 
10 minutes (per 50 mL suspension), ca. 45 mL of liquid was removed from each sample 
and ca. 45 mL deionised water (>10 Mega Ohm) was added followed by vigorous 
shaking using a vortex mixer. Each sample was then recentrifuged at 4500 rpm for five 
minutes and ca. 45 mL liquid was removed to give concentrated slurry. Steps were 
repeated ca. 3-5 times to ensure the removal of all residual ions with neutral pH. The 
obtained concentrated slurry was then freeze dried for further analysis.  
 
Figure 2-9 Centrifuge showing the rotor with a capacity of four buckets. 
2.6.2 Freeze Drying 
After centrifugation all samples were freeze dried using a VirTis Genesis Pilot 
Lyophilizer 35XL (SP Scientific UK) at 0.3 Pa for 24 hours. The samples obtained were 
first frozen in liquid N2 prior to freeze drying.  
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2.6.3 Chemical analysis 
Chemical analysis of all  samples were carried out using Thermo Scientific K-Alpha X-
ray photoelectron spectrometer with a two chamber vacuum system (loadlock and 
analysis chamber). The XPS used a monochromated Al K-alpha source (E = 1486.6 eV) 
with maximum power of 72 W. X-rays were microfocused at source to give a spot size 
on the sample in the range of 30–400 µm. The monochromator comprised of a single 
toroidal quartz crystal set in a Rowland circle with a radius 250 mm. The surface 
sensitivity (typically in the range 40-100 Å) makes this technique ideal for 
measurements of elemental ratio as oxidation states. The vacuum analysis chamber 
pressure was set at ~ 3x 10-8 Torr. The spectra were collected at an energy of 150 eV 
for survey scans and at 50 eV for high resolution regions. The detector used was a 128 
channel position sensitive detector. The spectral intensity of the Ag 3d 5/2 peak from a 
clean metal sample was >2.5 Mcps at a FWHM of 1.0 eV. The XPS spectra were 
processed using the CasaTM software. The binding energy scale was calibrated by a C 
1s peak at 285.0 eV. 
2.6.4 Scanning Electron Microscopy 
A JEOL JS-6301F scanning electron microscope located at Department of Archaeology, 
University College London (UK) was used to analyse the nanoparticles prepared by the 
CPFS process. The SEM was operated at 25 kV and all samples were carbon coated 
prior to measurements. 
2.6.5 Transmission Electron Microscopy 
Transmission electron microscope (TEM) images were collected using a JEOL JEM-
1200EX II Electron Microscope. Digital images were taken with a side mounted AMT 
2K high sensitivity digital camera (Debens, East Grinstead, UK). A small amount of 
sample (< 10 mg) was dispersed in 10 mL neat methanol (Merck, Darmstadt, Germany) 
and then ultrasonicated (Model USC100T, VWR, East Grinstead, UK) for 2 minutes to 
yield a very dilute suspension. A few drops of the resulting suspension were then 
deposited on a carbon-coated copper grid (Agar Scientific, Stansted, UK) which was 
used as the TEM specimen.  The grid was dried in air at room temperature prior to use 
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in the double tilt holder of the TEM. Image JTM software (version 5.0) was used for 
estimating particle sizes, using a sample of 200 particles for each measurement. 
2.6.6 Powder X-ray Diffraction 
A Bruker AXS D4 EndeavourTM XRD diffractometer was used for XRD collection of 
all samples. The data were collected in the 2θ range from 5 to 80 ° with a scanning step 
of 0.05 ° and a count time of 2 sec.step-1 using Cu-Kα radiation (λ = 1.5406 Å). 
DIFFRACplus EvaTM software was used for the phase analysis of the data by spectral 
matching with standard reference patterns. The crystallite sizes were estimated by using 
the Scherrer equation. 
                                             L = 0.9 λ / β cos θ 
Where L = crystallite size, β = full-width half maximum,  λ = wavelength of X-rays 
(1.5406 nm for Cu- Kα), and  θ is the angle corresponding to the peak. 
2.6.7 FTIR Spectroscopy  
Chemical structural properties of HA and other Group 2 metal phosphates were 
analysed using Fourier Transform Infrared spectroscopy (FTIR), Nicolet 6700 FTIR 
(Thermo Nicolet, UK). A Photo-Acoustic sampling accessory was used, which allowed 
analysis of neat samples, without the need for any sample preparation. The sample 
chamber was purged with helium gas. The FTIR spectra were collected in the range 
4000 - 400 cm-1 at 4 cm-1 resolution averaging 256 scans. Background was obtained 
using carbon black.  
2.6.8 Raman Spectroscopy 
A Confocal Raman Thermo Nicolet DXR™ Spectrometer, equipped with a 780nm laser 
was used in order to obtain further confirmation of chemical structural properties and in 
addition provide supplementary crystallographic data and confirm substitutions in the 
apatite lattice. Samples were analysed in powder form as neat materials without any 
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sample preparation. The spectral Acquisition parameters used were; 100 scans, 5.4 mw 
laser power, and the spectra obtained at 4 cm-1 resolution.  
2.6.9 BET Surface Area Analysis 
BET surface area (N2 adsorption) measurements of all samples were made using an 
ASAP 2420 micromeritics BET machine which is capable of analysing six samples 
simultaneously, whilst degassing twelve additional samples. Prior to use, sample tubes 
were washed with methanol and then dried overnight in an oven at 100 °C. The powder 
samples were accurately weighed and degassed for 12 hours at 180 °C prior to BET 
analyses.  
After degassing, they were weighed again and then analysed for nitrogen absorption. 
Liquid N2 was supplied by BOC, UK. The absorption isotherm data and surface area  
were recorded for different samples. 
 
Figure 2-10 BET surface area analysis measurement 
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2.6.10 Dynamic light scattering 
DLS measurements were taken using a Malvern Instruments Zetasizer operated in 
backscatter (173 °) mode. The sample slurry produced by the CPFS process (solid 
content ~ 1% by volume) was diluted with methanol then placed in an ultrasonic bath 
for 10 minutes to disperse the sample. Square cuvettes with a path length of nominally 
10 mm were used for measurements. The intensity of light scattered by the sample was 
recorded  with the measurement angle of 173 °). The hydrodynamic diameter was taken 
as an average of at least ten measurements. 
2.6.11 Zeta potential measurements 
Zeta potential measurements were taken using a Malvern Instruments Zetasizer 
operated in backscatter mode (173 °). The electrical charge on the particle surface which 
provides information about the colloidal stability of the system was performed by using 
a procedure based on the knowledge of zeta potential, by application of the Helmholtz-
Smoluchowski model [30-32]. The relationship between electrophoretic mobilitiy and 
zeta- potential is shown by this equation.  
                                                 2εzf(Ka) / 3 η 
where Ue is the electrophoretic mobility, ε is the dielectric constant, z is the zeta 
potential, f(Ka) is Henry’s function, and η is the viscosity. 
The measurements were carried out using an electrophoretic technique in which the 
sample slurry produced by the CPFS process (solid content ~ 1% by volume) was 
diluted with methanol then placed in an ultrasonic bath (Model USC100T, VWR, East 
Grinstead, UK) for 5 minutes to disperse the sample. A clear disposable zeta cell was 
used as a measurement chamber for analysis and the colloidal stability was determined 
by measuring electrophoretic mobility of the dispersed particles in the applied electric 
field. The reported values for zeta potential are the average of at least three repeat 
measurements.      
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2.6.12 Electrophoretic deposition  
Electrophoretic deposition was carried out in a self-made EPD cell, consisting of a 250 
ml glass beaker and a holder for fixing electrodes. The electrodes were parallel to each 
other connected to a MA410 3DC power supply. Both the cathode and anode were of 
the same dimensions. The deposition electrode was the cathode. The deposition of HA 
particles on the 316L stainless steel substrate was performed at the constant voltage of 
50 V and various deposition times ranging from 1 min. to 20 min. For this purpose, a 2 
wt% suspension of HA was prepared by suspending 2g of the powder in 100 mL 
ethanol. Electrodes were dipped in the suspension and the distance between two 
electrodes was kept at 2 cm. For a uniform deposition and acquirement of stable 
suspension, the suspension was ultrasonicated for 10 minutes prior to deposition on the 
metal substrate.  
 
       Figure 2-11 Schematic diagram of electrophoretic deposition of dispersed 
nanoparticles 
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2.7 In vitro biocompatibility  
2.7.1 Culture of human osteoblast cells  
MG63 human osteocarcoma-osteoblast cells were expanded in complete culture 
medium consisting of Dulbecco’s Modified Eagle’s Medium (DMEM) (Biosera, 
Uckfield, East Sussex, UK) supplemented with 10 % fetal calf serum (FCS), 2 mM L-
glutamine and 100 mg.mL-1 penicillin and streptomycin (Sigma-Aldrich, Dorset, UK). 
Cells were kept incubated at 37 oC with a 95 %  oxygen and 5 % CO2 humidified 
atmosphere and media changes were performed every 2-3 days. The disc-shaped  
sample pellets (13 mm diameter) were sterilised in 70 % ethanol for 1 hour followed by 
PBS washes. Sample discs were then seeded with 25,000 cells and cultured for 7 days 
with media changes every 2-3 days. MG63 cells were used between passages 60-65 and 
cellular responses to the sample discs were evaluated by cell viability assay and cell 
morphological appearance.  
2.7.1.1 Cell viability 
Cell viability of MG63 cells on sample discs was assessed at days 1, 4 and 7 of culture 
using Resazurin (7-hydroxy-3H-phenoxazin-3-one-10-oxide) assay. The Resazurin 
assay incorporates an oxidation-reduction (REDOX) indicator that fluoresces in 
response to metabolic activity from growing cells. Briefly, culture medium was 
removed from cells and a known amount of fresh medium containing 0.1 mM Resazurin 
sodium salt (Sigma-Aldrich, Dorset, UK) was added and cells were incubated at 37 oC 
for 4 h. Negative controls or sample discs with no cells showed a blue coloured solution 
(oxidised) while samples with cells showed a purple-pink coloured solution (reduced). 
Reduction of Resazurin was detected using fluorescence in opaque 96-well plates on a 
FLx800 microplate fluorescence reader (BioTek, Potton, Bedfordshire, UK) using 
wavelengths of 540 nm excitation and 635 nm emission.  
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2.7.1.2 Cell morphology  
Cellular morphology of MG63 cells on sample discs was visualized at day 7 using 
fluorescence microscopy. Briefly, cells were fixed in 3.7 % formaldehyde and 
permeabilized with 0.5 % Triton-X100 before staining with DAPI (4′,6-diamidino-2-
phenylindole dihydrochloride) (1 µg mL-1) and phalloidin-TRITC (phalloidin-
tetramethylrhodamine B isothiocyanate) (1 µg mL-1) (Sigma-Aldrich, Dorset, UK) for 
cell nucleus and actin-cytoskeleton respectively. Images were captured using an Image 
Express™ epifluorescent microscope (Axon Instruments/Molecular Devices, Union 
City, CA, USA) using the built in x20 objective. Individual images of nucleus and 
cytoskeleton were compiled together using Image JTM (Image Processing and Analysis 
in Java, National Institute of Health, Bethesda, Maryland, U.S.). 
2.7.1.3 Statistics 
All material characterization techniques were performed on all samples using the CPFS 
reactor. Cell experiments were performed twice in triplicate and samples made at 
different reaction conditions were compared for significant differences using one-way 
ANOVA followed by Tukey’s post-hoc test. All quantitative data are presented as mean 
± standard deviation. Significant differences are marked as * p < 0.05. 
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Chapter 3  
Rapid and Continuous Plastic Flow Synthesis of 
Phase Pure Nano-Hydroxyapatite  
3.1 Introduction 
Calcium phosphates (CaP) are well known for their use as bone graft substitutes, 
coatings on metallic implants, as reinforcements in biomedical composites and as 
components in bone and dental cements (Elliott, 1994, Hench, 1991, Willems et al., 
1992). Hydroxyapatite (HA) [Ca10(PO4)6(OH)2] is chemically similar to biological 
apatite, the main mineral constituent of teeth and bone (Liu et al., 2001a), and exhibits 
comparable  biocompatibility, bioactivity and low solubility in wet media. HA and other 
calcium phosphates have been employed as scaffold materials to encourage new bone 
formation for osteoinductive coatings on metal implants and as a bulk bone filler 
(Hench, 1998b, Hench, 2000, Katti, 2004). The dissolution of calcium phosphate 
bioceramics (in vivo and in vitro) is highly dependent on the particle size, composition, 
and crystallinity of the powder as well as the pH of the solution in question (Klein et 
al., 1990, Ducheyne et al., 1993).  
Multiple techniques have been used for the preparation of HA powders and coatings 
including solid state syntheses (Güler et al., 2011), spray pyrolysis (Jokanović and 
Uskoković, 2005), sol gel techniques (Hench and West, 1990),  chemical vapour 
deposition (CVD) (Darr et al., 2004), solvothermal processes (Wang et al., 2006b), 
microwave synthesis (Nazir et al., 2013) and wet precipitation methods (Haque et al., 
2007). The majority of the described literature methods for the production of nano-
sized HA powders are either multi-step, inconsistent, energy intensive or time 
consuming (Wang et al., 2006b, Pang and Bao, 2003, Phillips et al., 2003, Lim et al., 
1997, Kothapalli et al., 2005, Kim et al., 2005) and the wet chemical methods almost 
always require very careful control over reaction pH during the mixing of two or more 
reagents. For example, batch hydrothermal syntheses of HA powders have normally 
been performed in the temperature range 60 – 150 °C for up to 24 h to produce 
crystalline HA rods that are usually agglomerated (Arce et al., 2004). For room 
temperature batch syntheses, failure to permit enough maturation time for the reagents 
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gives a non-stoichiometric as-prepared powder, which then phase separates into two 
phases upon heat-treatment, which can affect biological properties in vivo (Li-yun et 
al., 2005). Thus, there is an interest in developing simple, low cost, and reproducible 
techniques, which could work under relatively mild conditions to synthesize high 
purity HA and other ceramic materials in a short timeframe with well-defined particle 
size.   
Hydroxyapatite synthesized by the different aforementioned literature techniques is 
considered to be an ideal and frequently studied biomaterial for coating depositions on 
metallic implants. Multiple techniques have been used for the preparation of HA coating 
deposition on metallic implants such as sputter coating (Lacefield, 1988), plasma 
spraying (Dey et al., 2009), pulse laser deposition (Paital et al., 2010), dip coating 
(Wang et al., 2010), doctor blade (Yano et al., 1998) and electrophoretic deposition 
(Stoch et al., 2001). The major problems related to high temperature deposition 
processes, such as plasma spraying, besides the HA decomposition, are associated with 
difficulties to produce a uniform coating over the complex substrate geometry. To 
overcome these issues the electrophoretic deposition (EPD) of high surface area of as-
prepared HA nano-precipitates can be used. This is an alternative to using commercially 
available pre-calcined powders, which densify at temperatures typically higher than 
1200 ∘C on metal substrates (Kaminski et al., 1968, Balla et al., 2010, Kim et al., 1997).   
Electrophoretic deposition (EPD) is a versatile, cost effective, simple and rapidly 
expanding method attracting increasing interest as an important tool in advanced 
materials processing and nanotechnology for a wide range of technical applications 
(Ryan et al., 2006, Iqbal et al., 2012, Zhitomirsky and Gal-Or, 1997). In order to 
effectively apply this technique to process materials, it is essential to produce a stable 
suspension containing charged particles free to move when an electric field is applied. 
Therefore EPD can be applied to any solid that is available as a fine powder or as a 
colloidal suspension, including metals, polymers, ceramics and glasses. However, a 
post-sintering step is normally needed to further densify the deposit, to eliminate 
porosity and to enhance the bonding strength between coating and metal substrate 
(Paital and Dahotre, 2009, Sygnatowicz and Tiwari, 2009, Fathi and 
Doostmohammadi, 2009). Metals are frequently used as orthopedic implants because 
of their mechanical properties and formability (Sarkar and Nicholson, 1996, Wei et 
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al., 2001). However, metals are nonbioactive with poor adhesion strength and release 
toxic ions when in direct contact with surrounding living tissue (Boccaccini and 
Zhitomirsky, 2002, Van der Biest and Vandeperre, 1999). Therefore, coating of metal 
implants with bioceramics, such as hydroxyapatite (HA) or bioactive glass encourages 
natural bone growth at the interface of the prosthetic device (Heavens, 1990, Besra 
and Liu, 2007).  
The UCL Clean Materials Technology Group has prior expertise in use of high 
temperature routes to HA and its variants, and they recognize the limitations of the 
process, namely that the CHFS process uses high temperatures and pressures to generate 
bioceramics which are likely to be contaminated with metals from the reactors at levels 
that are far above those which would be acceptable for their use in clinical applications. 
Furthermore, many of the particle sizes obtained (65-150 nm) in such reactors are not 
particularly small indeed are very similar to those obtained using more conventional 
synthesis methods (Chaudhry et al., 2006, Chaudhry et al., 2008, Darr and Poliakoff, 
1999). Smaller particles would open up and improve many applications such as more 
rapid dissolution (due to higher surface area) or use as injectable or as a hard filler for 
bone replacement. Therefore, there is a desire to be able to produce smaller nano-sized 
calcium phosphates using methods which allow for fine control over particle sizes, 
preferably under relatively mild conditions of temperature and pressure, and with a 
purity acceptable for use in a clinical setting such as for bone replacement. 
In this chapter, the rapid and continuous plastic flow synthesis (CPFS) reactor for the 
production of phase pure stoichiometric HA at (near) ambient conditions (room 
temperature to up to 80 °C), and at atmospheric pressure over a period of a few minutes 
is described. In this new flow system, aqueous solutions of calcium nitrate tetrahydrate 
and diammonium hydrogen phosphate were mixed and heated for a residence of 5 
minutes at a pH in the range ca. 10-11. It was observed that particle properties could be 
affected, e.g. such as particle size and shape, by selection of conditions such as the bath 
temperature, reaction pH, reaction time in flow and variation in Ca:P ratio [UK Patent 
Filed Application No. 1317747.2].  
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3.2 Experimental 
3.2.1 Synthesis of Stoichiometric Nano-Hydroxyapatite 
Method 1: Phase pure nano-hydroxyapatite (HA) was prepared using a simple CPFS 
system as described in section 2.2.1. The experimental process involved pumping 0.3 
M phosphoric acid solution and 0.5 M calcium hydroxide solutions into the CPFS 
reactor (Ca:P molar ratio 1.67) via separate Gilson pumps. Both reagent solutions were 
pumped at 20 mL min-1, to meet at a T-piece. This initial mixture was connected to 8 m 
long tubing (surrounded by an oil bath set at the desired temperature). The flow rates 
used for calcium hydroxide and phosphoric acid solutions for pump 1 and pump 2, 
respectively, were selected to give a total residence time of 5 minutes. The product 
suspension was collected in a beaker at the exit point of the process. The precipitation 
of HA can be described by equation. 
10[Ca(OH)2] + 6 H3PO4                  [Ca10(PO4)6(OH)2] +18 H2O 
Method 2: Pure nano-hydroxyapatite (HA) was-prepared using a CPFS system the 
design of which is described in section 2.2.1. The reagents used in the process were 0.3 
M diammonium hydrogen phosphate solution and 0.5 M calcium nitrate solution, 
respectively (gives Ca:P molar ratio 1.67). The pH of the precursors was made up to 10 
by adding 5.0 mL and 15.0 mL of ammonium hydroxide to calcium nitrate (500 mL), 
and diammonium hydrogen phosphate solutions (500 mL), respectively. Both reagent 
solutions were pumped at 20 mL min-1, The flow rates used for calcium nitrate and 
diammonium hydrogen phosphate solutions for pump 1 and pump 2, respectively, were 
selected to give a total residence time of 5 minutes and the product suspensions were 
collected in a beaker at the exit point of the process. The precipitation of HA can be 
described by the following equation. 
10[Ca(NO3)2.4H2O] + 6[(NH4)2HPO4] + 8NH4OH              [Ca10(PO4)6(OH)2] 
+20NH4NO3 + 46 H2O 
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The aqueous suspension obtained from both procedures were washed, centrifuged, 
frozen and then freeze-dried. Details are given in section 2.3.2. The as prepared HA 
samples were each heat-treated at 1200 °C for 1hr according to ISO standard methods 
[ISO13779-3] to confirm the thermal stability and phase purity of the obtained 
nanopowders.  
3.2.1.1 HA Disc Preparations 
For cell biocompatibility studies, the obtained as-prepared powder was compacted into 
cylindrical discs of 13 mm diameter and 2 mm thickness by using a laboratory hydraulic 
press at 5 MPa.   
3.2.1.2 Electrophoretic Deposition Procedure 
A 2 wt% suspension of HA was prepared by suspending 2 g of the powder in 100 mL 
ethanol. Electrodes were dipped in the suspension and the distance between the two 
electrodes was kept 2 cm. For a uniform deposition and acquirement of stable 
suspension, the suspension was utrasonicated for 10 minutes prior to deposition on 
metal substrate.  
Electrophoteric deposition was carried out in a self-made EPD cell, consisting of a 150 
mL glass beaker and a holder for fixing electrodes at a distance of 15 mm. The 
electrodes were parallel to each other connected to a MA410 3DC power supply (Iskra). 
Both the cathode and anode were of the same dimensions. The deposition electrode was 
the cathode. The electrophoretic deposition of HA particles on the 316L stainless steel 
substrate plates was performed at a constant voltage of 50 V, since it was determined to 
be optimal for EDP of HA deposition onto the 316L steel. The experiments were 
performed at various deposition times ranging from 1 min. to 20 min. at constant voltage 
of 50 V. The current density of 1 mA was recorded during the deposition process. The 
coated substrate was withdrawn from the suspension and dried in a convection oven at 
80 °C for 24 h. In order to obtain a thick HA coating, a repeated deposition method was 
employed instead of single deposition to overcome deposit spalling problem. The 
quality of coatings not only depends strongly on the applied current density and the 
corresponding voltage but also on the conductivity and Zeta potential of the HA 
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suspension. Coating morphology was studied by scanning electron microscopy (Jeol, 
model JSM-6301F). 
3.2.2 Synthesis of Hydroxyapatite and Effect of System Parameters 
3.2.2.1 Effect of Reaction Temperature 
Six separate reactions were carried out to study the effects of different reaction 
temperatures on the end products using the CPFS system and keeping all other 
parameters same. The CPFS system is described in section 2.2.1.  
For each case, samples were synthesized under basic pH 10 conditions with a Ca:P ratio 
of 1.67. 59 g (0.25 moles) and 19.8 g (0.15 moles) of calcium nitrate and diammonium 
hydrogen phosphate were separately dissolved in 1000 mL deionised water for stock 
solution. The pH was adjusted to pH 10 by adding 30 mL ammonium hydroxide solution 
to each solution. The samples were labeled as HA30, HA40, HA50, HA60, HA70 and 
HA80 (where the number represents the bath temperature), depending on reaction 
temperatures ranges from 30 to 80 °C, respectively. The pH values were measured from 
suspensions immediately after collection.  
Pump rates of 20 mL min-1 were used for calcium nitrate and diammonium hydrogen 
phosphate solutions. All reactions were carried out at atmospheric pressure. Results 
showed that apatite obtained below 60 °C after heat-treatment at 1200 °C for 1 hour was 
impure synthetic hydroxyapatite whilst phase pure hydroxyapatite was obtained at 60, 
70 and 80 °C, respectively. Details are summarized in Table 2-3. 
3.2.2.2 Effect of Different Flow rates  
In total, five different reactions were carried out using the CPFS system (described in 
section 2.2.1). 59 g of calcium nitrate were dissolved in 1000 mL deionised water to 
result in 0.25 M stock solution. The pH of this solution was adjusted to pH 10 by adding 
30 mL of neat ammonium hydroxide solution. 19.8 g of diammonium hydrogen 
phosphate were dissolved in 1000 mL of deionised water to result in a 0.15M stock 
solution. Reactions were carried out using 200 mL of calcium nitrate and diammonium 
hydrogen phosphate solutions for each case.  
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The calcium nitrate and diammonium hydrogen phosphate solutions were pumped at  
50, 40, 30, 20 and 10 mL min-1, respectively at 60 °C and atmospheric pressure. After 
collection, all samples were centrifuged, washed and freeze-dried as explained earlier; 
see section 2.3.1.1. The product was obtained as a free flowing fine white powder with 
~ 85 % yield.   
3.2.2.3 Effect of Precursor Concentration 
A series of experiments (six in total) were carried out by varying concentration and by 
keeping all other parameters the same. For each case, samples were synthesized under 
basic pH 10 conditions with Ca:P ratio 1.67.  
The fine HA powder obtained from all reactions using different concentration were 
hereafter referred as 1HA, 0.5HA and 0.25HA and 0.125HA.. It was observed that 
tailoring reaction concentration while keeping the reaction time at five minutes in all 
reactions greatly influenced the particle size and specific surface area (summarized in 
Table 2-5). All reactions were carried out at 60 °C and atmospheric pressure. The 
product was obtained as fine white powder with ~ 85 % yield.  
3.2.2.4 Effect of System Parameters on Surface Area and Yield 
In total, seventeen different reactions were carried out by changing reaction 
temperature, flow rate and concentration using the CPFS system described in section 
2.2.1.  For each case, samples were prepared under pH 10 conditions with Ca:P ratio 
1.67. All temperature, flow rate and concentration regime designations are summarized 
in detail in tables 2-4, 2-5 and 2-6, respectively.  
The surface area and product yield of all these reactions were calculated and it was 
observed that by increasing reaction concentration and temperature, surface area 
decreased, whereas particle size increased with almost the same product yield (~ 85 %).  
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3.3 Results and discussion 
3.3.1 Synthesis of Hydroxyapatite (Effect of Temperature) 
3.3.2 Transmission Electron Microscopy 
Transmission electron microscope images of sample HA60 as shown in Figure 3-1 
confirmed that small crystallites had been obtained.  
 
Figure 3-1 Transmission electron microscope images of hydroxyapatite nano-rods of 
sample HA60 synthesized using calcium nitrate and diammonium hydrogen phosphate 
precursors at 60 °C and five minutes residence time via CPFS (a), bar = 200 nm, (b), 
bar = 20 nm, (c),  bar = 50 nm and (d), bar = 100 nm.  
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Phase pure as prepared HA synthesized using calcium nitrate and diammonium 
hydrogen phosphate solutions as starting materials at 60 °C in the CPFS system had a 
rod like particulate morphology and average length along the longest axis of each 
particle was ca. 25 ± 5 nm and 5 ± 1 nm along the smaller axis (200 particles sampled). 
The phase pure HA particles synthesized using calcium hydroxide and phosphoric acid 
solutions as starting reagents as shown in Figure 3-2, had almost the same particle size 
(ca. 20 ± 5nm) and surface area (254 m2g-1). This study revealed that the CPFS process 
works equally well with different nature of precursors (acidic or basic).  
 
Figure 3-2 Transmission electron microscope images of hydroxyapatite nano-rods of 
sample HA60 synthesized using calcium hydroxide and phosphoric acid precursors at 
60 °C and five minutes residence time via CPFS (bar  = 100 nm).  
Hydroxyapatite nanoparticles obtained at 70 and 80 °C possessed particle size of  ~ 80 
± 15 nm and ~ 95 ± 15 nm along the longest axis ca. 12 ± 5 nm and 15 ± 5 nm along 
the smaller axis (200 particles sampled) as shown in Figure 3-1. These results showed 
that reaction temperature is one of the key factor for attaining different particle sizes. 
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Figure 3-3 Transmission electron microscope images of hydroxyapatite nano-rods of 
samples HA70 and HA80 synthesized at 70 and 80 °C  in five minutes residence time 
via CPFS (a), (bar = 500 nm), and for (b), (bar = 100 nm).  
3.3.3 Scanning Electron Microscopy 
Hydroxyapatite sample synthesized at 60 °C in five minutes residence time and heat-
treated at 1200 °C for 1 hr possessed particle sizes of ca. 120 ± 15 nm along the longest 
axis and 60 ±10 nm along the smaller axis (200 particles sampled) as shown in Figure 
3-4 (a) and (b). SEM images were also captured for both as prepared and heat-treated 
(1200 °C, 1h) HA60 samples as shown in Figure 3-4 (c) and (d) respectively. 
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Figure 3-4 TEM images (a,b) and SEM images (c,d) of heat-treated hydroxyapatite 
nano-rods of samples HA60. 
3.3.4 BET Surface Area Analysis 
It was observed that tailoring the reaction temperature (60 – 80 °C), while keeping the 
reaction time constant at 5 minutes, greatly influenced the particle size and specific 
surface area as shown in Fig. 3-3. BET surface area measurements of as prepared HA60 
possessed a remarkably high surface area of 263.9 m2g-1.  To the best of our knowledge 
this is one of the highest surface areas ever reported in the current literature for as 
prepared phase pure HA powdered needles.  HA70 and HA80 samples made with the 
same residence time of 5 minutes, revealed smaller suface areas of 195.48 and 113 m2g-
1 respectively. On the other hand, heat-treated HA60, HA70 and HA80, revealed surface 
areas of 9.5 ± 0.1, 5.9 ± 0.1 and 4.9 ± 0.1 m2 g-1, respectively.  
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3.3.5 Powder X-ray Diffraction 
The powder X-ray diffraction data of phase pure hydroxyapatites generally displayed 
broad peaks due to the apatite structure as shown in Figure 3-5. Post synthesis heat-
treatment studies were performed on all three as prepared HA samples made at 60, 70 
and 80 °C respectively, to confirm the phase purity and stoichiometry of as prepared 
samples.  
 
Figure 3-5 Powder X-ray diffraction patterns of phase pure as prepared hydroxyapatite 
made at temperature (a), 60 °C (sample HA60), (b), 70 °C (sample HA70), and (c), 80 
°C (sample HA80). 
Non-stoichiometric HA generally gives the phase- separated product upon additional 
heat-treatment above 1000 °C which can significantly affect biological properties in 
vivo and in vitro. Figure 3-7 showed that upon heat-treatment at 1200 °C for 1 hour, the 
X-ray diffraction peaks became considerably sharper and well resolved and gave a good 
match to the phase pure hydroxyapatite (reference pattern JCPDS [09-432]). 
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Other studies carried out by lowering temperature (below 60 °C and time (below 5 
minutes) have shown that apatite obtained below 60 °C after heat-treatment at 1200 °C 
for 1 hour was not phase pure synthetic hydroxyapatite as shown in Figure 3-6. This 
observation showed that the residence time is an important factor in order to achieve a 
stoichiometric hydroxyapatite and that CPFS can confer high-temperature stability of 
the apatite powders if the correct conditions are used.  
 
Figure 3-6 Powder X-ray diffraction patterns of products made at temperature (a), 30 
°C (b), 40 °C  and (c), 50 °C, respectively. 
3.3.6 Heat-treatment Studies 
No additional peaks were observed in heat-treated samples of HA60 (synthesized at 60 
°C, five minutes residence time via CPFS) even at 1200 °C for one hour which revealed 
excellent high temperature stability of as prepared HA powders made via CPFS. Figure 
3-7 depicted the heat-treatment studies of HA60 at different temperatures ranging from 
200 to 1200 °C.  
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It was observed that the conduction of reactions at 60 oC required a maturation time of 
at least 5 minutes in the flow system, and that, for the lowest temperature of 60 C, 
particle nucleation dominated, however, the particles had insufficient energy to grow 
larger via Ostwald ripening. So small particulates with very high surface area are 
obtained at 60 °C. 
 
 Figure 3-7 Heat treatment of phase pure HA60 at different temperatures made at   60 
°C via CPFS. 
3.3.7 Effect of Reaction Temperature 
The properties of the precipitated material depended on the temperature, concentration, 
pH, time and other precipitation conditions such as variation in Ca:P ratio and residence 
time.  It was observed that by increasing reaction temperature, the particle size increased 
whereas surface area decreased as shown in Figure 3-8. It was observed that by tuning 
the reaction parameters, products of any required particle size (ranging from 20-150 
nm) and surface area (ranging from 95-300 m2g-1) can be produced using CPFS system. 
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Figure 3-8 Effect of temperature on BET surface area and TEM particle size analysis 
3.3.8 X-ray Photoelectron Spectroscopy 
 A chemical analysis of phase pure HA sample HA60 was done by using XPS analysis 
as shown in Figure 3-9. The peaks at 134 eV corresponded to P 2p spectra of 
hydroxyapatite. While the binding energy values for O 1s and Ca 2p were measured as 
532 and 347 eV, respectively. The Ca 2p spectrum as shown in Figure 3-10 (a) could 
be resolved into two peaks for Ca 2p3/2 and 2p1/2 (two spin-orbit pairs) at 347.4 and 
351.3 eV, respectively, which are related to hydroxyapatite. In Figure 3-10 (b), the 2p 
peak can also be deconvoluted into two peaks with a spin orbit splitting for p1/2 and p3/2 
levels with binding energy values of 134.2 and 133.4 eV, respectively. Figure 3-10 (c), 
depicts the core level spectrum of O 1s and the peaks at 530.4 and 531.8 eV are 
attributed to the phosphate group, and contribution of hydroxyl group in hydroxyapatite 
crystal, respectively (Mahabole et al., 2005, Costescu et al., 2010a, Lu et al., 2000).  
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Figure 3-9 XPS survey spectrum of phase pure HA60 sample made via continuous 
plastic flow synthesis 
3.3.9 Fourier Transform Infrared Spectroscopy 
  FTIR and Raman spectroscopy were used to analyse the samples and aid identification 
of different calcium phosphates. FTIR data of as-prepared HA samples (HA60, HA70 
and HA80) showed characteristic peaks of phase pure, stoichiometric HA. The peak at 
3569 cm-1 was assigned to the O-H stretching mode (νs) of the hydroxyl group (Rehman 
and Bonfield, 1997) in the spectra of HA60, HA70 and HA80 as shown in Fig. 3-11. 
The hydroxyl band at 3569 cm-1 in the spectrum of HA60 has a lower intensity 
compared to HA70 and HA80, which is also masked by broad H2O absorption (Figure 
3-11). It was observed that the hydroxyl peak grew stronger and sharper with increasing 
synthesis temperature from 60 to 80 °C as shown in Figure 3-11. The intensity of peak 
1639 cm-1 corresponding to the bending mode (ν2) for absorbed water was observed to 
decrease with increasing synthesis temperature. This suggested that loosely bonded OH- 
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groups became more incorporated into the lattice with an increase in reaction 
temperature.  
 
 
Figure 3-10[a-c] XPS Spectra of Ca 2p,O 1s and P 2p recorded from the phase pure 
HA60  
Peaks at 1453 and 1414 cm-1 were assigned to the stretching modes (ν3) of some 
adsorbed carbonate ions on the surface of HA. No HPO4
2- vibration at 867 cm-1 was 
observed. However, the carbonate vibration at 872 cm-1 corresponding to the bending 
mode (ν2) of the O-C-O linkage in carbonate also became weaker in the HA80 sample 
with increasing synthesis temperature. The peak at 637 cm-1 corresponded to the νL 
vibration mode of hydroxyl group in all HA samples made at 60, 70 and 80 °C, 
respectively using novel CPFS reactor. 
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Peaks at 1100 and 1031 cm-1 corresponded to the (P–O) asymmetric stretching mode 
(ν3) of phosphate, whilst the peak at 961 cm-1 corresponds to the symmetric stretching  
(ν1) of the same bond. The sharpness and intensity of peaks at 602, 564 and 466 cm-1 
corresponding to the bending mode of the O-P-O linkage in phosphate, increased with 
increasing reaction temperature from 60 to 80 °C as shown in Fig 8c. The most obvious 
change in the spectrum of HA80 is the increase in the hydroxyl peak centered at 3569 
cm-1 compared to the HA60 and HA70 samples made on the CPFS reactor.  
 
Figure 3-11 FTIR spectra of phase pure hydroxyapatite synthesized at (a), 60 °C( 
HA60)  (b), 70 °C (HA70) and (c), 80 °C (HA80), respectively  
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3.3.10 Raman Spectroscopy 
  Raman spectroscopy was conducted in order to supplement crystallographic data and 
detect substitutions in the apatite lattice. The peaks in the Raman spectra shown in 
Figure 3-12 corresponded to those normally observed for HA (Penel et al., 1998). The 
peak at 965 cm-1 for HA60, HA70 and HA80 corresponded to a symmetric stretching 
mode (ν1) of the P-O bond in phosphate.  
 
Figure 3-12 Raman spectra of phase pure hydroxyapatite synthesized at (a), 60 °C 
(HA60)  (b), 70 °C (HA70) and (c), 80 °C (HA80), respectively. 
It was observed that peaks became narrower and more intense with increasing synthesis 
temperature in the sample HA80 as compared to the samples HA70 and HA60 made via 
CPFS. Peaks at 610, 593 and 583 cm-1are likely to correspond to the bending mode (ν4) 
of the O-P-O linkage in phosphate as shown in Figure 3-12. Peaks at 1078, 1049 and 
1030 cm-1 corresponded to asymmetric stretching modes (ν3) of the P-O bonds in 
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phosphate. An increase in intensity and sharpness of these peaks with temperature, 
indicated an increase in crystallinity with increasing temperature. 
3.3.11 Cell Viability Study 
Human osteoblast cells (MG63) were cultured on CPFS HA disks from and cell viability 
was studied over the course of 7 days (Figure 3-13). At day 1, cell viability was similar 
on all HA disk samples indicating that initial cell attachment was not enhanced by any 
surface. At day 4, cell viability increased on both HA 60 and HA 70, while it remained 
constant on HA 80, when compared with day 1.  
 
Figure 3-13 MG63 viability on HA discs. Cell viability was measured at days 1, 4 and 
7 via Alamar blue assay for MG63s cultured on HA 60, HA 70, HA 80 and cHA (Mean 
± SD, n = 6). * p <0.05.  
A similar trend was observed at day 7, however, all HA samples had an increased cell 
viability compared with day 1 and 4. At both days 4 and 7, HA 60 had significantly 
higher cell viability then both HA 70 and HA 80, while HA 70 had significantly higher 
cell viability than HA 80. MG63 viability on commercial HA (cHA) was compared with 
HA samples prepared using novel CPFS method and was initially higher (day 1) than 
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all prepared HA samples. Cell viability on cHA remained higher than HA 70 and HA 
80 at all time points but at days 4 and 7 it was equal to and less than HA 60. These 
results indicate that the newly developed CPFS technique for the production of HA, has 
made samples which are biocompatible and that support osteoblast proliferation. 
However, for these samples, cell viability at day 7 was dependent on preparation 
temperature (60 > 70 > 80). 
3.3.12 Cell Morphology 
MG63 morphology was observed at day 7 (Figure 3-14) on each HA type. Cells were 
evenly distributed on cHA and showed a typical square-like osteoblast morphology. 
MG63s were also evenly spread across the surface of HA 60 and showed an osteoblastic 
morphology but the cell cytoskeleton was also more elongated than on cHA and the 
cells appeared to form cell-cell bridges. 
On HA 70, cells were more spares and generally less-well spread than those on cHA 
and HA 60, with the majority showing a rounded morphology. MG63s on HA 80 were 
also generally quite rounded and formed clusters. These results indicate that even cell 
spreading and anostoeblastic morphology are favoured on HA60 compared with HA70 
and HA80 and that they compare well with cHA.    
3.3.13 Zeta Potential Measurements 
Zeta potential measurements were performed in order to investigate the colloidal 
stability related to surface charge of the pure HA.  
Zeta potential gives the electrostatic potential of particles which is directly related to 
their dispersion stability; the higher the zeta potential values the greater the electrostatic 
repulsion and therefore the higher will be the colloidal stability of the suspension. The 
pH value has been shown to influence the Zeta potential and conductivity of HA 
suspension. This implies that we can adjust the pH value of suspension by the addition 
of acid or alkaline (HNO3,NaOH) to a desirable one, so as to obtain an ideal and stable 
suspension of HA particles. 
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Figure 3-14 MG63 morphology on HA discs. Cells were visualised at day 7 for cell 
nucleus (DAPI in blue) and cytoskeleton (phalloidin-FITC in green) for MG63s 
cultured on HA 60, HA 70, HA 80 and commercial HA. Scale bar is 100 µm.  
The Zeta potentials of HA suspension at different pH were analysed using a zeta 
potential analyser. A zeta potential of -70 mV was measured for as prepared HA at pH 
10.5 which indicated a high negative surface charge as shown in Figure 3-15. The higher 
surface charge would be expected to stablise the particles from agglomeration.  
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               Figure 3-15 Zeta potential measurement of as prepared HA at different pH 
3.4 Electrophoretic Deposition on Metallic Implants 
The SEM image in Figure 3-16 shows the as prepared HA coating on 316L stainless 
steel substrate by EPD at 50 V for 5 min. The coating was found to be homogenously 
deposited on the surface with no major visible cracks and a few surface level pores.  
 
Figure 3-16 HA coating on 316L Stainless steel before heat-treatment 
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Figure 3-17(a-h) Scanning electron micrographs of surface morphologies of different 
coatings, (a), (b) 5 min. deposition time, (c), (d) 10 min. (e), (f) 15 min. and (g), (h) 20 
min. deposition time at 50V. 
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Surface analysis of the deposition carried out at the ﬁxed voltage of 50 V for 5, 10, 15 
and 20 min revealed that the surface is packed with agglomerates resulting in a rough 
porous surface (Figure 17e to h). The presence of surface pores is considered beneﬁcial 
for promoting osteointegration and providing pathways for diffusion of nutrients. It was 
observed that by increasing deposition time (20 min.), the adhesive strength and 
smoothness of coating reduced as shown in Figure 3-18. 
 
        Figure 3-18 HA coating on 316L SS for 20 min. deposition time at 50 V. 
Examination of the cross-section of the coating of HA onto 316L SS at 50 V for 10 min 
(Figure 3-19) showed well compact layer of coated HA onto the substrate, furthermore 
no evidence of delamination of the coating was observed at the interface, indicating that 
the coating is strong enough to tolerate imposed stresses which results from the 
constrained volume shrinkage during the drying cycle. 
 
Figure 3-19 Cross section morphology of HA coating on 316 L SS substrate for 10 min. 
at 50V. 
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3.4.1 Effect of other System Parameters on the Properties of 
Hydroxyapatite 
3.4.1.1 Effect of Different Flow rates / Residence Time 
Residence time is considered an important factor to get the phase pure nanosized 
hydroxyapatite particles. A series of different reactions were performed using a CPFS 
system at different residence time ranging from 0 to 50 minutes as shown in Figure 3-
20. It was observed that at 60 °C, the system takes 5 minutes to produce phase pure 
hydroxyapatite with remarkably high surface area and very small particle size. While if 
we go above 60 °C, we get phase pure product in considerably less time period (even 
less than one minute at 80 °C).  
 
Figure 3-20 Relationship between residence time and reaction temperature on the phase 
purity of product. 
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3.4.1.2 Effect of Reaction Concentration 
The reaction concentration is also considered a key factor after temperature to obtain 
phase pure nano-sized hydroxyapatite of required surface area and size. The method 
worked at all concentration ranging from mMoles to Moles. It was observed that at 
lower reaction concentration, the particles with high surface area (~ 265 m2g-1) and 
small particle size (~20 nm) were obtained. The method worked equally well at higher 
concentrations of precursors. However, the particle size increases, with a subsequent 
lowering of surface area as shown in Figure 3-21. Therefore, at higher concentrations 
of precursors, the method can still be used for the rapid and continuous manufacture of 
stoichiometric hydroxyapatite or other bioceramics (e.g. calcium phosphates and their 
derivatives). Under such conditions, the particles are typically around one hundred 
nanometers or more in length and surface areas are about 100 m2g-1as shown in Figure 
3-21. 
 
        Figure 3-21 Effect of concentration on BET surface area and TEM particle size analysis 
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3.4.1.3 Effect of System Parameters on the Surface Area and Yield 
For this study, a series of reactions were carried out by changing reaction parameters 
one at one time to see the effect of each system parameters on the surface area, particle 
size and yield (%). It was observed that the variation in flow rates, residence time and 
temperature regimes gave minimal or no variation in product yield (~ 85 %) in all 
reactions. However these system variations in system parameters affected the particle 
size and surface area as summarized in table 2-3, 2-4 and 2-5.  It was observed that by 
tailoring reaction temperature, any specific products can be obtained with controlled 
particle size (in the range 25 - 95 nm) within 5 minutes at a synthesis temperature in the 
range of 60 to 80 °C with approximately the same yield ( ~ 85 %). 
3.5 Conclusions 
The work in this chapter constitutes the first ever report on synthesis of high surface 
area (95-300 m2g-1), nano-sized phase pure hydroxyapatite (20-150 nm) in a continuous 
plastic flow at near ambient conditions (room temperature to 80 °C and atmospheric 
pressure). Continuous (plastic) flow synthesis (CPFS) technique provides a rapid, facile 
and economical pathway to obtain high surface area, nano-sized HA and other calcium 
phosphate bioceramics and then coating these bioceramics onto metallic substrates.  
Cell toxicity analyses confirm the  biocompatiblity of this material. Cell culture 
experiments on HA discs using human origin osteocarcoma osteoblast cells showed 
diffrentiation into various cell types depending on the surface and culture conditions. 
Cell adhesion on HA60 (highest surface area) was substantially greater than HA70 and 
HA80. So these results indicate that high surface area nanosized HA rods have potential 
to be used in bone regeneration /replacement applications. 
Electrophoretic deposition studies performed at 50 V for 5 min furnished ca. 200 nm 
thick coating of 5% PVA coated HA on 316L SS. It was noticed that the addition of 5% 
PVA into HA powder successfully improved the adhesion of the powder on the substrate 
and thus eliminating the need for heat treatment of the coated substrate. Coating 
thickness and surface morphologies were effectively controlled by varying deposition 
time.  
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It was observed that all apatites made at CPFS at or above 60 °C, five minutes residence 
time, were phase pure. However, increasing reaction temperature and concentration 
above 60 °C, resulted in lower surface area and lager particle size and.  
It was observed that samples synthesized at 60 °C or above this temperature at pH 10 
were all phase pure with a wide range of particle size and surface area. Other samples 
made below 60 °C and pH 10, resulted in the phase separated product (with traces of β-
TCP). It is concluded that in the CPFS system, reaction temperature was the dominating 
factor for attaining more thermally stable apatites. 
From the literature reports of high temperature synthesis of HA we can see that at such 
high temperatures (200-300 °C), substantial growth or agglomeration of smaller nuclei 
occurs to form substantially larger particles typically > 100 nm in size.  Additionally, 
there is a disadvantage of having to use high temperature continuous reactors, in that 
they are metal pipes due to the high reaction temperatures and therefore if such a process 
were used to make bioceramics, they would contain substantial levels of leached metals 
from the steel. This would mean that the bioceramics may not be acceptable for clinical 
use according to the latest international standards and guidelines. Therefore this CPFS 
process represents a low cost, clean, synthesis technique, which works relatively under 
mild conditions and allows the synthesis of high purity stoichiometric HA and other 
bioceramic materials in a considerably short-time period with fine control over particle 
size )and surface area), well below 100 nm in size.  
 
 
 
 
3.6 Future Work 
Future work will address the ability of the CPFS nano-HA to support osteogenic 
differentiation. The combined cell observations indicate that high surface area 
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nanosized HA rods made via CPFS may have the potential to be used for biomedical 
applications where bone regeneration /replacement is required.  
Furthermore, this high surface area HA products will be utilized to make porous 
scaffolds by freeze casting process by the addition of polyvinyl alcohol (PVA) as a 
binder and emulsifying agent. The purpose of study is to enhance the mechanical 
strength of HA for applications in bone tissue engineering. It would be interesting to 
perform reactions at different reaction pH to obtain different HA morphologies.  
The high temperature stability (stable up to 1200°C) of these hydroxyapatite made via 
CPFS with remarkably high surface area (up to 263.9 m2g-1) and small particle size 
(typically 20nm) compared to that reported in the literature would make these 
nanobioceramics more promising materials for use in injectables, coatings on metallic 
implants, as fillers or additives into commercial products such as toothpastes, materials 
for the controlled release of drugs or other controlled release therapies, reinforcements 
in biomedical composites and in bone and dental cements. 
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Chapter 4  
Synthesis and Characterization of Phase Pure Brushite, 
Clacium Deficient HA and Tricalcium Phosphate 
Bioceramics 
4.1 Introduction 
Calcium phosphate (CaP) bioceramics are well known for their use in bone repair 
applications for use as bulk defect fillers, injectables, the hard phase of biocomposites 
and coatings on implants because of their excellent biocompatibility and 
osteoconductivity. There are numerous forms of CaP structures which typically form a 
family of compounds called ‘apatites’(Elliott, 1994). The general formula 
Ca10−x(HPO4)x(PO4)6−x(OH)2−x, with 0 ≤ x < 2, is non-stoichiometric apatite, while 
calcium phosphates have a Ca:P molar ratio starting from 0.5 for [Ca(H2PO4)2] to 2.0 
for [Ca4(PO4)2O]. Compounds such as brushite [CaHPO4.2H2O] and hydroxyapatite 
[Ca10(PO4)6(OH)2] have been the focus of many recent studies (Kundu et al., 2010a, 
Kundu et al., 2010b). Hydroxyapatite (HA) and brushite (DCPD) have been considered 
as potential bone substitute materials, of which the latter raised great interest in recent 
times because of its high resorbibility (Lemaitre et al., 1987, Lemaitre, 1995, Bohner, 
2000, Lu et al., 2002). Brushite powders are resorbed more quickly as compared to HA 
(Nilsson et al., 2002) as brushite is a metastable compound when used under 
physiological conditions (Vereecke and Lemaître, 1990). A significant characteristic of 
brushite is its use as a precursor for producing HA (Roop Kumar and Wang, 2001)[10-
12]. In addition, it is a common CaP phase stable under weakly acidic environments of 
pH range 4–6. However, its storage stability is questionable due to its instantaneous 
transformation to form HA. It can lose water to form monetite [CaHPO4] upon storage. 
However, in order to exploit the potential use of brushite for gene delivery, it is 
enormously important that the phase not only be synthesized under physiological 
conditions but also remain stable under those environments (Kumar et al., 1999, Fulmer 
et al., 2002) 
 
  128 
The most common method in the literature for synthesizing brushite is by the addition 
of a water soluble calcium source (e.g., CaCl2.2H2O, Ca(NO3)2.4H2O, or 
Ca(CH3COO)2.H2O) and a phosphate source (e.g., NH4H2PO4, (NH4)2HPO4, Na2HPO4, 
NaH2PO4, KH2PO4 or K2HPO4) at a Ca:P molar ratio of 1 under acidic conditions of pH 
in the range of 5-6. The precipitated product is typically washed with deionized water, 
and air-dried (Ngankam et al., 1999, Sivakumar et al., 1998, Skytte Sørensen and 
Lundager Madsen, 2000, Xie et al., 2002). In contrast, phase pure brushite powders can 
also be prepared by reacting Ca(OH)2 suspension with a stoichiometric amount of 
H3PO4 (Ca:P ratio 1.67) and maintaining the solution pH in the range 5-6 (Martin and 
Brown, 1997, Ferreira et al., 2003). Brushite can also be prepared by combining two 
phosphate powders in the presence of water (Charriere et al., 2001, Mirtchi et al., 1989, 
Van Landuyt et al., 1999) e.g. β-TCP (Ca3(PO4)2) and monocalcium phosphate 
monohydrate (Ca(H2PO4)2·H2O) in the presence of sodium pyrophosphate (Na2H2P2O7)  
as a setting regulator. Mixing of the powders is done in a sulfuric acid solution and 
brushite form is transformed into dehydrated monetite form by losing its water of 
crystallization upon heat-treatment at 110 oC (Linde, 1991). Based on the experimental 
solubility values of different calcium phosphate phases recently described by Tang et 
al. it is noted that phase pure brushite has a 3.4 times higher dissolution rate compared 
to TCP at pH 5.5 (Tang et al., 2003). 
Calcium deficient hydroxyapatite, CDHA) has also attracted much attention as 
components in injectable bone cements; regulating particle properties is frequently used 
to control cement setting behaviour (Hench, 1998b, Chaudhry et al., 2006). Natural 
bone consists of calcium deficient HA (Ca:P molar ratio <1.67) and possesses the high 
ion-exchange ability of various cations. Therefore, calcium-deficient HAP is extremely 
used as an ion-exchange media, such as the distillation of water and soil contaminated 
with heavy metals as well as biomedical applications (Nakahira et al., 2004, Nakahira 
et al., 2006). The dissolution of calcium phosphate bioceramics (in vivo and in vitro) 
was found to be dependent on the Ca:P ratio, crystallinity, and pH of the solution 
(Kannan et al., 2005, Yoshida et al., 2005, Kannan and Ferreira, 2006, Pan et al., 2003). 
 
 
 
In contrast, beta-tricalcium phosphate, β-TCP, [Ca3(PO4)2], another resorbable CaP 
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bioceramic, has a greater dissolution rate compared to HA in vivo. Thus, the use of 
biphasic calcium phosphate ceramics composed of HA and β-TCP mixtures for bone 
grafts can support rapid bone formation around the implant site compared to HA 
alone (Ginebra et al., 2004, Klein et al., 1983). 
TCP powders were commonly synthesized by solid state or thermal decomposition 
reactions. In thermal decomposition, calcium deficient hydroxyapatite was generally 
used for the synthesis under acidic conditions. TCP powder cannot be precipitated 
directly from an aqueous solution under room temperature, but it (also called 
whitlockite) can only be obtained when some of the calcium ions are replaced by Mg2+or 
Mn 2+ ions (LeGeros, 1986, LeGeros, 1990, Dorozhkin, 2000). 
Hydroxyapatite has become the most extensively studied calcium phosphate 
bioceramic but that of a biphasic HA/TCP powder is still under analysis. Biphasic 
HA /TCP powders can be synthesized as by product during the synthesis of pure HA 
and pure TCP or by the thermal treatment of calcium deficient HA (Ca/P = 1.5~ 
1.67) above 700 °C (Kohri et al., 1993, Ducheyne et al., 1993, Radin and Ducheyne, 
1993).  
In this chapter, the novel, continuous plastic flow synthesis process is used to synthesize 
phase pure brushite, beta-tricalcium phosphate and calcium deficient hydroxyapatite 
nanoparticles. The effect of changing pH and Ca:P molar ratio in solution on the final 
product is also addressed. Furthermore, use of brushite nanoparticles for the production 
of monetite and calcium pyrophosphates by additional steps such as heat treatments is 
also investigated.  
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4.2 Experimental 
4.2.1 Synthesis of Brushite Calcium Phosphate 
Phase pure brushite was prepared at room temperature using a simple CPFS system as 
described in section 2.2.1. 0.6 M diammonium hydrogen phosphate solution and 0.5 M 
calcium nitrate solutions were pumped in the CPFS (Ca:P molar ratio 0.8) using pump 
1 and pump 2, respectively. Both reagent solutions were pumped at 20 mL min-1, to 
meet at T-piece. This initial mixture were connected to 5 m long tubing surrounded by 
an oil bath at the desired temperature. For flow rates of calcium nitrate and diammonium 
hydrogen phosphate for pump 1 and pump 2, respectively, this gives a total time of 3 
minutes for the reaction. The pH of the reaction was maintained at 5.5 to obtain phase 
pure product. The final suspension was collected in a beaker at the exit point. A Sigma 
4K15 Centrifuge with a rotor housing four buckets, having a capacity of seven 50 mL 
Falcon tubes each, was used to centrifuge the aqueous slurries at 4500 rpm for 10 
minutes. After centrifugation, all samples were freeze-dried as described in section 
2.3.1.1. 
4.2.2 Synthesis of Calcium Deficient Hydroxyapatite  
Other calcium phosphate phases (β-TCP, CDHA) were also obtained by changing pH 
and Ca:P ratio (1.5~ 1.67) and by keeping other conditions same as summarized in Table 
2-6. The as-prepared calcium deficient hydroxyapatite was prepared at 70 °C using a 
simple continuous (plastic) flow synthesis system (CPFS). Details of the CPFS process 
are described in section 2.2.1. In this process, 0.3 M diammonium hydrogen phosphate 
solution and 0.48 M calcium nitrate solutions were used (Ca:P molar ratio: 1.6). The pH 
of both the solutions prior to the reaction was kept above pH 8.5. 5.0 mL of ammonium 
hydroxide were added to calcium nitrate (500 mL) and diammonium hydrogen 
phosphate solutions (500 mL), respectively. Both reagent solutions were pumped at 20 
mL min-1, to meet at a T-piece. This initial mixture were connected to 8 m long tubing 
surrounded by heating jacket. The flow rates used for calcium nitrate and diammonium 
hydrogen phosphate solutions for pump 1 and pump 2, respectively, were selected to 
give a total residence time of 5 minutes.  
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The pump rates of 20 mL min-1 were used for calcium nitrate and diammonium 
hydrogen phosphate solutions. The reaction was carried out at 70 °C and atmospheric 
pressure. The resulting suspension was centrifuged, washed and freeze-dried as 
explained earlier; see section 2.3.1.1. The product obtained was a fine white powder 
with  ~ 80 % yield. 
4.2.3 Synthesis of β-Tricalcium Phosphate 
 In this process, 0.3 M diammonium hydrogen phosphate solution and 0.45 M calcium 
nitrate solutions were used (Ca : P molar ratio: 1.5). Both reagent solutions were 
pumped at 20 mL min-1, to meet at a T-piece. This initial mixture were connected to 8 
m long tubing surrounded by a heating jacket. The reaction was carried out at 70 °C and 
atmospheric pressure. The resulting product was centrifuged, washed and freeze-dried 
as explained earlier; see section 2.3.1.1. The product obtained was fine white powder 
with  ~ 80 % yield. Phase pure crystalline product  (β-TCP) was obtained by the heat-
treatment of as-prepared powder at 1100 °C.  
The as prepared and heat-treated powdered samples were compacted into cylindrical 
discs of ca. 13 mm diameter and 2 mm thickness by using a hydraulic press at 5 MPa.   
 
4.3 Results and Discussions 
The precipitation of brushite from solution does not always take place at the start of the 
reaction. Ferreira and coworkers (Ferreira et al., 2003) reported that various steps are 
required in the formation of brushite. The first step is the quick precipitation of HA 
(Equation.1) and as a result of the decrease in pH, this is followed by the formation of 
brushite nuclei. At this stage, two species, brushite and HA coexist in the solution. 
Recent reports have shown that the crystallization rate of brushite is much greater than 
that of HA at room temperature (Singh et al., 2010). 
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Figure 4-1 Ions needed for the growth of HA [reproduced from Ferreira (Ferreira et al., 
2003) 
Thus, the existing HA can be transformed into dehydrated brushite form, resulting in an 
increase of pH as shown in Equation 2. 
5Ca(OH)2 + 3H3PO4                               Ca5OH(PO4)3 + 9H2O   (1) 
Ca5OH(PO4)3 + 2H3PO4 + 9H2O                    5CaHPO4 + 2H2O   (2) 
Ca(OH)2 + H3PO4                     CaHPO4 2H2O   (3) 
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4.3.1 Transmission Electron Microscopy 
Transmission electron microscope images of the samples are shown in Figure 4-2. This 
confirmed the synthesis of small crystallites with an average particle size along the 
longest axis of each particle of ca. 35 ± 15 nm (200 particles sampled) for CPFS phase 
pure brushite, with the particles having a roughly spherical morphology. 
 
Figure 4-2 Transmission electron microscope images of brushite synthesized at room 
temperature in 3 minutes residence time via CPFS (a,c) magnification 50k (bar = 500 
nm), (b,d) magnification 200k (bar = 100 nm) 
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On the other hand, particles obtained from CDHA had flower like, tubular 
morphology and possessed  particle size of ca. 95 ± 15 nm as shown in Figure 4-3. 
TEM images of sample whitlockite possessed spherical morphology with the 
average particle size of ~ 45  ± 15 nm (100 particles sampled).  
 
 
 
Figure 4-3 Transmission electron microscope images of calcium deficient HA made at 
70 °C  in five minutes residence time via CPFS (a,c) magnification 50k (bar = 500 nm), 
(b,d) magnification 200k (bar = 100 nm)  
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Figure 4-4 Transmission electron microscope images of beta-tricalcium phosphate  (a) 
magnification 50k (bar = 500 nm), (b) magnification 200k (bar = 100 nm)  
BET surface area measurements (N2 adsorption) of as precipitated HA and CDHA 
samples yielded sufrace areas of ca 195 and  80 m2 g-1, respectively while heat-
treated samples at 1000 °C for one hour revealed surface areas of 4.9 ± 0.1 and 5.9 
± 0.1 m2 g-1, respectively. The results of the present study are in agreement with 
previous reports that indicate that the amorphous HA made at ambient conditions 
possesses a surface area of 90 m2 g-1 after oven-drying and 113 m2 g-1 after freeze-
drying (Chaudhry et al., 2006). 
4.3.2 Powder X-ray Diffraction 
XRD analysis indicated that the as-synthesized products obtained at a lower temperature 
of 22 °C were exclusively brushite particles (Safronova et al., 2009). The XRD patterns 
shown in Fig. 4-5 show the most intense peaks are at 2θ values of ca. 11.6, 20.9, 23.6 
and 29.3° assigned to the (020), (121), (040) and (112) Miller indices of brushite.  The 
XRD data, confirmed that the products obtained were fairly well-crystallized. 
Brushite is readily transformed into monetite (CaHPO4) by losing its water of 
crystallization upon heating above 110 oC [40] as described in Equation 4. The presence 
of calcium pyrophosphate (Ca2P2O7) in a heat-treated sample indicates the presence of 
HPO4
2−. This phase can be formed by the loss of one H2O molecule from two HPO4
2− 
groups of brushite under high-temperature conditions. The transition of monetite into 
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pyrophosphate typically occurs at temperatures above 400 °C as described in Equation 
5. 
CaHPO4·2H2O → CaHPO4 + 2H2O   (4)  
2CaHPO4 → Ca2P2O7 + H2O   (5) 
The results of the present study are in agreement with previous reports (Tas and Bhaduri, 
2005) that indicate that the brushite can be transformed into monetite (in this case at ca. 
180 °C) and the monetite to calcium pyrophosphate transition is possible (here it was 
completed above 440 °C). Thus, an alpha calcium pyrophosphate phase was observed 
at both 500 and 700 °C. Furthermore, a beta-calcium pyrophosphate phase was obtained 
after heat treatment at 850 or 1000 °C, respectively.  
The presence of calcium pyrophosphate in a heat-treated brushite sample indicates the 
presence of HPO4
2−. Calcium pyrophosphate is formed by the loss of one H2O molecule 
from two HPO4
2− groups of brushite under heat treatments at various conditions. The 
transition of monetite into pyrophosphate typically occurs at temperatures above 400 
°C. 
The powder X-ray diffraction results confirmed that the products obtained at 70  °C 
in five minutes residence time using CPFS reactor (HA, β-TCP, CDHA and biphasic 
HA / β-TCP)  were phase pure. The lattice constants of HA were similar to reference 
JCPDS Pattern no. 09-432. No decomposition of HA into other phases was observed 
even after heating at 1200 °C in air for 1h.  
The XRD plot obtained for the sample Whitlockite showed good agreement and 
excellent match with JCPDS pattern 09-0426 Syn Ca3(PO4)2]. 
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Figure 4-5 Brushite nanoparticles made at room temperature in five minutes residence 
time via CPFS and heat-treated  at 300 °, 500 ° and 1000 °C.  
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      Figure 4-6  X-ray diffraction patterns of pure HA, CDHA, HA+TCP and β-TCP 
4.3.3 FTIR Spectroscopy 
Brushite formation was also confirmed by FTIR spectral analysis. Figure 4-7 shows the 
FTIR spectra of products obtained at different temperatures. The spectra exhibit easily 
distinguishable bands attributed to PO4
3− for the non heat-treated form of brushite. 
Bands at ca. 525 and 575 cm-1 were attributed to the ν4 bending vibrations of the P-O-
P linkage. Peaks at 873 and 1225 cm-1 were assigned to the HPO4
2- group of brushite 
were observed in all samples.  
The data were in good agreement with the previous reports of Vallet-Regi and 
Gonzalez-Calbet (Joshi and Joshi, 2003, Vallet-Regi and González-Calbet, 2004) and 
Lu and coworkers (Lu et al., 2006). A band at 985 cm-1 was due to the P-O(H) ν1 
symmetric stretching vibration of PO4
3-. Whilst a peak at 1060 cm-1 was due to the ν3 
vibration of the PO4
3- group. A broad band in the range 3400–3600 cm-1 was observed, 
due to the stretching (νs) mode of H-bonded OH− or water. The FTIR spectra thus show 
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that the nano-particles obtained in the as-synthesized samples were brushite, whereas 
calcium pyrophosphate was obtained after calcination. 
 
 Figure 4-7 FTIR spectra of brushite nanoparticles obtained at different temperatures 
FTIR and Raman spectroscopy were used to analyze the different calcium 
phosphates samples (made at 70 °C in five minutes residence time via CPFS) and 
aid identification of different calcium phosphates as shown in Figure 4-8. FTIR data 
revealed peaks at 3420 and 632 cm-1 (corresponding to stretching vibrations of the 
hydroxyl group in HA. The intensity of a peak at 1637 cm -1, corresponding to the 
bending mode for lattice water, was observed to decrease with increasing synthesis 
temperature. Peaks at 1453 and 1414 cm-1 correspond to the stretching modes, 
respectively, of some substituted carbonate in the HA. 
 
 
 
 
  140 
The weak absorption peak at 880 cm-1 was assigned to the P–O–H vibration in the 
HPO4
2- group which exists in non-stoichiometric HA. Peak at 1031 cm-1 corresponds 
to the P–O asymmetric stretching mode of phosphate, whilst the peaks at, 534 and 
466 cm-1 correspond to O–P–O bending modes. An increase in intensity and 
sharpness of these peaks with temperature, indicates an increase in crystallinity.  
 
 
 Figure 4-8 FTIR spectra of pure HA, CDHA, HA+TCP and β-TCP nanoparticles 
obtained at different temperatures 
4.3.4 In-vitro Biocompatibility 
The osteoblast cells cultured on phase pure as prepared brushite samples (pressed discs) 
showed continuous proliferation as shown in Figure 4-9. The cells were seen to attach, 
spread and grow on the surface which indicated that material was non-toxic to the cells.  
A significant increase in the growth of osteoblast cells with culturing time was observed. 
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Figure 4-9 Human osteoblast cell proliferation as pressed discs of brushite nanopowder 
after 1, 4 and 7 days of culture  
   
Figure 4-10 Pressed discs of brushite nanopowder imaged at day 7, MG63 nucleus 
(blue) and cytoskeleton (green)  
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Morphological images taken of these cells on day 7 are shown in Fig. 4-10. The cells 
were round and almost flattened against the surface that showed the colony formation 
and was attributed to continuous proliferation. 
A human osteoblast cell proliferation study was conducted on all 4 samples (pure 
HA, CDHA, HA+TCP and β-TCP). The osteoblast cells cultured on all ceramic 
samples showed continuous proliferation. Cells were seen to attach, spread and grow 
on all types of samples as shown in fig. 4-11. A significant increase in the growth of 
osteoblast cells with culturing time was observed on all  samples, and the highest 
level of viability was observed for whitlockite. This could be due to the faster 
dissolution rate of whitlockite sample as compared to pure HA.  
 
 
Figure 4-11 MG63 viability on HA discs. Cell viability was measured at days 1, 4 and 
7 via Alamar blue assay for MG63s cultured on pure HA, CDHA, HA+TCP and 
whitlockite (β-TCP). 
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Figure 4-12 MG63 morphology on HA discs. Cells were visualised at day 7 for cell 
nucleus (DAPI in blue) and cytoskeleton (phalloidin-FITC in green) for MG63s 
cultured on pure HA, CDHA, HA+TCP and pure whitlockite (β-TCP). 
4.3.5   X-ray Photoelectron Spectroscopy 
A chemical analysis of the phase pure brushite sample was performed by using XPS 
analysis.  The XPS survey spectrum of brushite is shown in Figure 4-13. Besides the 
expected Ca, P and O peaks, a small C 1s peak was also observed which was due to 
carbon tape used for all analysis. The binding energy scale was calibrated by a C 1 s 
peak at 285.0 eV. The peaks at 134 eV corresponded to P 2p spectra of hydroxyapatite. 
The binding energy values for O 1s and Ca 2p were measured as  532  and 347 eV, 
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respectively. The Ca/P elemental ratio in the analysed sample was the expected one i.e 
0.8.   
 
         Figure 4-13 XPS Survey spectrum of phase pure brushite nanopowder 
The Ca 2p spectrum could be resolved into two peaks for Ca 2p3/2 and 2p1/2 (two spin-
orbit pairs) at 347.5 and 351.2 eV, respectively, which are related to calcium apatite 
[44]. In Fig. 4-15b, the 2P peak at 133.8 eV  can also be deconvoluted into two peaks 
with a spin orbit splitting for p1/2 and p3/2 levels with binding energies of 134.2 and 
133.4 eV, respectively (Lee et al., 2003, Lu et al., 2000).  
 
Figure 4-15c, shows the XPS spectrum of O 1s and the peaks at 530.6 and 532.2 eV that 
are attributed to the phosphate group, and adsorbed water in apatite crystal, respectively 
[46]. These values were consistant with those measured for standard brushite powders 
(within the 0.2 eV precision of the measurements) (Mahabole et al., 2005, Landis and 
Martin, 1984).  
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Figure 4-14 [a-c] XPS Spectra of Ca 2p,O 1s and P 2p recorded from the phase pure 
brushite made at room temperature in 3 minutes residence time via CPFS system. 
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4.4 Conclusions 
The reactive crystallization and thermal decomposition study of brushite was conducted 
in a plastic flow reactor. Different phases were observed in the synthesis of brushite. 
The first phase that was formed in situ was HA followed by the appearance of few 
crystals of brushite. Both phases coexist in the solution for first two minutes of the flow 
reaction. However after a reaction time of at least two minutes at room temperature and 
pH 5.5 HA transformed to phase pure stable brushite crystals. The reaction pH and 
temperature were shown to play an important role in the formation of single phase 
brushite.  
Cell toxicity analysis of the brushite as pressed discs confirmed the biocompatibility of 
this material as a consequence of  cell proliferation up to 7 days. Thus the obtained 
brushite nanopowder is a promising candidate material to be considered for further use 
in biomedical applications where bone substitution or controlled resorbibility of bone 
grafts is requied. 
It was observed that by tailoring Ca:P ratio and pH and by keeping other reactor 
parameters the same, any phase pure calcium phosphate product with contolled 
particulate properties can be achieved using CPFS system. 
In summary, Continuous  (plastic) flow synthesis (CPFS) technique provides a rapid (as 
low as 3 minutes), facile and economical pathway to obtain brushite and other calcium 
phosphate bioceramics with high purity, suitable size and ultra low level of impurities. 
The results of the in vitro studies showed that the all synthesized samples (pure HA, 
CDHA, HA+TCP and pure whitlockite) are biocompatible. Hence the current work 
deals with the preparation of synthetic calcium phosphates with optimum properties 
closer to those of living hard tissues like bone and teeth, aiming at better and more 
effective biomedical ceramics for use as powders or as nanocomposites in future efforts.  
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4.5 Future Work 
Since the solution pH was determined to be the dominating factor in order to get the 
accurate phase along with Ca:P ratio It would be interesting to use different pH ranges 
(acidic and basic) for attaining a range of different calcium phosphates and their nano-
composite mixtures. 
The current work deals with the preparation of synthetic phase pure calcium phosphates 
with optimum properties closer to those of living hard tissues like bone and teeth, aiming 
at better and more effective biomedical ceramics for use as powders or as 
nanocomposites in future efforts. 
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Chapter 5  
Continuous Plastic Synthesis and Characterization of 
Nano-sized Magnesium and Strontium Substituted 
Calcium Apatite  
5.1 Introduction 
Calcium phosphate bioceramics are well known for their use in bone repair applications 
for example as bulk defect fillers, injectables, the hard phase of biocomposites and 
biocompatible coatings on implants. Synthetic hydroxyapatite (HA), 
[Ca10(PO4)6(OH)2], is chemically similar to the mineral component of hard tissues 
(biological apatite) and is widely used in hard tissue augmentation and replacement with 
slow resorption (Elliott, 1994, Wu et al., 2004, Hench and Wilson, 1993). HA can 
physiochemically bond to bone and promote bone formation, which is necessary for 
implant osseointegration. Osseointegration is needed to repair bone loss and to increase 
implant efficiency and stability (Norhidayu et al., 2008).  
Biological and physiochemical properties of HA can be tailored by the substitution of 
Ca with certain ions, some of which are present in the natural apatites of bone. Most 
biological apatites are non-stoichiometric because of the presence of minor constituents 
which include cations e.g. Mg2+, Mn2+, Zn2+, Na+, Sr2+ or anions e.g. HPO4
2− or CO3
2−. 
HA is capable of accepting substitute ions within its lattice and trace ions substituted in 
apatites can effect lattice parameters as well as crystallinity, dissolution kinetics, surface 
charge and other physical properties (Miao et al., 2005).  
Magnesium (Mg2+) is a divalent cationic substitute for calcium (Ca2+) in the HA lattice. 
Such substitution often reduces crystallinity, increases solubility, and lowers the 
temperature at which conversion of HA into β-Tricalcium phosphate (β-TCP) occurs 
(Suchanek et al., 2004b, Wu et al., 2005, Bertoni et al., 1998, Suchanek et al., 2004a). 
As the amount of substituted magnesium affects thermal stability of apatite or other 
phases, this has implications for sintering behavior [3]. For example, the β-TCP to α-
TCP phase transformation normally occurs at ca. 1180°C for the pure Ca compounds. 
However, Mg2+ substitution for Ca2+ can increase the transformation temperature up to 
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ca. 1500 °C (Chaudhry et al., 2008, Bigi et al., 1993, Yoshida et al., 2005). This enables 
enhanced sintering of β-TCP at elevated temperatures without deleterious formation of 
α-TCP (the latter is a less bioactive polymorph). Magnesium substitution levels of up 
to 1.6 wt% have been reported using wet precipitation reactions (BLUMENTHAL, 
1989). Surprisingly, as much as 28.4 wt% in HA has also been demonstrated in previous 
studies using mechano-chemical synthesis routes (Mayer et al., 1997). However, an 
excess of Mg2+ can also be detrimental as it is known to reduce bioactivity in vivo in 
certain biomaterials (Suchanek et al., 2004b). The complete substitution of Mg2+ for 
Ca2+ in HA has been shown to prohibit the formation of an extracellular matrix and has 
deleterious effect on bone cells (Yang et al., 2005, Zyman et al., 2006, Serre et al., 
1998). 
Mg2+ as one of the key substitutes for Ca2+ in natural apatites and is expected to have 
reasonable biocompatibility and favorable biological properties. Human bone, enamel 
and dentine comprise 1.0, 0.4, and 1.2 wt% of Mg2+, respectively, and it is believed that 
Mg2+ ions may play an important role in the initial formation of tooth apatites and have 
a significant effect on their physiochemical properties. As well as Mg-HA, other phases 
such as Mg-whitlockite can also be made from precipitation reactions at relatively low 
temperatures (< 95°C) which has been known as a promising bone replacement material 
because of its high bioactivity and resorbable properties.   (Serre et al., 1998, Chaudhry 
et al., 2008).  
Among the group 2 cations that can replace calcium in HA, Sr2+ has gained interest for 
its possible beneficial biological role. Strontium is present in the mineral phase of bone 
and connective tissue at levels of 320-400 mg of strontium. Clinically, strontium has 
been observed to confer beneficial effects on bone growth especially at the regions 
where high metabolic turn-over occurs (Blake et al., 1986). It also known to be 
beneficial in the treatment of osteoporosis. In vitro, strontium increases the number of 
osteoblast cells followed by the reduction osteoclast cells whereas strontium 
administration decreases bone resorption and stimulates bone formation.  Furthermore, 
in addition to its antiresorptive activity, strontium has been found to have anti-
osteoporosis and antiosteopenic acitivity in animal models. The beneficial effects in 
osteoporosis were as a result of mechanical strength of bone (in animal models). 
Strontium treatment increased bone mineral density (BMD), bone mineral content 
  150 
(BMC), bone volume and microarchitecture, reduced bone fracture risk and improved 
the mechanical performance of whole bone without affecting the estimated material 
properties of the bone tissue (Canalis et al., 1996, Panzavolta et al., 2008, Grynpas et 
al., 1996, Marie et al., 2001, Dahl et al., 2001, Marie, 2005).  
Strontium can replace calcium in the HA structure across the compositional range. The 
solid solutions, which have previously been obtained by hydrothermal methods or by 
treatment at high temperatures, display a linear variation in the lattice parameters with 
composition. Other literature reports suggested the replacement sites of Sr for Ca in Ca-
HA (Zhu et al., 2006, Kikuchi et al., 1994, Bigi et al., 1998).  
In this chapter, CPFS system is successfully used to synthesize magnesium and 
strontium substituted calcium phosphate bioceramics with unique physical and 
compositional attributes (ion substitution level, particle size, crystallinity and phase 
composition) that possess novel properties, which would be useful in the development 
of bioceramics.  
5.2 Experimental 
5.2.1 Synthesis of Magnesium Substituted Calcium Phosphates 
All samples were made at 70 °C using a novel continuous plastic flow synthesis (CPFS) 
system. The details of the CPFS system are described in section 2.2.1. In the synthesis 
process, separate reservoirs of calcium nitrate with different wt% of metal ions (Ca + 
Mg)/P = 1.67) ranging from 1 to 10 wt%, and diammonium hydrogen phosphate, 
respectively, were pumped to meet at a Polyflon™ T-piece through a Polyflon™ 
straight union reducer. Amonium hydroxide was used to maintain the pH of both the 
solutions prior to the reaction above pH 10. The residence time from the T-piece to the 
exit of the tubing was 5 minutes. All reactions were carried out at 70 °C and atmospheric 
pressure. The product was collected as a suspension in a beaker at the exit point and 
centrifuged, washed and freeze dried as explained earlier in section 2.3.1.1. The dried 
free flowing white powders were then heat-treated at 1000 °C for 2 hours in air at the 
heating rate of 10 °C/min.  
 
In total, ten reactions were carried out using magnesium nitrate as magnesium ion 
source. The samples were labelled as 1Mg-CaP, 2Mg-CaP, 3Mg-CaP, 4 Mg-CaP, 5Mg-
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CaP, 6 Mg-CaP, 7Mg-CaP, 8Mg-CaP, 9Mg-CaP and 10Mg-CaP, respectively. The 
numbers in the sample IDs represent the expected magnesium content (wt%). The dried 
white powders were then heat-treated at 1000 °C for 2 hours in air at the heating rate of 
10 °C/min.  
5.2.2 Synthesis of Strontium Substituted Calcium Phosphates 
Strontium-substituted calcium phosphates were made using CPFS system, the details of 
which are described in section 2.2.1. In the synthesis process, basic solutions of calcium 
nitrate and strontium nitrate (total conc. = 0.5M and (Ca + Sr)/P = 1.67) and 
diammonium hydrogen phosphate, respectively, were pumped to meet at a 1/16 inch 
Polyflon™ T-piece through a 1/8 in. Polyflon™ straight union reducer. The pH of both 
the solutions prior to the reaction was kept above pH 10. This initial mixture was 
connected to 8 m long 1/16 inch Polyflon™ PTFE that was coiled inside an oil bath, 
which gave an effective 5 minutes from the tee to the exit of the pipe. The suspension 
was collected in a beaker at the exit point and was then centrifuged at 4500 rpm for 10 
minutes. All samples were washed and freeze-dried as explained earlier; see section 
2.3.1.1. The product was obtained as white fine powder with approximately 85% yield. 
In total, seven reactions were carried out using strontium nitrate as strontium ion source. 
The samples were labelled as 1Sr-HA, 5Sr-HA, 10Sr-HA, 15Sr-HA, 20Sr-HA, 25Sr-
HA, 30Sr-HA, respectively. The numbers in the sample IDs represent the expected 
strontium content (wt%). 
5.2.2.1 Disc Preparation 
The obtained powders from magnesium and strontium substituted calcium phosphate 
reactions were compacted into cylindrical discs of ca. 13 mm diameter and 2 mm 
thickness by using a hydraulic press at 5 MPa. These samples were used for cell viability 
studies after sterilization in 70 % ethanol for 1 hr.  
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5.3 Results and Discussions 
5.3.1 Transmission Electron Microscopy 
The novel CPFS system was successfully used for cation substitutions (Mg2+, Sr2+) of 
calcium phosphates. For selected samples, TEM images were collected to investigate 
the particle morphology with increasing magnesium content or with changes in phase. 
TEM images of sample pure HA, shown in Figure 5-1 (a) and (b), reveal distinct 
nanorods of size ~ 85 ± 15 nm (200 particles sampled), along the longest axis and ~ 15 
± 5 nm (100 particles sampled), along the smaller axis.  
 
 
Figure 5-1 Transmission electron microscope images of phase pure hydroxyapatite 
made at 70 °C in five minutes residence time via CPFS (a) = bar = 500 nm, (b) = bar = 
100 nm.  
TEM images of sample 1Mg-CaP [Figure 5-2 (a) and (b)] revealed small rod shaped 
agglomerates with the average particle size of ~ 70 ± 16 nm (200 particles sampled). 
Sample 6Mg-CaP [Figure 5-2 (c) and (d)] revealed semi-spherical shaped morphology, 
suggesting a deviation from the rod like morphology.  
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Figure 5-2 Transmission electron microscope images of sample (a), = Pure HA, bar = 
500 nm, (b) = Pure HA, bar = 100 nm, (c), = 1Mg-CaP, bar = 500 nm, (d) = 1Mg-CaP, 
bar = 100 nm, (e) = 6Mg-CaP, bar = 500 nm, (f) = 6Mg-CaP, bar = 100 nm, (g), (h) = 
10Mg-CaP, bar = 100 nm.  
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In contrast, TEM images of sample 10Mg-CaP possessed spherical morphology in large 
agglomerations with the average particle size of  ~ 35  ± 15 nm (100 particles sampled). 
The TEM images reveal that rounded Mg-whitlockite (identified from PXRD) particles 
are possibly hollow as shown in Figure 5-2 (e) and (f). 
 
Figure 5-3 Transmission electron microscope images of strontium substituted calcium 
phosphates made at 70 °C in five minutes residence time via CPFS 10Sr-HA (a) = bar 
= 200 nm, (b) = bar = 20 nm, 20SrHA (c) =  bar = 200 nm, (d) = bar = 20 nm, 30Sr-HA 
(e) = bar = 200 nm, (f) = bar = 20 nm.  
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TEM images were also collected for Strontium substituted HA to investigate the particle 
morphology and size. Figure 5-3 (a) and (b) for sample 5Sr-CaP reveal distinct nanorods 
of size ~ 75 ± 15 nm (100 particles sampled), along the longest axis. Further increase in 
strontium concentration lead to larger particles with rod like morphology as observed 
in Figures 5-3 (c) to (f) for samples 10Sr-CaP [~ 90 ± 15 nm] to 30Sr-CaP [100 ± 20 
nm], respectively. It was observed that the presence of strontium in the HA lattice 
slightly increased the particle size as compared to pure HA as shown in Figure 5-1 (a) 
and (b). 
5.3.2 Powder X-ray Diffraction 
The presented novel CPFS system was successfully used for magnesium substitution of 
calcium phosphates. Powder X-ray diffraction (XRD) data were collected for all 
samples to investigate how Mg substitution affected phase composition and phase 
purity. The PXRD data for samples up to 3 wt% Mg-CaP, shown in Figure 5-4, gave a 
good match to the standard line pattern for crystalline HA [ICDD pattern 09-0432, 
Ca5(PO4)3(OH)]. Samples 4Mg-CaP, 6Mg-CaP and 7Mg-CaP were identified as 
biphasic mixtures, with a good match to the aforementioned pattern for HA and 
whitlockite, respectively.  
Increasing the magnesium content further (8Mg-CaP and 10Mg-CaP) resulted in 
significantly broader peaks, which were assigned as phase pure Mg-whitlockite. This 
was not surprising, as magnesium is known to impede the crystallization and growth of 
calcium phosphates in solution and also to stabilize whitlockite. Table 5-1 also showed 
the different XRD phases along with measured magnesium contents in the product. The 
XPS analysis was used to determine the substitution level of magnesium in different 
calcium phosphate samples. It was observed from detailed measurement analysis that 
the measured magnesium contents in all samples were  very close to the expected value 
as shown in Table 5-1. 
It was noticed that particles with low magnesium contents were generally rod shape. 
Whilst more rounded agglomerates were observed by increasing magnesium 
concentration in reagent solution.  
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Figure 5-4 Powder X-ray diffraction patterns of heat treated (1000 °C, 1hr in air) Mg-
substituted calcium phosphates. The wt% values quoted are based on the amount of 
magnesium in the precursor feed.  
These results suggested that CPFS is an efficient method to obtain a variety of products 
by varying the substitution level (pure HA, biphasic mixture and pure whitlockite).  
The powder X-ray diffraction patterns of the dry heat treated (1000 °C in air for 1h) 
products with different strontium contents are shown in Figure 5-5. All the patterns 
indicated that they are constituted of hydroxyapatite as a unique crystalline phase. The 
XRD patterns of the HA samples containing both Ca2+ and Sr2+ ions together generally 
exhibit broader diffraction peaks, in agreement with a reduced degree of crystallinity.  
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Table 5-1 Sample identification corresponding to wt% based on XPS analysis along 
with XRD and BET surface area analysis. Key: HA = hydroxyapatite, Mg-HA = 
magnesium substituted hydroxyapatite, MgW = magnesium whitlockite, BCP = Mg-
HA + Mg-W. 
 
The broadening is more evident for the samples with smaller Sr content, suggesting a 
greater difficulty for Ca-HA to accomodate the larger strontium ion than for SrHA to 
host the smaller calcium ion.  
Sample ID 
          Mg 
Added (wt%) 
           Mg 
Measured (wt%) 
    XRD 
Phase 
BET Surface 
Area (m2g-1) 
Pure HA 0 0 HA 195 
1Mg-CaP 1 0.8 Mg-HA 160 
2Mg-CaP 2 2.1 Mg-HA 139 
3Mg-CaP 3 2.9 Mg-HA 119 
4Mg-CaP 4 3.7 BCP 91 
5Mg-CaP 5 5 BCP 95 
6Mg-CaP 6 5.8 BCP 80 
7Mg-CaP 7 6.5 BCP 75 
8Mg-CaP 8 7.4 MgW 81 
10Mg-CaP 10 9.1 MgW 102 
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Figure 5-5 Powder X-ray diffraction patterns of heat-treated (1000 °C, 1hr in air) Sr-
substituted calcium phosphates. The nominal wt% values quoted are named according to 
the amount of strontium ions in the precursor feed.  
5.3.3 BET Surface Area Analysis 
Figure 5-6 shows the trends in BET surface areas for the magnesium substituted calcium 
phosphate samples. For phase pure HA and 1Mg-CaP, the BET surface area were 
recorded as 195 m2g-1 and 160 m2g-1, respectively. Samples from 4Mg-CaP and 7Mg-
CaP (biphasic mixture) had lower surface areas of 91 and 75 m2g-1. whilst phase pure 
10Mg-whitlockite had a surface area of 102 m2g-1. One of the possible reasons for the  
lower surface area  is the increased particle agglomeration observed in TEM images 
(fig. 2 c-f). On the other hand, samples 8Mg-CaP and 10Mg-CaP (phase pure Mg-
whitlockite) revealed a noticeable increase in surface area (102 m2g-1) compared to 
biphasic mixture (see table 5.1). The afformentioned results can be supported by XRD 
and TEM as shown in Figure5-4 and Figure 5-2 (e, f). 
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Figure 5-6 BET surface area of as prepared HA, Biphasic Mg-HA and Mg-whitlockite 
calcium phosphates. The data points from left to right corresponded to samples Pure 
HA, 1Mg-CaP, 2Mg-CaP, 3Mg-CaP, 4Mg-CaP, 5Mg-CaP, 6Mg-CaP, 8Mg-CaP, 
10Mg-CaP. 
Table 5-2 shows the measured strontium contents and their effect on BET surface area 
of strontium substituted calcium phosphates. It was observed that the measured contents 
of strontium in the final product were lower than the actual contents added as shown in 
Table 5-2. By increasing strontium concentration, BET surface area decreased whereas 
particle size increased as shown in Figure 5-3. 
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Table 5-2 Sample identification corresponding to wt% based on XPS analysis along 
with BET surface area analysis 
5.3.4 X-ray Photoelectron Spectroscopy 
Chemical analyses of  magnesium substituted calcium phosphate sample (8Mg-CaP) 
were performed using XPS analysis as shown in Figure 5-7. The P 2p, Ca 2p, O 1s, and 
Mg 2p core level spectra of Mg-HA was taken as shown in Fig. 5. The Ca 2p spectrum 
could be resolved into two peaks [Figure 5-8 (a)] for Ca 2p3/2 and 2p1/2 at 347.4 and 
351.3 eV, respectively, which are related to hydroxyapatite. In Figure 5-8 (b), the 2p 
peak  can also be deconvoluted into two peaks for p1/2 and p3/2 levels with binding 
energies of 134.2 and 133.4 eV, respectively. Figure 5-8 (c), depicts the core level 
spectrum of O 1s and the peaks at 530.4 and 531.8 ev are attributed to the phosphate 
group, and hydroxyl group or adsorbed water in hydroxyapatite crystal (Mahabole et 
al., 2005, Costescu et al., 2010a, Lu et al., 2000), respectively. The Mg 1s core level 
spectrum can be deconvoluted into two peaks with the binding energies of 1304 and 
1307 eV, respectively as shown in Figure 5-8 (d). 
     Sample  
          ID 
             Sr 
Added (wt%) 
             Sr 
Measured (wt%) 
BET Surface Area 
           (m2g-1) 
Pure HA 0 0 195 
1Sr-CaP 1 0.4 154 
10Sr-CaP 10 7.1 143 
15Sr-CaP 15 11.9 138 
20Sr-CaP 20 14.2 132 
25Sr-CaP 25 18.5 135 
30Sr-CaP 30 21.1 121 
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Figure 5-7 XPS survey spectrum of magnesium substituted calcium phosphate (8Mg-
CaP) sample made at 70 °C in a continuous plastic flow reactor 
A representative survey spectrum for strontium substituted hydroxyapatite (10SrHA) 
made at 70 °C is presented in figure 5-9. The peak at 134 eV was an overlap of Sr 3d 
and P 2p because Sr 3d5/2 and Sr 3d3/2 with binding energies of 133.2 and 134.8 eV were 
very closed to P 2p3/2 and P 2p1/2 peaks with binding energies of 133.4 and 134.2eV, 
respectively. The deconvoluted spectra for O, Ca, P and Sr are presented in figure 5-10. 
The peaks at 134 eV corresponded to P 2p of the phosphate groups in hydroxyapatite. 
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Figure 5-8 [a-d] XPS Spectra of Ca 2p,O 1s and P 2p and Mg 1s recorded from the 
synthesized CaP sample 8Mg-CaP.  
The Ca 2p spectrum could be resolved into two peaks for Ca 2p3/2 and 2p1/2 (two spin-
orbit pairs) at 347.4 and 351.3 eV, respectively, which are related to hydroxyapatite [36] 
In Figure 5-10 (b), the 2P peak  can also be deconvoluted into two peaks with a spin 
orbit splitting for p1/2 and p3/2 levels with binding energies of 134.2 and 133.4 eV, 
respectively [37]. Figure 5-10 (c), depicts the core level spectrum of O 1s and the peaks 
at 530.4 and 531.8 eV are attributed to the phosphate group, and adsorbed water in 
hydroxyapatite crystal, respectively. The binding energy values for the Sr 3d spectrum 
were measured as 133.2 and 134.8 eV, respectively [38]. 
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Figure 5-9 XPS survey spectrum of strontium substituted calcium phosphate (10Sr-CaP) 
made at 70 °C in 5 minutes residence time via CPFS  
5.3.5 Fourier Transform Infrared Spectroscopy 
The FTIR spectrum for sample 1Mg-CaP as shown in Figure 5-11 showed peaks similar 
to those normally seen for HA. Peaks at 3570 cm-1 and 636 cm-1  corresponds to the 
hydroxyl group, whilst the peaks at 1150-990 cm-1 and 964 cm-1 correspond to 
asymmetric and symmetric  P-O stretching of the phosphate group, respectively. The 
peaks at 605 and 567 cm-1 correspond to the O-P-O bending mode. The intensity of 
hydroxyl peaks at 3570 and 633 cm-1 generally decreased with increasing content of 
magnesium in the corrersponding FTIR spectra. 
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Figure 5-10 [a-d]. XPS Spectra of Ca 2p,O 1s and P 2p recorded from 10Sr-CaP made 
via CPFS at 70 °C in five minutes residence time 
The samples with magnesium substitution of 6 wt% or higher revealed a broader 
phosphate peak in the range of 1550-1450 cm-1 which coincided with a decrease in 
crystallinity of Mg-whitlockite (as shown in XRD data, Figure 5-4). The band at 871 
cm-1 corresponding to ν2 stretching vibrations of the carbonate or hydrogen phosphate 
groups. Since the intensity of the major carbonate bands between 1420 and 1450 cm-1 
samples decreases with increasing magnesium as shown in Figure 5-11, this band can 
be attributed to the carbonate groups. 
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Figure 5-11 FTIR spectra of pure HA and Mg substituted calcium phosphates made at 
70 °C in a CPFS reactor. 
The FT-IR spectra for strontium-substituted calcium phosphate nanoparticles were also 
measured. It was observed that the solid solutions show a decrease in the relative 
intensity of the absorption bands due to O-H stretching and libration modes. 
Furthermore, the OH stretching band, which is at 3572 cm−1 in Ca–HA, progressively 
shifts to higher wave numbers on increasing the strontium content, up to 3590 cm−1 for 
Sr–HA, whereas the OH− libration band shifts from 630 to 537 cm−1, in agreement with 
the results previously reported for Ca–HA and Sr–HA [39]. The infrared absorption 
bands due to phosphate groups shift to lower wave numbers on increasing the relative 
content of strontium. Figure 5-12 shows how the bands due to the symmetric stretching 
(ν1) and bending (ν4) modes of phosphate groups move, respectively, ν1 from 962 
(Ca–HA) to 947 cm−1 (Sr–HA) and ν4 from 603 (Ca–HA) to 592 cm−1 (Sr–HA). 
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 Figure 5-12 FTIR spectra of strontium-substituted hydroxyapatite made at 70 °C in a 
CPFS reactor. 
5.3.6 Raman Spectroscopy 
Raman spectroscopy was conducted in order to supplement crystallographic data and 
detect substitutions in the apatite lattice.  Figure 5-13 shows Raman spectra for 
magnesium substituted calcium phosphates. Peaks  from 1 to 3 wt% Mg-CaP  are very 
similar to those observed for phase pure HA. Peaks at ca. 1080 and 1054 cm-1 in the 
Raman spectra, for these samples were attributed to asymmetric stretching  of the P–O 
bond in phosphate. The peak around 970 cm-1 corresponds to the symmetric stretching 
mode of the P–O bond of the phosphate group. In pure HA, this peak normally appeared 
at 963 cm-1. This peak shifting could be because of  the increased incorporation of 
magnesium in  the HA lattice. 
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Figure 5-13 Raman spectra of pure HA and Mg- substituted CaPs made at 70 °C in a 
CPFS reactor. 
Figure 5-14 shows the Raman spectra of strontium substituted calcium phosphates. The 
peak at 965cm-1 corresponds to a symmetric stretching mode of the P-O bond in 
phosphate. Peaks at 610 and 483 cm-1 are likely  corresponded to the bending mode of 
the O-P-O linkage in phosphate. Peaks at ca. 1080  and 1054 cm-1 in the Raman spectra 
correspond to asymmetric stretching of the P–O bond in phosphate. 
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 Figure 5-14 Raman spectra of strontium-substituted calcium phosphates made at 70 °C 
in a CPFS reactor. 
5.3.7 Zeta Potential Measurements 
Zeta potential measurements were performed in order to investigate the colloidal 
stability related to surface charge of the pure HA and strontium substituted HA. Zeta 
potential therefore can be considered as a measure of colloidal stability as it give the 
electrostatic potential of particles which is directly related to their dispersion stability 
by the electrostatic repulsion.  
The greater the electrostatic repulsion, the higher the zeta potential values and therefore 
higher will be the colloidal stability of the suspension.  A zeta potential of 28 mV was 
obtained for pure HA and 33 and 35 mV for 10 and 20 mol % strontium substituted HA, 
respectively which indicates the high positive surface charge. The higher surface charge 
shows the high zeta potential value, which protects the particle agglomeration resulting 
in a more stable dispersion. 
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5.3.8 Cell Viability Study 
Cell viability studies were investigated for 13mm diameter disks of pure HA, 4% 
biphasic and 8% pure whitlockite samples. Human MG63 osteoblast cells were cultured 
on CPFS Mg-CaP discs and analysed for cell viability at days 1, 3 and 7 (Figure 5-15). 
At day 1, cell viability was lowest for both heat treated (4Mg-CaP HT and 8Mg-CaP 
HT) discs while both as prepared (4Mg-CaP AP and 8Mg-CaP AP) discs had 
significantly higher viability but this was only 50 % that of pure HA.  
 
 
Figure 5-15 MG63 viability on CPFS Mg-CaP discs. Alamar blue viability assay was 
performed at days 1, 4, and 7 to observe MG63 viability on AP and HT CPFS Mg-CaP 
discs consisting of 4 % or 8 % Mg, as well as CPFS pure HA. Mean ± SD, * p <0.05.  
Cell viability increased on all compositions at day 4 suggesting that all discs supported 
cell proliferation, however, viability was significantly higher on as prepared 8Mg-CaP 
discs than all other Mg containing compositions and was similar to pure HA. At day 7, 
cell viability increased further for 8Mg-CaP discs and pure HA, with as prepared 8Mg-
CaP discs having higher viability than heat-treated discs and similar levels to pure HA. 
However, there was no increase in cell viability on as prepared 4Mg-CaP discs, which 
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showed similar levels to day 4. These results indicate that as prepared discs encouraged 
greater cell attachment than heat-treated discs while the presence of 8Mg-CaP sample 
encouraged greater cell proliferation than 4 Mg-CaP.  
 
Human osteoblast cell viability study was also carried out on selected as prepared 
samples of 5Sr-CaP, 10Sr-CaP and 20Sr-CaP, respectively. Pure HA sample made on 
the CPFS system was used as a control. It was observed that by increasing strontium 
content, cell viability increased. A considerable increase in cell viability was noted on 
day 7 for all three as prepared samples [5Sr-CaP, 10Sr-CaP and 20Sr-CaP].  It was 
determined that strontium substitution in calcium phosphate enhanced the cell viability 
as compare to pure HA as shown in Figure 5-16. 
5.3.9 Cell Morphology 
On pure HA, cells covered most of the surface and showed a typical osteoblastic 
morphology, with many cells overlapping in dense areas and some cells stretching out 
to other cells in less dense areas. There was a marked contrast in MG63 morphology 
and size between as prepared and heat-treated discs for both 4 % and 8 % Mg-CaP. 
Cells on as prepared discs had larger nuclei and expressed more actin than cells on heat-
treated discs as well as showing a more osteoblast-like morphology. Many of the cells 
on heat-treated discs were rounded up and showed little spreading. Figure 5-17 also 
shows that cells on all 4Mg-CaP discs were sparser than cells on comparable 8Mg-CaP 
discs, which is in good agreement with cell viability results.  
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Figure 5-16 MG63 viability on CPFS Sr-CaP discs. Alamar blue viability assay was 
performed at days 1, 4, and 7 to observe MG63 viability on AP CPFS Sr-CaP discs 
consisting of 5 % or 10 %  and 15 % Sr, as well as CPFS pure HA. Mean ± SD, * p 
<0.05.  
These results indicate that as prepared discs favour an osteoblastic morphology 
compared with heat-treated discs. The combined cell observations indicate that CPFS 
Mg-CaP are biocompatible, support cell attacment and proliferation and may serve as a 
potential biomaterial for bone regeneration/replacement therapies.  
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Figure 5-17 MG63 morphology of Mg-CaP discs made at 70 °C in a CPFS reactor. 
Cells were visualised at day 7 for cell nucleus (DAPI in blue) and cytoskeleton 
(phalloidin-FITC in green) for MG63s cultured on AP or HT Mg-CaP discs containing 
4 % or 8 % Mg as well as pure HA. Scale bar is 100 µm.  
Osteoblastic cell morphologys on some selected Sr-CaP samples (5Sr-CaP, 10Sr-CaP 
and 20Sr-CaP) were carried out on day 7. It was observed that cells formed bridges 
across the undulations and spread over them, which indicated that material was non-
toxic for cells. Morphological images were taken of these cells on day 7 as shown in 
Figure 5-18. There were no substantial differences in the cell morphology of all three 
samples. The cells were round and almost flattened against the surface that showed the 
colony formation and attributed to continuous proliferation.  
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Figure 5-18 MG63 morphology of Mg-CaP discs made at 70 °C in a CPFS reactor. Cells 
were visualised at day 7 for cell nucleus (DAPI in blue) and cytoskeleton (phalloidin-
FITC in green) for MG63s cultured on AP Sr-CaP discs containing 5 %, 10 %  and 15 % 
Sr as well as pure HA. Scale bar is 100 µm.  
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5.4 Conclusions  
Phase pure HA and a series of magnesium and strontium-substituted calcium 
phosphates were successfully synthesized using a CPFS system from calcium nitrate 
tetrahydrate [Ca(NO3)2.4H2O], and diammonium hydrogen phosphate [(NH4)2HPO4)] 
precursor solutions at (near) ambient conditions (70 °C, atmospheric pressure) in a rapid 
single step.  
Careful control of the quantities of reactants used, resulted in phase pure nano-sized HA 
rods, biphasic mixture of HA and pure Mg-whitlockite. Cell toxicity analysis showed 
excellent biocompatiblity of these materials. Increase in magnesium content above 3% 
led to precipitation of biphasic mixture of magnesium substituted hydroxyapatite 
starting from sample (1MgCa-P) and Mg-whitlockite. Magnesium content above 7% 
(shown by XPS) led to the formation of pure Mg-whitlockite. Increasing magnesium 
content affected the morphology of obtained particles, beginning from roundening of 
HA-rods till the formation of small nano-sized hollow spherical particles of Mg-
whitlockite.  
 The combined cell observations indicate that high surface area nanosized magnesium 
and strontium calcium phosphates made via CPFS were biocompatible and have the 
potential to be used for biomedical applications where bone regeneration /replacement 
is required. 
It is concluded that the CPFS system is a versatile and useful tool for the synthesis of 
pure and ion substituted calcium phosphates with tailorable properties such as 
composition, particle size, and surface area. With its unique features, the obtained 
product is a promising material with biological properties and has potential to be used 
in biomedical applications where small size, fine particle size distribution control and 
bone regeneration /replacement or controlled resorbibility of bone grafts is a vital 
requirment. 
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5.5 Future Work 
By using CPFS system parameters (temperature, flow rate / residence time, pH etc.) it 
would be interesting to improve cationic and anionic substitution levels in different 
calcium phosphates. Coupled ionic substitutions in calcium hydroxyapatite in the CPFS 
system would also be interesting. 
The results of the present study have shown that the addition of strontium to calcium 
phosphate greatly enhanced the cell viability. In addition, because of its antibacterial 
nature and radiopacity properties, It could be a better tool for dental restorative 
materials. The findings reported here should be helpful in future clinical investigations. 
Osteoblastic cell attachment and viability analysis confirmed the high biocompatiblity 
of magnesium and strontium-substituted materials.  Future work should address the 
ability of CPFS to support osteogenic differentiation and what affect cationic [Mg2+, 
Sr2+] concentration and heat-treatment has on this.  
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Chapter 6  
Synthesis and Characterization of Carbonate and 
Silicate-Substituted Calcium Phosphates Made via 
Continuous Plastic Flow Synthesis 
6.1 Introduction 
Synthetic hydroxyapatite, HA, [Ca10(PO4)6(OH)2], is a bioactive bioceramic that is 
chemically similar to the mineral component of hard tissues (biological apatite). HA is 
widely used in hard tissue replacement (Hench, 1991) because of its ability to stimulates 
bone formation, necessary for implant osseointegration. Rapid osseointegration is 
required to improve the implant efficiency and to decrease damage to adjacent tissues 
after implantation (Zdrenþu et al., 2004). HA properties can be enhanced by both 
cationic and anionic substitutions. Biological apatite is non-stoichiometric because of 
the presence of metal ions (Mg2+, Mn2+, Zn2+, Na+, Sr2+, HPO4
2− or CO3
2−). HA is 
capable of accommodating substitute ions within its lattice. Trace ions substituted in 
apatites can have a dramatic effect on crystallinity, dissolution kinetics and other apatite 
properties like surface charge, lattice parameters etc. (Miao et al., 2005).  
Human bone contains about 8 wt% (de Groot, 1983) of carbonate content, depending 
on the age of the individual (Rey et al., 1991, Burnell et al., 1980). Keeping in view the 
hydroxyapatite structure, carbonate groups can occupy both the hydroxyl and the 
phosphate site, offering both A-type and B-type carbonate substitution, respectively. In 
1963, Kuhl and coworkers (Kühl and Nebergall, 1963) suggested the following formula 
for B-type substitution in HA. 
Ca10-x+y(CO3)x(PO4)6-x(OH)2-x+2y 
The B-type carbonate substitution is more favorable and found in the bone of a variety 
of species, with the A/B type ratio in the range of 0.7–0.9 (Rey et al., 1989). The 
presence of B-type carbonate in the apatite lattice was shown to cause a higher solubility 
but decrease in crystallinity for both in vitro and in vivo tests (LeGeros, 1990). Moreover 
the A-type carbonate surface shown less affinity (as compared to un-substituted HA) 
  177 
towards human trabecular osteoblastic which was attributed by lower cell attachment as 
well as reduction in polar component of the surface of the A-type carbonate-substituted 
biomaterial (Redey et al., 1999, Redey et al., 2000).  HA bonding to adjacent tissue is a 
slow process, therefore, carbonate-substituted HA is considered as an optimised 
biomaterial because of faster bonding ability between an implanted surface and human 
bone. Carbonate ion substitution for phosphate ions involves a reduction in the number 
of calcium ions to maintain charge balance (Ito et al., 1997, Tang et al., 2003).  
   Although HA is known to be bioactive and osteoconductive it has a slow dissolution 
rate and reduced ability to form a stable interface with its surrounding tissue, and to 
encourage the new bone formation (Hench, 1993). Also, undoped HA does not degrade 
substantially but rather remains as a permanent fixture susceptible to long term failure 
(Mastrogiacomo et al., 2005). The substitution of silicon in the HA lattice is one of the 
possible method to improve the osseointegration (Porter, 2006). In 1970, Carlisle and 
coworkers described the function of silicon in bone, wherein the presence of 0.5 wt% 
silicon was stated in mineralised osteoid regions in mice and rats (Carlisle, 1970).  
According to Hench, the deterioration in the proliferation and function of osteoblasts 
due to osteoporosis are correlated with the loss of naturally existing silicon (Bianco et 
al., 2009, Hench, 1998b). Silicon has been reported to play a significant role in collagen 
formation (Carlisle, 1982)]. It has also been observed that silicon-substitution in HA 
leads to a smaller crystallite size and faster dissolution rate (Thian et al., 2006b, Porter 
et al., 2003, Botelho et al., 2006, Patel et al., 2002). Due to the significant role of silicon 
in calcified bone, attempts have been made to incorporate silicon in the HA lattice. 
Silicon-substituted HA has been synthesised using wet-precipitation and batch 
hydrothermal techniques (Kim et al., 2003, Gibson et al., 1999, Hing et al., 2006, Tang 
et al., 2005, Leventouri et al., 2003).  
 
 
 
Gibson et al. produced phase pure Si-HA by wet precipitation method using calcium 
containing source and a phosphate source under basic pH by using silicon acetate as the 
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source of silicate ions (Gibson et al., 1999).  
The efforts have also been made on the development of silicon-substituted HA coatings 
on metal implants for improved osseointegration (Thian et al., 2006a, Thian et al., 
2007). Silicon enters the HA lattice in the form of silicate ions which substitute 
phosphate ions. Silicon content up to 4 wt% in HA has been reported in literature using 
a batch hydrothermal synthesis (Tang et al., 2005, Gibson et al., 2002). 
6.2 Experimental 
6.2.1 Synthesis of Carbonate (CO32-)-Substituted Calcium Phosphate 
 A series of Carbonate substitution reactions were carried out for this study. Urea 
(carbonate ion source) was added to diammonium hydrogen phosphate (adjusted pH 10). 
This solution was reacted with calcium nitrate solution (adjusted pH 11). A 
Ca:[PO4
3+CO3
2-] molar ratio of 1.67 was maintained in all precursor solutions. The pH 
of both the solutions was adjusted using neat ammonium hydroxide solution.  
A continuous plastic flow synthesis system, which consists of two HPLC Gilson pumps 
fitted with 25 mL pump heads, was used for all synthesis. The details are described in 
section 2.2.1. The pH of both the solutions prior to the reaction was kept above pH 10. 
The initial mixture was pumped at 20 mL min-1 and connected to 8 m long tubing 
surrounded by a heating jacket whereupon reaction completed in 5 minutes which was 
the residence time for the reaction. All reactions were carried out at 70 °C and 
atmospheric pressure. The suspension was collected in a beaker at the exit point. The 
aqueous suspension obtained was centrifuged, washed and freeze dried as described in 
section 2.3.1.1.  Samples are labelled as 2CHA, 4CHA, 6CHA and 8CHA. The initial 
numbers in the sample IDs show the nominal carbonate content (wt%). 
 
6.2.2 Synthesis of Silicate (SiO42-)- Substituted Calcium Phosphate 
A similar procedure was repeated for the synthesis of silicon substituted calcium 
phosphates using the CPFS system. In the process, 0.3 M diammonium hydrogen 
phosphate solution containing silicate ions and 0.5 M calcium nitrate solutions were 
pumped at 20 mL min-1 in the CPFS reactor (Ca:P molar ratio: 1.67). The pH of 
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diammonium hydrogen phosphate solution was adjusted to pH 10 using neat ammonium 
hydroxide solution. This initial mixture were connected to 8 m long PTFE tubing 
surrounded by a heating jacket whereupon  the reaction has completed in 5 minutes. 
The suspension was collected in a beaker at the exit point. The aqueous suspension 
obtained was centrifuged, washed and freeze dried as described in section 2.3.1.1.  All 
reactions were carried out at 70 °C and atmospheric pressure. The samples are labeled 
as 1Si-HA, 2Si-HA, 3Si-HA, 4Si-HA, 5Si-HA, 6Si-HA, 7Si-HA, and 8Si-HA. The 
numbers in the sample IDs represent the nominal silicon content (wt%) according to 
how much silicate precursor was used in the precursors. 
The obtained powders were compacted into cylindrical discs of 13 mm diameter and 2 
mm thickness by using a laboratory hydraulic press at 5 MPa. These samples were used 
for cell viability studies after sterilization in 70 % ethanol for 1 hour.  
6.3 Results and discussion 
6.3.1 Transmission Electron Microscopy 
Transmission electron microscopy was used to analyse the particle size and 
morphology. Pure as prepared HA synthesized in the CPFS system had a rod like 
morphology as shown by TEM in Figure 6-1 (a) and 1(b) and average length along the 
longest axis of each particle was ~ 85 ±15 nm (200 particles sampled). TEM images of 
4CHA sample as shown in Figure 6-2 (a) and (c) confirmed the synthesis of small 
crystallites. The average length along the longest axis of each particle was ~ 80 ± 15 nm 
(200 particles sampled), with the particles having rod-like morphology. Sample 8CHA 
revealed semi-rod shaped morphology, suggesting a slight deviation from the rod like 
morphology. The average length along the longest axis of each particle was ~ 70 ± 10 
nm (200 particles sampled) as shown in Figure 6-2 (b) and (d). 
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Figure 6-1 Transmission electron microscope images of hydroxyapatite nano-rods of 
(a), (bar = 500 nm), and for (b), (bar = 100 nm).  
  
Figure 6-2 Transmission electron microscope images of 4CHA (a,c) and 8CHA(b,d) 
nano-rods made at 70 °C in five minutes residence time via CPFS, (a,b) (bar = 500 nm), 
and for (c,d) (bar = 100 nm).      
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TEM images were also collected for Si substituted HA to investigate the particle 
morphology and size with increasing silicon content. Figure 6-3 (a) and (c) for sample 
4SiHA reveal distinct nanorods of size ~ 100 ± 15 nm (200 particles sampled), along 
the longest axis. Whilst the average length for 8SiHA particles along the longest axis 
was ~ 120 ± 15 nm (200 particles sampled) as shown in Figure 6-3 (b) and (d). It was 
observed that the presence of silicon in HA lattice slightly increased the particle size as 
compared to pure HA as shown in Figure 6-3. 
   
Figure 6-3 Transmission electron microscope images of 4SiHA (a,c) and 8SiHA (b,d) 
nano-rods made at 70 °C in five minutes residence time via CPFS, (a,b) (bar = 500 nm), 
and for (c,d) (bar = 100 nm).      
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6.3.2  BET Surface Area Analysis 
Figure 6-4 shows the trends in BET surface areas for the carbonate substituted calcium 
phosphate samples (determined using XPS). There was a little change in the BET 
surface area by increasing urea content. All carbonate substituted samples had the 
surface areas in the range 111 - 136 m2g-1. 
One of the possible reasons for lower surface area with small particle size was the 
increase in particle agglomeration with small size as observed in Figure 6-2. In contrast, 
silicon substituted HA samples showed a noticeable increase in surface area in the range 
113 - 163 m2g-1 which might be  due to a slight difference in size or agglomeration as 
compared to the carbonate. 
 
Figure 6-4 BET surface area of carbonate and silicate substituted samples (made at 70 
°C in five minutes residence time via CPFS) as a function of substitution level. 
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6.3.3 Powder X-ray Diffraction 
Powder X-ray diffraction data were obtained for all samples to investigate how 
carbonate and silicate substitution influenced phase composition and phase purity. The 
XRD pattern suggests an apatite-like structure (sample 2wt% CO3-HA in Figure 6-5) 
and showed a good match to phase pure HA [compared to JCPDS pattern 09- 0432]. 
 
Figure 6-5 Powder X-ray diffraction patterns of heat treated (1000 °C, 2hr) CO3
2--  
substituted hydroxyapatite powders made using CPFS at 70°C in five minutes residence 
time.   
All XRD patterns for silicate-substituted samples in Figure 6-6 have a good match to 
JCPDS pattern 09-432, and suggested no substantial effect of increasing silicon content 
on phase-purity, crystallinity or PXRD size of the HA phase.  
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Figure 6-6 XRD patterns of heat-treated (1000 °C, 2hr in air) Si-substituted 
hydroxyapatite powders made using CPFS system at 70°C in five minutes residence 
time   
6.3.4 Fourier Transform Infrared Spectroscopy 
FTIR spectroscopy was carried out on all carbonate- and silicate-substituted samples in 
order to aid observations made using XRD. The FTIR analysis (Figure 6-7) detected 
strong peaks at the wavenumbers of the B-type CHA (870, 1430 and 1450 cm-1). The 
typical peaks of the A-type CHA (880, 1450 and 1540 cm-1) were not evident. 
The FTIR spectrum for sample SiHA in Figure 6-8 revealed peaks similar to those 
observed for carbonate-substituted samples. However, the weak band in the range 
1565–1380 cm-1 (corresponding to asymmetric stretching of the C–O band of CO32- 
group in both A- and B-type carbonate substitutions in HA) was understandably much 
lower in intensity as compared to the similar band seen in the FTIR spectrum of the 
carbonate substitution samples in Figure 6-7.  
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The weak peak centred at 872 cm -1 was due to the bending mode of the O–C–O linkage 
in a small amount of carbonate, which is present. This was also lower in intensity as 
compared to a similar peak observed at 876 cm -1 in Figure 6-7 (due to higher amount 
of carbonate ions present in the carbonate-substituted samples). 
 
Figure 6-7 FTIR spectral data of CO3
2- substituted hydroxyapatite powders made via 
CPFS system at 70°C in five minutes residence time   
A notable difference from the FTIR spectra in Figure 6-8 was that the OH -1 stretching 
peak at about 3571 cm -1 decreased in intensity with increasing silicon substitution 
(Figure 6-8). This supported the hypothesis that silicon was being substituted in the HA 
lattice in the form of silicate, SiO4
-4 substituting phosphate, PO3
-4. The most notable 
effect of silicon substitution on the FTIR spectra of hydroxyapatite is the changes in the 
PO4 bands between 800 and 1100 cm
−1 and 500–700 cm−1. 
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Figure 6-8 FTIR spectral data of Si-substituted substituted hydroxyapatite powders 
made using CPFS at 70°C   
6.3.5 Raman Spectroscopy 
Raman spectroscopy was conducted in order to supplement XRD data and investigate 
any structural changes with substitutions in the apatite lattice. Figure 6-9 shows Raman 
spectra for all the carbonate-substituted samples. The peak at 965cm-1 corresponded to 
a symmetric stretching mode of the P-O bonds  in the phosphate groups. Peaks at 610 
and 483 cm-1 are likely to correspond to the bending mode of the O-P-O linkage in the 
phosphate groups as shown in Figure 6-9. The band at 1070 cm-1 resulted due to a 
carbonate peak and intensity of the peak was largely dependent on the amount of 
carbonate ions present. 
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Figure 6-9 Raman data of CO3
2-- substituted hydroxyapatite samples made using CPFS 
at 70°C     
Raman spectra for all silicon-substituted samples are shown in Figure 6-10. The Raman 
spectra for SiHA samples revealed peaks at 1080 cm-1 and 1049 cm-1 attributed to 
asymmetric stretching of the P–O bonds in the phosphate groups. The peak around 960 
cm-1 corresponded to the symmetric stretching mode of the P–O bonds in the phosphate 
groups. Peaks at 595 and 438 cm-1 corresponded to the bending modes of the O–P–O 
linkages. 
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Figure 6-10 Raman spectra of Si-substituted hydroxyapatite powders made using CPFS 
at 70 °C   
6.3.6 Dynamic Light Scattering  
Particle size distribution was also conducted for some selected samples, pure HA, 
2CHA, 4CHA, 8CHA, 2SiHA, 4SiHA and 8SiHA. DLS measurements of pure 
hydroxyapatite sample synthesized at 70 °C in 5 minutes residence time reveals average 
particle size of ca. 159 and PDI (polydispersity index) value of 0.231.  
For samples 2CHA, 4CHA, 8CHA, 2SiHA, 4SiHA and 8SiHA, respectively, DLS 
measurements yielded average particle sizes of ca. 146, 149, 158, 159, 164, and 174 nm 
with unimodal distribution of particles. Whilst PDI values of 0.268, 0.264, 0.272, 0.207, 
0.239 and 0.270 were recorded.  DLS measured diameter (100-300nm) with PDI of 0.3 
or less shows good dispersion. It was also observed that DLS measurement results are 
in good agreement with TEM determined distributions.   
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6.3.7 Cell Viability Study 
A human osteoblast cell proliferation study was conducted on selected carbonate 
(2CHA, 4CHA, 6CHA) and silicate (2SiHA, 4SiHA, 8SiHA) samples. The pure HA 
sample made via CPFS at 70 °C (reaction time: 5 min.) was used as a control. The 
osteoblast cells cultured on all ceramic samples showed continuous proliferation. The 
cell viability was studied over the course of 7 days (Figure 6-11). At day 1, cell viability 
was almost similar on all samples indicating that initial cell attachment was not 
enhanced by any surface.  At day 4, cell viability gradually increased on all 5 samples 
(pure HA, 4SiHA, 8SiHA, 4CHA and 8CHA) but a noticeable increase was observed 
for 4SiHA and 8SiHA samples. 
 
Figure 6-11 MG63 viability on CPFS, SiHA and CHA discs. Alamar blue viability 
assay was performed at days 1, 4, and 7 to observe MG63 viability on as prepared discs 
consisting of 4 % or 8 %  SiHA and CHA as well as CPFS pure HA. Mean ± SD, * p 
<0.05.  
A similar trend was observed at day 7, however, all five samples had an increased cell 
viability compared with day 1 and 4. At both days 4 and 7, 4SiHA and 8SiHA had 
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significantly higher cell viability than 4CHA, 8CHA and pure HA. It was observed that 
silicon substitution in HA greatly enhance the osteoblatic cell proliferation.  
6.3.8 Cell Morphology 
MG63 morphology was observed at day 7 (Figure 6-13) on all five samples. Cells were 
seen to attach, spread and grow on all types of samples as shown in Figure 6-12. Cells 
were evenly distributed on pure HA and showed a typical square-like osteoblast 
morphology. On 4SiHA, cells were more sparse and generally less-well spread than 
those on pure HA and CHA, whilst cells were spread very well on 8SiHA sample as 
shown in Figure 6-12.  
 
Figure 6-12 MG63 morphology of SiHA and CHA discs made at 70 °C in a CPFS 
reactor. Cells were visualised at day 7 for cell nucleus (DAPI in blue) and cytoskeleton 
(phalloidin-FITC in green) for MG63s cultured on as prepared discs containing 4 % or 
8 % SiHA and CHA as well as pure HA. Scale bar is 100 µm.  
On the other hand, cell spreading was less pronounced in carbonate samples compared 
to silicate substituted samples, with the majority showing a rounded morphology. 
Results revealed better bone cell cytoskeletal organisation and greater growth activity 
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for osteoblast cells cultured on SiHA than on CHA. This could be due to the faster 
dissolution or higher surface area of the SiHA samples compared to CHA. 
6.4 Conclusions 
A CPFS reactor was used to successfully synthesise ion substituted calcium phosphates 
from calcium nitrate tetrahydrate [(Ca(NO3)2.4H2O), and diammonium hydrogen 
phosphate (NH4)2HPO4 )] precursor solutions at (near) ambient conditions in a rapid 
single step. Careful control of the quantities of reactants used, resulted in phase pure 
nano-sized carbonate and silicon substituted hydroxyapatite that retained the apatite 
structure even after heat-treatment at 1000 °C for two hours.  
Cell toxicity analysis confirmed excellent biocompatiblity of these materials.  These 
results indicate that newly developed CPFS technique for the production of pure HA 
and ion substituted HA, has made samples which are biocompatible and that support 
osteoblast proliferation. With its unique features, the obtained product is a promising 
material with biological properties and has potential to be used in biomedical 
applications where small size and fine particle size distribution control may be 
beneficial e.g. injectables for spinal fusion or as a filler in a biocomposite. 
6.5 Future Work 
Silicon substitution level may be enhanced by using different precursor solution (other 
than silicon tetraacetate) for better dissolution and more effective results. To further 
strengthen the proficiency of CPFS system, It would be interesting to correlate CPFS 
system parameters with different substitution levels in HA.  
Osteoblastic cell attachment and viability analysis confirmed the high biocompatiblity 
of silicon-substituted materials.  Future work should address the ability of CPFS to 
support osteogenic differentiation and what affect anionic [CO3
2-,  SiO4
2-] substitution 
has on this.  
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Chapter 7   
Synthesis and Surface Modification of Calcium, 
Strontium and Barium-Hydroxyapatite Nanorods 
Incorporating Functionalized Surfaces for Dental 
Restoration 
7.1 Introduction 
Hydroxyapatite (HA) is of interest as a synthetic bone substitute that has a wide range 
of applications in the dentistry health care products and medicine (Wei and Ma, 2004, 
Choi et al., 2006, Khan et al., 2008, Domingo et al., 2003, Sadat-Shojai et al., 2010). 
Dentine is a natural composite which forms part of teeth and is based on an organic 
matrix of mainly collagen, a small quantity of citrate, and an inorganic mineral phase 
(filler) consisting of nano-sized (<100 nm) biological apatite crystals. Synthetic HA 
resembles some of the properties of biological apatite found in natural teeth and bone 
offers numerous properties, which can be exploited for biomedical applications and in 
restorative dentistry  (intrinsically radio-opaque, good polishability, high wear 
performance) (Arcı́s et al., 2002, Willems et al., 1992, Giannini et al., 2004). Synthetic 
HA potentially has a large amount of P–OH groups on the surface of particles, therefore 
many organic or inorganic substances have been introduced to HA surfaces via the P–
OH groups.  Increasing the number of surface P–OH groups is of interest because they 
can act as anionic surface charges and also offer a favourable environment for protein 
adsorption. Furthermore, increased numbers of P–OH groups can lead to increased 
electrophoretic mobility and good dispersibility in an aqueous phase (via the charge 
stabilization mechanism) groups (D'Andre and Fadeev, 2003, Borum-Nicholas and 
Wilson, 2003, Vega et al., 2003, Borum and Wilson, 2003, Tanaka et al., 2005, Tanaka 
et al., 2004, Choi et al., 2006).   
There is considerable interest in the use of bioceramics as the hard segment in 
biomedical nanocomposites, particularly in dental applications. The reinforcement of a 
conventional dental resin with highly dispersed hydroxyapatite nanocrystals seems, in 
principle, a potential restorative material for non load bearing human tooth tissues as it 
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could mimic the tooth to some extent (Willems et al., 1992, Arcı́s et al., 2002, Saito et 
al., 1994). A key factor in the failure of many biomedical composites occurs at the 
interface between the hard / ceramic segment and polymer matrix. This is usually due 
to a weak mechanical bond between the two phases. Chemical coupling of ceramics to 
a polymer matrix provides a means of improving interfacial bonding between the hard 
particles and polymer in a composite. This can be achieved by creating reactive bonding 
sites/groups on the surface of the inorganic filler particle, which can be used to form 
bonds between the inorganic filler and polymer (Bonfield et al., 1998, Haque et al., 
2007).   
For the synthesis of HA and other biocermics, the method of preparation greatly 
influences the properties, nature and crystallinity of the precipitated powder. Reaction 
parameters for synthesis are also important such as temperature, pH, time and other 
precipitation conditions like aging time, variation in Ca:P ratio, concentration, mixing 
dynamics, choice of precursor, etc. (Raynaud et al., 2002, Ahn et al., 2001, Rodrıguez-
Lorenzo et al., 2001). The majority of the reported literature methods for HA synthesis 
are multi-step, inconsistent, energy intensive or time consuming processes (Pang and 
Bao, 2003, Phillips et al., 2003, Lim et al., 1997, Kothapalli et al., 2005, Wang et al., 
2006a, Kim et al., 2005) and almost always involve the need to have careful control 
over reaction pH during the mixing of reagents. In this report, we describe a rapid and 
direct route for the synthesis of phase pure surface grafted nano-HA using a continuous 
(plastic) flow synthesis (CPFS) reactor at 70 ◦C. The main objective of this work was to 
gain insights into the chemistry and use of surface functionalised hydroxyapatite as a 
reinforcing filler component for photo-cured BisGMA/TEGDMA  dental restorative 
infiltrants.  
Strontium and barium ions are divalent and have the ability to be incorporated into 
hydroxyapatite crystals. Among the many divalent cations that can be substituted for 
calcium in hydroxyapatite, strontium is of interest because of its beneficial effect on 
bone formation and prevention of bone resorption. Strontium and barium 
hydroxyapatite (with no calcium) have gained interest in recent years because of their 
high density and radiopaque properties. The doping of Sr in the hydroxyapatite structure 
for implants has been shown to increase bone mineral density (BMD), bone mineral 
content (BMC), bone volume and microarchitecture, reduced bone fracture risk and 
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improved the mechanical performance of whole bone without affecting the estimated 
material properties of the bone tissue (Bigi et al., 2007, Okayama et al., 1991).  
Radiopaque dental materials are beneficial in making diagnosis and monitoring existing 
restoration. However, there is still a lack of dental material that is tooth coloured, 
minimally invasive and has satisfactory radiopacity. In a recent study on dental 
restorative materials containing Sr and Ba-HA (no calcium), it has been found that Sr-
HA appeared to be a better radiopaque filler when it is mixed as a composite with a 
polymeric matrix.   
In this chapter, a CPFS reactor is used to successfully synthesize surface grafted Group 
2 metal phosphates and and to use these modified HA as filler component to develop a 
novel radiopaque resin infiltrant for dental applications. 
7.2 Experimental 
7.2.1 Synthesis Methodologies 
7.2.1.1 Surface- Modified Calcium Hydroxyapatite Preparation 
The pure nano-hydroxyapatite (HA) was prepared using a continuous (plastic) flow 
synthesis system (CPFS) the design of which is described in section 2.2.1. 0.3 M 
diammonium hydrogen phosphate solution and 0.5 M calcium nitrate solutions were 
pumped in the CPFS (Ca:P molar ratio:1.67) using pump 1 and pump 2, respectively. 
The pH of both the solutions prior to the reaction was kept above pH 10. 5.0 mL and 
15.0 mL of ammonium hydroxide were added to calcium nitrate (500 mL) and 
diammonium hydrogen phosphate solution (500 mL), respectively. Both reagent 
solutions were pumped at 20 mL min-1 to meet at a T-piece. This initial mixture was 
connected to an 8 m long coiled tube surrounded by a heated jacket at 70 °C . For flow 
rates of calcium nitrate and diammonium hydrogen phosphate for P1 and P2, this gives 
5 minutes residence time. The products were collected as a suspension in a beaker at the 
exit point and centrifuged and freeze dried as described earlier in section 2.3.1.1. The 
surface modified hydroxyapatites were obtained following a similar procedure as for 
pure nano-HA, except the calcium containing precursor additionally contained the 
appropriate amount of  (0.05 M) the modifying organic chemical. Product was obtained 
as a fine white powder with ~ 85% yield. Resulting nanopowders were termed PVA-
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HA (polyvinyl alcohol), A-HA (adipic acid), C-HA, (citric acid), VPA-HA 
(vinylphosphonic acid) and MA-HA (methacrylic acid).  
7.2.1.2 Surface- Modified Strontium Hydroxyapatite Preparation 
The surface modified strontium (containing no calcium) hydroxyapatite nanopowders 
were prepared at 70 °C using the continuous (plastic) flow synthesis system (CPFS), the 
details of which are described in section 2.2.1. In the synthesis process, 0.5M basic 
solutions of strontium nitrate with organic surface modifier (Sr+RCO2
-R) / P = 1.67) 
and 0.3 M diammonium hydrogen phosphate, respectively, were pumped to meet at a 
T-piece. The pH of both the solutions prior to the reaction was ideally kept above pH 
12. This initial mixture was connected to an 8 m long pipe, which was coiled inside an 
oil bath, which gave an effective 5 minutes residence time from the tee to the exit of the 
pipe. The obtained white precipitates were centrifuged and freeze dried as described 
previously (section 2.3.1.1). 
7.2.1.3 Surface- Modified Barium Hydroxyapatite Preparation 
A similar procedure was adopted for the synthesis of Ba-hydroxyapatite using the CPFS 
system as described earlier in section 2.2.1. In the synthesis process, basic solutions of 
barium hydroxide with organic surface modifier (Ba+RCO2
-R) /P = 1.67) were used. 
The pH of both the solutions prior to the reaction was ideally kept above pH 12. This 
initial mixture was connected to an 8 m long plastic tube, which was coiled inside an 
oil bath, which gave an effective 5 minute residence time from the tee to the exit of the 
pipe. The obtained precipitates were centrifuged and freeze dried as described 
previously (section 2.3.1.1). All reactions were carried out at 70 °C and atmospheric 
pressure. Product was obtained as a fine white powder with ~ 85% yield. 
 
 
 
7.2.2 Dental composite preparation 
The organic matrix consisted of 60 wt% Bis-GMA  and 40 wt%  diluent TEGDMA as 
a comonomer. Various mass fractions of surface-modified hydroxyapatite, 
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nanoparticles were added into the monomer. The solution was stirred for 24 hours and 
shifted to a light sensitive vial to avoid photocuring prior to addition of further 
components (initiator, coinitiator, filler). 0.5 wt% camphorquinone and 2 wt% 
dimethylaminoethyl methacrylate along with 0.2 wt% N, N-Dimethyl-p-toluidine were 
added into the monomer solution as the initiator and coinitiators, respectively. After 
mixing thoroughly for 2 hours, the mixture was carefully transferred into a disk shaped 
Teflon mold (diameter 6mm, thickness 1mm). Then samples were photo-cured using a 
blue LED activation light (Demetron LC, Ser no 66004022, KERR corporation, 
Danbury).  X-ray images were then taken of the samples after leaving the sample to cure 
for at least 30 minutes. The similar procedure was repeated for surface modified 
strontium and barium phosphates.  
7.2.2.1 Radiopacity Investigation Procedure 
For each sample, a Teflon mould was used to produce 3 disks, measuring 6 mm in 
diameter and 1 mm in thickness, in accordance to ISO 4049. The specimens were photo-
polymerized using a blue LED light. The specimens were ground with 150-grit 
sandpaper to create a flat surface. Specimens were measured using a digital micrometer. 
One specimen of each sample and an aluminium wedge were placed side by side on an 
occlusal radiographic film. The step wedge served as a standard for each radiographic 
exposure. Films were exposed for 0.6 milliseconds with a radiography unit at 70 kV and 
8 mA, the object to film distance was 300mm. 
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7.3 Results and Discussions 
7.3.1 Transmission Electron Microscopy 
Transmission electron microscope images of ungrafted hydroxyapatite samples as 
shown in Figure 7-1 confirmed that very small crystallites had been synthesised. The 
particles obtained at 60 °C possessed a small particle size of ca. 25 ± 5 nm (200 particles 
sampled) along the longest axis and of ca. 7 ± 2 nm along the smaller axis as shown in 
Figure 7-1 (a) and (b). Phase pure as prepared HA synthesized at 70 °C in the CPFS, 
the particles had a rod like morphology and average length along the longest axis was 
ca. 85 ± 15 nm (200 particles sampled) and average width was 15± 5 nm as shown in 
Figure 7-1 (c) and (d).  
 
 
Figure 7-1 Transmission electron microscope images of hydroxyapatite nano-rods 
made at 60 °C (a,b) and 70 °C (c,d) in five minutes residence time via CPFS, ( (bar =  
(a) and (c) = 100 nm,  (b) = 20 nm, (c) = 500 nm  
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Figure 7-2 Transmission electron microscope images of surface modified 
hydroxyapatite nano-rods made at 70 °C in five minutes residence time via CPFS (a,b) 
methacrylic acid modified hydroxyapatite, (c,d) vinyphosphonic acid modified 
hydroxyapatite and (e,f) adipic acid modified hydroxyapatite with bar sizes (a), (c) and 
(e) = 500 nm, and for (b), (d) and (f) bar = 20 nm. 
TEM images of surface grafted hydroxyapatite synthesized at 70 °C in five minutes 
residence time via CPFS were also recorded. It was observed that methacrylic acid  
grafted HA particles possessed a small particle size of ca. 25 ± 5 nm (200 particles 
sampled) along the longest axis and of ca. 7 ± 2 nm along the smaller axis as shown in 
Figure 7-2 (a) and (b). 
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Figure 7-3 Transmission electron microscope images of surface modified strontium 
(a,b) and barium (c,d) hydroxyapatite nano-rods made at 70 °C in five minutes residence 
time via CPFS  with bar sizes (a) and (c) = 500 nm, and for (b) and (d) = 100 nm. 
On the other hand, vinylphosphonic and adipic acid based HA particles possessed a 
slightly larger particle size of ca. 35 ± 5 nm (200 particles sampled) along the longest 
axis and of ca. 7 ± 2 nm along the smaller axis as shown in Figure 7-2 [c-f]. 
Other surface functionalized Group 2 metal phosphates (Sr-HA, Ba-HA) were also  
synthesized successfully at 70 °C in five minutes residence time using CPFS system 
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parameters. It was observed that methacrylic acid grafted strontium hydroxyapatite  
nanoparticles possessed a particle size of ca. 40 ± 5 nm (200 particles sampled) along 
the longest axis and of ca. 7 ± 2 nm along the smaller axis as shown in Figure 7-3 (a) 
and (b). In comparison, methacrylic acid based barium hydroxyapatite nanoparticles 
revealed a relatively larger particle size of ca. 80 ± 15 nm (200 particles sampled) and 
average width was 15± 5 nm as shown in Figure 7-3 (c) and (d).  
7.3.2 BET Surface Area Analysis 
BET surface area measurements of the as prepared HA made at 70 °C in five minutes 
residence time via CPFS had a BET sufrace area of 195 m2g-1, whilst surface modified 
PVA-HA (polyvinyl alcohol), A-HA (adipic acid), C-HA, (citric acid), VPA-HA 
(vinylphosphonic acid) and MA-HA (methacrylic acid) synthesized under the same 
conditions had BET surface areas of 143, 208, 201, 225 and 231 m2g-1, respectively, as 
shown in Figure 7-4. On the other hand, surface grafted strontium and barium 
hydroxyapatite nanoparticles revealed the BET surface area of 148 and 90 m2g-1, 
respectively. 
7.3.2.1 Effect of Temperature on BET Surface Area 
A comparative study based on pure HA and surface grafted HAs was carried out at 
different temperature regimes (60, 70 and 80 °C) in five minutes residence time via 
CPFS system. BET surface area measurements of as-prepared HA sample typically gave 
surface areas of 264, 195 and 113 m2g-1 as shown in Figure 7-5.  
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Figure 7-4 BET surface area analysis of pure HA, surface modified PVA-HA 
(polyvinyl alcohol), A-HA (adipic acid), C-HA, (citric acid), VPA-HA 
(vinylphosphonic acid) and MA-HA (methacrylic acid), respectively, made at 70 °C in 
five minutes residence time via CPFS system 
Similar reactions were carried out using methacrylic acid and vinyphosphonic acid 
surface modifying agent on HA surface at 60, 70 and 80 °C. It was noticed that in the 
presence of surface grafted agents, the surface area remained high even on increasing 
temperature from 60 to 80 °C as shown in Figure 7-5. These exciting findings indicated 
that surface grafting agents restrict the particle growth, resulted in small size particles 
with very high surface area ranging from 220 to 265 m2g-1under all temperature regimes 
(60, 70, 80 °C). 
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Figure 7-5 BET surface area analysis of pure HA, surface modified V-HA 
(vinylphosphonic acid) and M-HA (methacrylic acid), respectively, made at 60, 70 and 
80 °C in five minutes residence time via CPFS system 
7.3.3 Zeta Potential Measurements 
Zeta potential measurements were performed on selected samples to investigate the 
colloidal stability related to surface charge of the pure HA and surface modified HA. 
Zeta potential gives the electrostatic potential of particles which is directly related to 
their dispersion stability; the higher the zeta potential values, the greater the electrostatic 
repulsion and therefore the higher will be the colloidal stability of the suspension.  A 
zeta potential of -43.8 mV was measured for MA-HA (70 °C ) and -40.6 mV for VPA-
HA (70 °C ), respectively which would be expected to stablise the particles from 
agglomeration as shown in Figure 7-6.   
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Figure 7-6 Zeta potential of pure HA and surface modified methacrylic acid and 
vinylphosphonic acid-HA samples made at 70 °C in five minutes residence time via 
CPFS.  
7.3.4 Powder X-ray Diffraction 
The powder X-ray diffraction data of the surface modified hydroxyapatites all displayed 
broad peaks, which were typical of an apatite structure (Figure 7-7). Upon heat-
treatment (1000 °C for 2 hours) in air, the powder X-ray diffraction peaks of all samples 
became considerably sharper and well resolved and gave a good match to the phase pure 
hydroxyapatite reference pattern JCPDS [09-432]. No additional peaks due to 
secondary phases were observed in the XRD data after heat-treatment as shown in 
Figure 7-8.  
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Figure 7-7 Powder X-ray diffraction patterns of surface modified hydroxyapatite with 
(a) = Polyvinylalcohol modified hydroxyapatite (b) = adipic acid modified 
hydroxyapatite (c)= citric acid modified hydroxyapatite (d) = vinyphosphonic acid 
modified hydroxyapatite (e) = methacrylic acid modified hydroxyapatite, respectively. 
All samples were made in a continuous plastic flow system at 70 °C  with a residence 
time of 5 minutes. 
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Figure 7-8 Powder X-ray diffraction patterns of as prepared and heat-treated (1000 °C, 
2hrs) surface modified hydroxyapatite sample made in a continuous plastic flow system 
at 70 °C with a residence time of 5 minutes. 
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Figure 7-9 Powder X-ray diffraction patterns of as prepared methathacrylic acid grafted 
strontium hydroxyapatite nanoparticles made in a continuous plastic flow system at 70 
°C with a residence time of 5 minutes. 
The powder X-ray diffraction analysis of synthesized methacrylic acid grafted strontium 
hydroxyapatite product indicated that the products obtained at 70 °C in five minutes 
residence time was exclusively strontium hydroxyapatite particles. The XRD patterns 
shown in Figure 7-9 gave a good match to the phase pure strontium hydroxyapatite 
(Sr5(PO4)3(OH), reference pattern JCPDS [070-1511]).  
The XRD data of as prepared methacrylic acid modified barium hydroxyapatite 
confirmed that the product obtained was pure Ba-HA and fairly well-crystallized as 
shown in Figure 7-10. 
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Figure 7-10 Powder X-ray diffraction patterns of as prepared methathacrylic acid 
grafted barium hydroxyapatite nanoparticles made in a continuous plastic flow system 
at 70 °C with a residence time of 5 minutes. 
7.3.5 Fourier Transform Infrared Spectroscopy 
The FTIR spectra of all five as-prepared surface modified HAs are shown in Figure 7-
11. All spectra revealed peaks assigned to phosphate stretching and bending vibrations. 
The peaks at 1093 cm-1 and 1023 cm-1correspond to asymmetric (P-O) stretching of the 
phosphate groups whilst peaks at 602 and 560 cm-1 correspond to the symmetric (P-O) 
stretch. The weak  peak at 470 cm-1 was assigned to a phosphate bending mode.   
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Figure 7-11 FTIR Spectra of surface modified hydroxyapatite with (a) = 
polyvinylalcohol modified hydroxyapatite, (b) = adipic acid modified hydroxyapatite, 
(c) = citric acid modified hydroxyapatite, (d) = vinyphosphonic acid modified 
hydroxyapatite, (e) = methacrylic acid modified hydroxyapatite, respectively. All 
samples were made in a continuous plastic flow system at 70 °C  with a residence time 
of 5 minutes 
7.3.6 X-ray Photoelectron Spectroscopy 
  A chemical analysis of VPA-HA sample made at 70 °C were conducted using XPS as 
shown in Figure 7-12. As a general observation, the ratio Ca/P was nearly stoichiometric 
in phase pure HA, whilst it was observed that in surface modified HAs, the Ca:P molar 
ratio decreased from 1.67 to 1.37 due to the addition of organic modifiers. The 
deconvoluted spectra for C, O, Ca and P in sample VPA-HA are presented in Figure 7-
13. The Ca 2p spectrum could be resolved into two peaks for Ca 2p3/2 and 2p1/2 (two 
spin-orbit pairs) at 347.4 and 351.3 eV, respectively, which are related to 
hydroxyapatite. In Figure 7-13 (b), the 2p peak  can also be deconvoluted into two peaks 
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with a spin orbit splitting for p1/2 and p3/2 levels with binding energy 134.2 and 133.4 
eV, respectively (Mahabole et al., 2005, Costescu et al., 2010b, Lu et al., 2000). 
 
Figure 7-12 XPS survey spectrum of VPA-HA sample made via continuous plastic flow 
synthesis at 70 °C with a residence time of 5 minutes 
Figure 7-13(c), depicts the core level XPS spectrum of O 1s and the peaks at 531.5.4, 
532.1 eV and 533.6 eV are attributed to the hydroxy group, contribution of phosphate 
group and organic species, respectively. The peak at a binding energy of  288.5 eV in 
the C 1s spectrum was assigned to the RCOO- group (Casaletto et al., 2002) as shown 
in Figure 7-13 (d).  
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Figure 7-13 [a-d] XPS spectra of Ca 2p, P 2p, O 1s and C 1s for sample VPA-HA was 
made in a continuous plastic flow system at 70°C with a residence time of 5 minutes 
7.3.7 NMR Spectroscopy 
The organic surface modifier molecules were investigated by NMR spectroscopy in 
solution, which required complete dissolution in a deuterated solvent. VPA dissolved 
very readily in D2O and in d-methanol, d-concentrated sulfuric acid. However, only 
dilute solutions of VPA could be prepared in the solvents other than D2O, therefore, the 
NMR data for VPA as dilute solution were recorded. The coupling interaction between 
different proton environments (doublet, triplet) in vinylphosphonic acid were evaluated 
as 2J(HB, HA) = 21Hz, 3J(HB, P) =44.8Hz, 3J(HA, P) = 22.5 Hz, 3J(HA, HC) =19.1 Hz, 
3J(HB, HC) =12.7 Hz, 2J(HC, P) =19.1 Hz. The presence of different proton 
environments associated with the carbon atoms in VPA has proved that surface 
modification of VPA on HA has occurred. 
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 Figure 7-14  1H NMR spectrum of surface modified vinylphosphonic acid 
Variables such as volume or mass fraction of inorganic fillers, particle size distribution, 
and nature and extend of bonding between resin matrix and filler particles have 
significant effect on chemical and mechanical properties of dental composites.  
 
Figure 7-15 Radiographic images of (a) = commercially available dental composite 
(ICON), (b) = self- prepared dental composite with 20 wt% pure HA as a filler, (c) 20 
wt% methacyrlic acid modified- HA based dental composite, (d) 20 wt% 
vinylphosphonic acid modified-HA based dental composite.  
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In the last decade, attention has been given to the dental composites with reduced size 
of the filler particles, from micrometric (traditional composites) to nanometric sizes 
(advanced composites). Nanometric particles have high surface area to volume ratio, 
and hence potentially a large interfacial area for interaction with the organic matrix. 
Stronger interaction between filler and matrix can be achieved by optimizing the amount 
of filler particles and/ or characteristics of the organic coupling agent.  
 
Figure 7-16 Radiographic images of surface functionalized strontium hydroxyapatite 
based dental composite with (a) = 5%, (b) = 10%, (c) = 15% and (d) = 20% and  surface 
functionalized barium hydroxyapatite based dental composite with (e) = 5%, (f) = 10%, 
(g) = 15% and (h) = 20%, respectively. 
A comparative study for radiographic examination of commercially available dental 
composite and self made dental composite with 20 wt% addition of ungrafted pure HA, 
methacrylic acid–HA and vinylphosphonic HA,respectively was carried out as shown 
in Figure 7-15. It was observed that self prepared dental nanocomposite with 20% 
loading of filler particles showed better radiopacity results as compared to a commercial 
sample.  
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A similar study was also carried out using different loadings of fillers (5, 10, 15 and 
20%) of surface grafted strontium (a-d) and barium (e-h) hydroxyapatite as shown in 
Figure 7-16. The results indicated that surface functionalized strontium hydroxyapatite 
could be the better candidate for dental restorative materials because of its high 
radiopacity property. 
7.4 Conclusions 
The synthesis of surface modified HA for a range of surface modifiers was achieved in 
ca. 5 minutes in a continuous reaction at 70 °C. Surface modification with different 
carboxylic containing organic agents resulted in the production of nano-sized HA 
crystals which could be readily dispersed and possessed remarkably high surface areas. 
These fine, highly dispersed nanoparticles contain reactive groups on the surface; 
therefore they have great range of potential dental / biomedical applications. 
The synthesis of surface modified HAs for a range of surface modifiers was achieved 
in ca. 5 minutes using a continuous flow reaction at 70 °C. Surface modification with 
different carboxylic containing organic agents resulted in the production of nano-sized 
HA crystals which could be readily dispersed and possessed remarkably high surface 
areas (> 250 m2g-1).  
It was observed that surface modified VPA-HA (vinylphosphonic acid) and MA-HA 
(methacrylic acid synthesized at the same conditions as pure HA possessed a surface 
area of 254, 247, 210 m2g-1 and 265, 244 and 221 m2g-1, respectively at reaction 
temperature of 60, 70 and 80 °C. This fact is attributed to the growth restriction of HA 
nanoparticle in the presence of surface modified agents and smooth increase in surface 
area at various selected temperatures. 
It is concluded that these fine, highly dispersed nanoparticles (specifically Sr-HA) could 
be used as filler component to develop a novel radiopaque resin infiltrants for dental 
applications. As radiopaque dental materials are beneficial in making diagnosis and 
monitoring existing restoration. More research is needed to further improve the 
interaction of nanosized HA particles with the polymeric matrix, that allows to increase 
the total loading of the inorganic filler and, hence, to improve the mechanical properties. 
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7.5 Future Work 
Surface functionalized Group 2 metal phosphates will be exploited as a component of a 
drug delivery system for the controlled release of a therapeutic agent or as an additive 
for a tooth paste. 
It would be interesting to employ these newly formed nanoparticles as an injectable 
materials for bone repair, such as spinal fusion or other formulation in future 
application.  
Furthermore, these surface functionalized high surface area Group 2 metal  (Ca2+, Sr2+, 
Ba2+) phosphates will be utilized to make porous scaffolds by freeze casting process by 
the addition of polyvinyl alcohol (PVA) as a binder and emulsifying agent. The purpose 
of study is to enhance the mechanical strength of HA for applications in bone tissue 
engineering.  
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Chapter 8  
Continuous Plastic Flow Synthesis and In-Vitro 
Cytotoxicity Analysis of Hydroxyapatite-Titania and 
Hydroxyapatite-Magnetite Nanocomposites  
8.1 Introduction 
Increasing demands for smarter and smaller products call for the development of 
multiphase and multifunctional materials. Significant progress in ‘‘nanochemistry” has 
given birth to a newly emerging area called ‘‘nanohybrid” or ‘‘nanocomposite” 
materials, which results from the tuning of molecular level interactions of dissimilar 
inorganic components to form new, unique functional materials with improved 
properties (Loste et al., 2004). 
Despite a large number of applications of hydroxyapatite (HA) ceramics in orthopedics 
and dental implantation it has some inherent mechanical drawbacks. These include the 
poor tensile strength and high brittleness that undermine its use as a safe, stable and 
durable in vivo implantation material (Loste et al., 2004, Kuo and Yen, 2002). One of 
the strategies proposed to tackle these intrinsic issues of HA is to increase the relative 
density of HA ceramics by making its composite with some metal/metal oxide (Webster 
et al., 2000).  
Besides HA, many other implants usually metallic/metallic oxides have been widely 
employed in the body parts where load bearing properties of the implants are more 
significantly required like hip prostheses and dental implants. The excellent mechanical 
and corrosion-resistant properties and especially the cheaper availability and high 
biocompatibility of titanium/TiO2 have made it a success in surgical implantations 
(Pushpakanth et al., 2008, Laing et al., 1967, Albrektsson et al., 1983). The major 
technical issue with the use of titanium and TiO2 as bone implant is the bio-inertness of 
the oxide, which does not appreciably form an interface with surrounding bony tissue. 
Apart from its failure to form an active interface, titanium being much more stiff and 
hard than the surrounding bone tissue can result in the overall failure of the implant 
(Hayashi et al., 1991). So there is a strong need to resolve such issues with both HA 
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ceramics and titanium based implants.  
On the other hand TiO2 is a well-established photocatalytic and antimicrobial material 
used for the degradation of organic molecules and growth inhibition of bacteria 
(Nishikawa, 2003, Sunada et al., 2003). Therefore, the HA-TiO2 composite materials 
may be expected to combat bacteria and toxic organic materials (Fu et al., 2005, Nonami 
et al., 1998, Wu and Nancollas, 1998) and possess high fracture toughness and excellent 
biocompatibility (Li et al., 2002). 
The mechanical properties of hydroxyapatite can be enhanced by the addition of oxide 
phases particularly titania, alumina, zirconia, etc. (Prabakaran et al., 2005). These oxide 
materials are promising candidates for reinforcement due to their unique properties and 
low cost however, only a few research studies have been reported in this area (Lu and 
Yang, 2005, Teo et al., 2003). 
Magnetic nanoparticles have drawn much attention due to their ability to generate heat 
in high frequency alternating magnetic field in hyperthermia. Many reports regarding 
the use of these particles in hyperthermia have been published (Wu et al., 2007, Ma et 
al., 2004, Konishi et al., 2004). Although these magnetic particles are biocompatible 
with the human body and target-directive, they have long-term toxic effects so mixing 
of a suitable bioactive substrate is desirable. In particular, magnetite incorporated HA 
nanocomposites are a most effective solution for hyperthermia therapy of malignant 
bone tumor (Johannsen et al., 2005, Tampieri et al., 2012, Gloria et al., 2013, Murakami 
et al., 2008, Andronescu et al., 2010) In recent studies, these nanocomposite materials 
have also been employed as adsorbents (Dong et al., 2010, Wang, 2011, Hongqin et al., 
2012) and catalysts (Yang et al., 2010, Liu et al., 2010). 
The conventional procedures (Murakami et al., 2008, Andronescu et al., 2010, Covaliu 
et al., 2009, Yang et al., 2010) for the synthesis of HA-Magnetite nanocomposites have 
drawbacks as long reaction time is required for completing the formation of HA and 
magnetite followed by subsequent heat treatment and aging. Thus, the literature 
syntheses of HA-Magnetite nanocomposites generally involve multi-step procedures. 
Therefore, a simple process is required to be developed for the rapid formation of these 
bioactive nanocomposites. 
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In this chapter, a range of HA-Titania and HA-Magnetite nanoparticles was fabricated 
using a facile one-pot continuous plastic flow synthetic route. The characterization and 
biocompatibility of these newly developed nanocomposites were evaluated using 
various optical and analytical techniques. 
8.2 Experimental 
8.2.1 Synthesis of Titania 
Titania samples were made using a CPFS system, the details of which are described in 
section 2.2.1. In the synthesis process, 0.25 M titanium oxysulfate solution and 0.20 M 
basic solution of potassium hydroxide, were pumped to meet at a T-piece. The pH of 
both the solutions prior to the reaction was kept above pH 10. This initial mixture were 
connected to 8 m long PTFE tubing which was coiled inside an oil bath which gave an 
effective 5 minutes from the tee to the exit of the pipe. The suspension was collected in 
a beaker at the exit point and then centrifuged as described in section 2.3.1.1.  
8.2.1.1 Synthesis of Hydroxyapatite-Titania Nanocomposite 
The hydroxyapatites nanoparticles were obtained following a similar procedure as 
described in section 2.3.1.1. A range of HA-Titania nanocomposites were made using a 
CPFS system, the details of which are described in section 2.2.1. In the synthesis 
process, titania solution and basic solutions of calcium nitrate with diammonium 
hydrogen phosphate, were pumped to meet at a T-piece. The pH of both the solutions 
prior to the reaction was kept above pH 10. This initial mixture was connected to 8 m 
long 1/16 in. PTFE tubing, which was coiled inside an oil bath, which gave an effective 
5 minutes residence time from the tee to the exit of the pipe. All reactions were carried 
out at 70 °C and atmospheric pressure. The suspension was collected in a beaker at the 
exit point and then centrifuged at 4500 rpm for 10 minutes. The obtained white 
precipitates were centrifuged and freeze dried as described previously (section 2.3.1.1). 
 
The obtained powder was compacted into cylindrical discs of 13mm diameter and 2 mm 
thickness by using a laboratory hydraulic press at 5 MPa. These samples were used for 
cell viability studies after sterilization in 70 % ethanol for 1 hour.  
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8.2.2 Synthesis of Magnetite 
Magnetite nanoparticles were rapidly synthesised using continuous plastic flow 
synthesis at 70 °C in 5 minutes residence time at the conditions of pH 10. In this process, 
20.2g Iron nitrate and 11.52 g citric acid, were pumped to meet at a ‘‘Tee’’ piece mixer. 
This initial mixture was connected to 8 meter plastic tubing surrounded by heating 
jacket whereupon reaction was completed in 5 minutes, which is the residence time for 
the reaction. The suspension was collected in a beaker at the exit point. The dark brown 
precipitates of magnetite were centrifuged and dried by using freeze drier (as described 
in section 2.3.1.1). 
8.2.2.1 Synthesis of Hydroxyapatite-Magnetite Nanocomposite 
Hydroxyapatite nanoparticles were prepared using a similar method as described in 
section 2.3.1.1. HA-Magnetite composites were made by passing HA and magnetite 
samples through CPFS system. The initial mixture was connected to 8 meter plastic 
tubing surrounded by a heating jacket whereupon reaction was completed in 5 minutes, 
which is the residence time for the reaction. All reactions were carried out at 70 °C and 
atmospheric pressure. The suspension was collected in a beaker at the exit point and 
then centrifuged at 4500 rpm for 10 minutes. The obtained brown precipitates were 
centrifuged and freeze dried as described previously (section 2.3.1.1). 
8.3 Results and Discussions 
8.3.1 Powder X-ray Diffraction 
Figure 8.1 shows the XRD patterns of sample with different compositions of HA-TiO2 
nanocomposites annealed at 600 °C for 1 h. All the samples, irrespective of TiO2 
composition, show well-defined peaks indicating the good crystallinity of these 
samples.  All the diffraction peaks could be readily indexed with the pure hexagonal 
phase, which is in accordance with the bulk HA crystals (JCPDS card # 09-0432).   
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Figure 8-1 X-Ray diffraction analysis of TiO2-HA composites made at 70 °C in 5 
minutes (residence time) at the conditions of pH 10-11using CPFS reactor 
The XRD pattern of HA-Magnetite nanopowder showed good correlation with 
stoichiometric hydroxyapatite (JCPDS 09-0432 card), with a small shifting in angles, 
probably due to increase in magnetite content. The magnetite peaks at   35.43o and 
43.05o  was observed in 25 and 30 mass % magnetite-HA samples as shown in Figure 
8.2. 
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 Figure 8-2 X-Ray diffraction analysis of Magnetite-HA nanocomposites made at 70 
°C in 5 minutes (residence time) at the conditions of pH 10-11using CPFS reactor 
8.3.2 Transmission Electron Microscopy 
Transmission electron microscope images of Titania-HA composite as shown in Figure 
8.3 confirmed the synthesis of small sphere like structures of Titania on the surface of 
HA rods.  
The average length along the longest axis of rod shaped HA particle was ca. 85 ± 15 
nm (200 particles sampled) with the titania particles of ca. 7nm ± 1.5 nm on the surface 
having sphere-like morphology. Transmission electron microscope images of 40 and 60 
mass % HA-TiO2 nanocomposite as shown in Figure 8.3 confirmed the synthesis of 
small sphere like structures of Titania on the surface of HA rods.  
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Figure 8-3 Transmission electron microscope images of pure hydroxyapatite nano-rods 
of sample HA60 (a),(bar = 200 nm), (b), (bar = 20 nm), (c),  (bar = 50 nm) and (d), ( 
bar = 100 nm).  
TEM images of as precipitated magnetite samples with 1 M precursor concentration 
revealed moderate agglomeration. Figure 8.4 revealed the average particle size (total 
particles counted = 250) of 8 nm ±1.8 nm for pure magnetite as shown in Figure 8.4(c) 
while average particle size of 85 nm ± 15 nm was observed by pure HA samples [Figure 
8.4(a) and (b)] made at 70 °C in five minutes residence time via CPFS. In Magnetite-
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HA composite, sphere like magnetite structures on the surface of HA rods has been 
observed as shown in Figure 8.4(d).   
 
 
Figure 8-4 Transmission electron microscope images of pure hydroxyapatite nano-rods 
(a),(bar = 500 nm), (b), (bar = 100 nm), pure magnetite (c),  (bar = 50 nm) and 
magnetite-HA composite with 30 wt% magnetite with the bar scale of ( (d) =50nm 
 
  223 
8.3.2 BET Surface Area Analysis 
BET surface area analysis for the HA-TiO2 composites revealed surface areas in the 
range of 147.6 m2g-1 to 209.1 m2g-1 on increasing the concentration of TiO2 from 5 wt% 
to 60 wt % as shown in Figure 8-5. 
The “as precipitated” amorphous HA-Magnetite samples made at 70°C temperature had 
a surface area range from 121.4 m2g-1 to 142.3 m2g-1 for the samples from 5 wt% to 30 
wt% respectively as shown in Figure 8-6. 
 
Figure 8-5 BET surface area of as precipitated HA-TiO2 nanocomposites made at 70  
°C in 5 minutes residence time via CPFS. The data points from left to right corresponded 
to samples 5wt% HA-TiO2, 10wt% HA-TiO2, 20wt% HA-TiO2, 40wt% HA-TiO2, 
50wt% HA-TiO2, 60wt% HA-TiO2, respectively. 
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Figure 8-6 BET surface area of as precipitated HA-TiO2 nanocomposites made at 70  
°C in 5 minutes residence time via CPFS. The data points from left to right corresponded 
to samples 5wt% HA- Fe3O4, 10wt% HA- Fe3O4, 15wt% HA-Fe3O4, 20wt% HA- Fe3O4, 
25wt% HA- Fe3O4, 30wt% HA- Fe3O4, respectively. 
8.3.3 Zeta Potential Measurements 
Zeta potential measurements were performed in order to investigate the colloidal 
stability related to surface charge of the nanocomposites. The greater the electrostatic 
repulsion, the higher the zeta potential values and therefore higher will be the colloidal 
stability of the suspension.  Zeta potentials of -11.4, -19.6, -22.7 and -23.6 mV were 
obtained for 20, 30, 40 and 50 wt% HA-Titania composites, respectively, which 
indicates the high negative surface charge. The higher surface charge evident from  the 
high zeta potential value, which protects the particle agglomeration resulting in a more 
stable dispersion.  
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8.3.4 X-ray Photoelectron Spectroscopy 
X-ray photoelectron spectroscopy experiments were performed to investigate the 
concentration of the titania in the lattice, their oxidation state and the effect on the 
structure. Generally the survey spectra for all samples exhibited strong peaks for 
titanium, oxygen, phosphorous and calcium as shown in Figure 8-7. The peaks at 134 
eV corresponded to P 2p spectra of hydroxyapatite. While the binding energy values for 
O 1s and Ca 2p were measured as  532  and 347 eV, respectively. 
 
 
Figure 8-7 XPS survey spectrum of of 20HA-TiO2 nanocomposite made via continuous 
plastic flow synthesis in 5 minutes residence time at 70 °C 
The Ca 2p spectrum could be resolved into two peaks for Ca 2p3/2 and 2p1/2 (two spin-
orbit pairs) at 347.4 and 351.3 eV, respectively, which are related to hydroxyapatite. In 
Figure 8-8(b), the 2p peak  can also be deconvoluted into two peaks with a spin orbit 
  226 
splitting for p1/2 and p3/2 levels with binding energies of 134.2 and 133.4 eV, 
respectively. Figure8-8(c), depicts the core level spectrum of O 1s peak, which showed 
that multiple O species were present on the surface. The sub-peak at the binding energy 
of 529.7 eV, could be assigned to O2- in TiO2, whilst the sub-peak at the binding energy 
of 531.5 eV corresponds to the contribution of  surface O-H / adsorbed water in the 
apatite (Mahabole et al., 2005, Lu et al., 2000, Zhang et al., 1998).  
 
 
 
Figure 8-8[a-d] XPS Spectra of Ca 2p,O 1s and P 2p recorded from 20 HA-TiO2 sample 
made at 70 °C in 5 minutes residence time via CPFS 
 
In Figure 8-8(d) the Ti 2p spectrum could be resolved into two spin-orbit pairs 2p3/2 
and 2p1/2 with binding energies of 458.7 and 464.8 eV, respectively, which are 
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characteristic of titanium in TiO2.. The x-ray photoelectron spectroscopy results confirm 
the formation of HA-TiO2 nanocomposite and also indicate that the HA-TiO2 
nanocomposite is stable under reaction conditions. 
Chemical analysis of 20HA-Magnetite was conducted using XPS as shown in Figure 8-
9. The peaks at 134 eV corresponded to P 2p spectra of hydroxyapatite. While the 
binding energy values for O 1s and Ca 2p and Fe 2p were measured as 532 and 347 and 
712 eV, respectively. 
 
Figure 8-9 XPS survey spectrum of of 10wt% HA-Magnetite nanocomposite made via 
continuous plastic flow synthesis in 5 minutes residence time at 70 °C 
8.3.5 Fourier Transform Infrared Spectroscopy 
The saturated peak of TiO2 below 700 cm
-1 is assigned to Ti–O and Ti–O–Ti bonding 
of titania. The small peak at 3600 cm-1 is attributed to stretching of –OH groups in the 
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powder. The peaks at 600, 952, 1033 cm-1 are attributed to PO4
3-. The intensity of –OH– 
absorption peaks at 358 and 627 cm-1 decreases in the nanocomposites with increasing 
titania concentration. The stretching vibration bands of PO4 labeled at 958 and 1031 cm
-
1 are observed in all the samples. The peaks labeled at 569 and 600 cm-1 indicate the 
bending mode of PO4
3-. The peak around 1400 cm-1 is attributed to  CO3
2-. 
 
Figure 8-10 FTIR analysis of HA-TiO2 nanocomposites made at 70 °C in 5 minutes 
residence time via CPFS 
The intensity of –OH– absorption peaks at 358 and 627 cm-1 decreases in the 
nanocomposites with increasing titania concentration. The peaks at 569 and 600 cm-1 
indicate the bending mode PO4
3-. While peak around 1400 cm-1 is observed for CO3
2- as 
shown in Figure 8-11. 
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Figure 8-11 FTIR analysis of magnetite-HA nanocomposites made at 70 °C in 5 minutes 
residence time via CPFS 
8.3.6 Raman Spectroscopy 
Raman spectroscopy was conducted in order to supplement crystallographic data and 
detect substitutions in the apatite lattice. The peak at 965cm-1 corresponded to a 
symmetric stretching mode of the P-O bond in phosphate. Peaks at 610 and 483 cm-1 
are likely corresponded to the bending mode of the O-P-O linkage in phosphate as in 
Figure 8-12.  
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Figure 8-12 Raman Spectra of TiO2-HA nanocomposites made at 70 °C in 5 minutes 
residence time via CPFS 
8.3.7 Cell Viability Study 
Human osteoblast cells (MG63) were cultured on pure HA and HA-TiO2 composite 
disks and cell viability was studied over the course of 7 days as shown in Figure 8-13. 
The pure HA sample was used as a control. The osteoblasts cultivated on all ceramic 
samples showed continuous proliferation. At day 1, cell viability was almost similar on 
pure HA and 20HA-TiO2 disks indicating that initial cell attachment was not enhanced 
by these surfaces, while slightly increased in 10HA-TiO2 and 40HA-TiO2. At day 4, 
cell viability increased on all sample, when compared with day 1. A similar trend was 
observed at day 7, however, all samples had an increased cell viability compared with 
day 1 and 4. At both days 4 and 7, pure HA and 40HA-TiO2 had significantly higher 
cell viability than both 10HA-TiO2 and 20HA-TiO2, while 40HA-TiO2 had significantly 
higher cell viability than pure HA. These results indicate that newly developed CPFS 
HA were biocompatible and supported osteoblast attachment and proliferation.  
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Figure 8-13 MG63 viability on pure HA and HA-TiO2 discs. Cell viability was measured 
at days 1, 4 and 7 via Alamar blue assay for MG63s cultured on pure HA, 10HA-TiO2, 
20HA-TiO2 and 40HA-TiO2 (Mean ± SD, n = 6). * p <0.05.  
8.3.8 Cell Morphology 
MG63 morphology was observed at day 7 (Figure 8-14) on each HA type. The cell 
proliferation results showed that there was a continuous growth of cells on all 
experimental samples. Cells were evenly distributed on pure HA and showed a typical 
square-like osteoblast morphology. MG63s were also evenly spread across the surface 
of the sample and showed an osteoblastic morphology. The cell cytoskeleton also 
appeared more elongated in pure HA sample than composites and the cells appeared to 
form cell-cell bridges. On 10HA-TiO2, cells were more sparce and generally less-well 
spread than those on pure HA, with the majority showing a rounded morphology. 
MG63s on 20HA-TiO2 and 40HA-TiO2 were also generally quite rounded and formed 
clusters. Cell toxicity analyses confirm the  biocompatiblity of this material. 
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Figure 8-14 MG63 morphology on pure HA and HA-TiO2 discs. Cells were visualized 
at day 7 for cell nucleus (DAPI in blue) and cytoskeleton (phalloidin-FITC in green) for 
MG63s cultured on pure HA, 10HA-TiO2, 20HA-TiO2 and 40HA-TiO2. Scale bar is 
100 µm.  
8.4 Conclusions 
In summary, Continuous Plastic Flow Synthesis (CPFS) reactor parameters were 
successful in synthesizing stoichiometric phase pure HA, Ion substituted calcium 
phosphates and nanocomposite materials for biomedical applications. The results have 
proved the versatility and rapidity of this particulate synthesis technology for the 
production of variety of nanobioceramics and other biomaterials. Hence the current 
work deals with the preparation of synthetic calcium phosphates with optimum 
properties closer to those of living hard tissues like bone and teeth, aiming at better and 
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more effective biomedical ceramics for use as powders or as nanocomposites in future 
efforts.  
It was observed cell adhesion on 40HA-TiO2 nanocomposite (highest surface area) was 
substantially greater than the control and low wt% HA-TiO2 nanocomposite. So these 
results indicate that high surface area nanosized HA-TiO2 nanocomposites have 
potential to be used in biomedical applications. 
8.5 Future Work 
It would be desirable to upgrade the CPFS systems to synthesize more quantity of 
aforementioned bioceramics and mixtures. Higher concentrations of calcium and 
phosphate source solutions or increased flow rate can also help to achieve this. 
Importantly, by using a flow system the work is readily scalable and thus has promise 
for scale-up. 
Nano-sized HA composites can improve the sintering kinetics and subsequently 
improve mechanical properties, because of its higher surface area. As a consequence,  
large efforts would be focused on the synthesis of nano-sized, high surface area HA 
nanocomposites in future applications.  
The combination of magnetic nanoparticles with the biocompatible hydroxyapatite 
suggests this composite material has potential to be used as drug delivery in future 
endeavor.  
The novel simplified CPFS reactor system at near ambient reaction conditions (70 °C, 
atmospheric pressure) can be applied in future to synthesize a variety of apatite based 
nanocomposite materials on large scale for various biomedical applications where bone 
regeneration /replacement is required.  
  
  234 
Chapter 9  
                                   Conclusions 
A two-pump CPFS system was found to be suitable for the synthesis of group 2 metal 
phosphates. Different precursor solutions to provide the calcium (calcium nitrate, 
calcium hydroxide) and phosphate sources (diammonium hydrogen phosphate, 
orthophosphoric acid) were used in this synthesis. Both reagent solutions were pumped 
to meet at a T-piece mixer, which further connected to an 8 metre long plastic tubing 
coiled inside an oil bath, allowing the reaction to reach completion. A variety of phase-
pure calcium (CaHA, CDHA, TCP, DCPD), barium and strontium phosphates were 
successfully synthesised using the novel CPFS reactor system at near ambient 
conditions (room temperature to 80 °C, atmospheric pressure). The Ca:P ratio, reaction 
pH and temperature were shown to play an important role in the formation of different 
phase-pure metal phosphates. 
Based on these promising results, the synthesis of variety of biologically beneficial 
cations (Mg2+, Sr2+, Ba2+) were addressed. Careful control of the quantities of the 
reactants used resulted in phase-pure nano-sized HA rods, biphasic mixture of HA and 
pure Mg-whitlockite. Cell toxicity analysis showed excellent biocompatiblity of these 
materials. An increase in magnesium content above 3% led to precipitation of a biphasic 
mixture of magnesium-substituted hydroxyapatite. Strontium- and barium-substituted 
calcium hydroxyapatite had great potential for use in dental nanocomposites because of 
radiopacity properties. It was observed that 100% substitution of strontium for calcium 
in the hydroxyapatite structure has the highest level of radiopacity as compared to 5, 20 
and 50% substitution. Similarly, carbonate and silicate ions (CO3
2-, SiO4
4-) were also 
substituted into calcium phosphates. Carbonate substitution up to ~ 8 wt% was achieved 
successfully. However, high substitution level in silicon was difficult to achieve due to 
the low dissolution rate of silicon acetate. A maximum silicon content of ~ 0.8 wt% was 
attained. 
In addition to ionic substitution, surface modification with different carboxylic 
containing organic agents (polyvinyl alcohol, adipic acid, citric acid, vinylphosphonic 
acid, and methacrylic acid) resulted in the production of nano-sized calcium phosphate 
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crystals which could be readily dispersed and possessed remarkably high surface areas. 
If the surface-functionalised bioceramics are heat-treated, they normally form non-
stoichiometric calcium phosphates depending on the conditions. This is because some 
of the organic acid groups are incorporated, replacing some of the phosphate ions that, 
typically, would have been in the as-prepared material. BET surface areas of the as-
prepared HA samples were 264, 195 and 113 m2g-1. While surface modified VPA-HA 
(vinylphosphonic acid) and MA-HA (methacrylic acid synthesised at the same 
conditions as pure HA possessed surface areas of 254, 247, 210 m2g-1 and 265, 244 and 
221 m2g-1, at reaction temperatures of 60, 70 and 80°C, respectively. This fact is 
attributed to the growth restriction of HA nanoparticles in the presence of surface 
modified agents and the smooth increase in surface area at various selected 
temperatures. These fine, highly dispersed nanoparticles contain reactive groups on 
their surfaces; therefore they have a great range of potential dental / biomedical 
applications. 
Poor radiopacity of dental materials is an issue, since radiopaque dental materials are 
advantageous in making diagnosis and monitoring existing restoration. However, there 
is still a lack of dental material that is tooth coloured, minimally invasive and has 
satisfactory radiopacity. In this study on dental restorative materials containing surface 
grafted CaHA and surface grafted Sr and Ba-HA (no calcium), it was found that Sr-HA 
appeared to be a better radiopaque filler when it was mixed as a composite with a 
polymeric matrix. The in vitro biocompatibility study was also carried out on selected 
metal phosphates made via a novel CPFS. Cell toxicity analyses confirmed the 
biocompatiblity of these materials. The combined cell observations indicate that high 
surface area nanosized materials have the potential to be used for biomedical 
applications where bone regeneration or replacement is required. 
The work presented in this thesis has shown that a wide range of nanomaterials can be 
produced using a CPFS reactor system. The properties of the precipitated nanoproduct 
depended on the temperature, concentration, pH and other precipitation conditions such 
as variation in Ca:P ratio and residence time. It was observed that by tuning the reaction 
parameters, products of any required particle size (ranging from 20-150 nm) and surface 
area (ranging from 95-300 m2g-1) can be produced using a CPFS system. 
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In closing, the CPFS system is a versatile and useful tool for the synthesis of pure, ion-
substituted and surface-grafted group 2 metal phosphates with tailorable properties such 
as composition, particle size, and surface area. With these unique features, the products 
obtained possess a substantially superior high temperature stability (e.g., hydroxyapatite 
stable up to 1200°C can be synthesised because it is stoichiometric with a Ca:P ratio of 
1.67) with remarkably high surface area (up to 264 m2g-1) and small particle size 
(typically 20 nm) compared to that reported in the literature. These high surface area 
materials (i.e., nanoparticles) are novel and have a great range of applications for use in 
replacement of living hard tissues, such as bone and teeth; as bone graft substitutes, 
injectables, coatings on metallic implants, as fillers or additives in commercial products, 
such as toothpastes; materials for the controlled release of drugs or other controlled 
release therapies, reinforcements in biomedical composites, and in bone and dental 
cements.  
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Chapter 10  
                                Future Work 
It has been shown that continuous plastic flow synthesis (CPFS) is a useful technique 
for the production of phase-pure, ion-substituted and surface-functionalised 
hydroxyapatite, and other group 2 metal phosphate nanoparticles produced in this thesis 
for a wide range of applications. The majority of the methods described in literature for 
the production of nanosized HA powders and other nanobioceramics were multi-step, 
inconsistent, energy intensive or time consuming and almost always required very 
careful control over reaction pH during the mixing of two or more reagents. For room 
temperature batch syntheses, failure to permit enough maturation time for the reagents 
gives a non-stoichiometric as-prepared powder, which then phase separates upon heat-
treatment, which can badly affect biological properties in vivo. The key benefits of the 
use of high temperature routes for the continuous production of HA and its variants had 
already been identified and described in the existing literature. We also recognised the 
limitations of the process, namely that the continuous hydrothermal flow synthesis 
process uses high temperatures and pressures to generate bioceramics which are likely 
to be contaminated with metals from the reactors at levels that far exceed those than 
would be acceptable for use in clinical applications. The difficulties associated with 
working at high system pressures limited applications of this process for future work. 
Furthermore, many of the particle sizes obtained in such reactors are not particularly 
small and, indeed, are very similar to those obtained using more conventional synthesis 
methods. Smaller particles would open up and improve many applications, such as a 
more rapid dissolution (due to higher surface area) or use as a hard filler for bone 
replacement. Therefore, there was an aim to produce smaller nano-sized calcium 
phosphates using methods which permit fine control over particle sizes, preferably 
under relatively mild conditions of temperature and pressure, and with a purity 
acceptable for use in a clinical setting, such as for bone replacement. 
This thesis has evaluated many of these aspects and applied the concept of a simple 
continuous plastic flow synthesis (CPFS) reactor to the rapid production (over a period 
of a few minutes) of phase-pure stoichiometric HA at (near) ambient conditions (60-
80°C), and at atmospheric pressure. In this new flow system, aqueous solutions of 
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calcium nitrate tetrahydrate and diammonium hydrogen phosphate were mixed and 
heated for a residence time of five minutes at a pH in the range of 10-11. It was observed 
that particle properties could be altered, e.g, particle size and shape, by varying 
conditions including bath temperature, reaction pH, reaction time in flow and Ca:P ratio 
[ Patent Filed, UK Patent Application No. 1317747.2].   
In the early chapters of this thesis, a variety of phase-pure, high surface area group 2 
metal phosphates were presented using continuous flow reactor followed by ion-
substituted, surface-grafted and composite formation reaction towards the end chapters. 
A large area of the future work, underlined by the work presented in Chapters 7 and 8, 
aimed at the introduction of a surface modified agent and formation of nanocomposites 
materials using different surface-functionalised agents on the particle surface would be 
useful to investigate further. It would be beneficial to study the effect of different 
solvents on particle dispersion and colloidal stability. Similarly, an investigation into 
the large scale synthesis of nanoparticles modified with different chemical agents would 
also be of interest from a commercialisation point of view. 
Furthermore, these high surface area HA products will be utilised to make porous 
scaffolds by freeze casting process through the addition of polyvinyl alcohol (PVA) as 
a binder and emulsifying agent. The purpose of study is to enhance the mechanical 
strength of HA for applications in bone tissue engineering. It would be interesting to 
perform reactions at different reaction pH to obtain different HA morphologies.  
An area of materials chemistry that would be useful to investigate further is the use of 
nanoparticles made by CPFS in porous scaffold and surface coatings for bone tissue 
engineering / replacement applications. As mentioned previously, HA obtained from 
CPFS reactor is phase-pure, thermally stable up to 1200 °C, and has a tremendously 
high surface area, which makes it a suitable candidate for high temperature coatings, 
e.g., spray coating etc., in future applications. 
The combined-cell observations indicate that high surface area nanosized HA rods, 
made via CPFS, were biocompatible and would have the potential to be used for 
biomedical applications where bone regeneration / replacement is required. Future work 
will address the ability of the CPFS nano-HA to support osteogenic differentiation. 
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Importantly, by using a flow system like this, the presented work is readily scalable and 
thus has promise for the large scale production of bioceramics. 
The scale-up of a continuous plastic flow reactor has been recently designed for the 
large scale production of these nanobioceramics (Kg/hr) and will be in use soon. The 
scaled up reactions would be beneficial as there is high demand for these 
nanobioceramics as potential bone substitute materials, especially in countries with high 
rates of accidents or natural disasters. Thus the process has the potential to offer high 
purity HA as medical device for hospitals / orthopaedic surgery and research field. The 
world’s top medical companies [Baxter (UK), Accentus (UK) and Polysciences (USA)] 
and hospitals are in collaboration with this project. By following HA ISO-Standards for 
sterilisation and packaging, further steps can be taken towards the commercialisation of 
this product. 
Additionally, the highly dispersed, high surface area, very small size of calcium 
phosphate bioceramics made via CPFS would open up new horizons in dental / 
biomedical applications such as injectables, coatings on metallic implants, fillers or 
additives in commercial products, such as toothpastes; materials for the controlled 
release of drugs or other controlled release therapies, reinforcements in biomedical 
composites, and in bone and dental cements.  
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